Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
66000,,Not Active,23298079,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '600.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '25.0'}]",CHEMBL4841453,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as reduction in bacterial growth at sub-MIC incubated for 25 days,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL4840338,J Nat Prod,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,3625514,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
66001,,,24350931,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '100.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5032142,"Antibacterial activity against Pseudomonas aeruginosa infected in Balb/c mouse stomach assessed as animal survival at 100 mg/kg, ip after 7 days",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5030557,J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,3772646,=,1,0,=,,Survival,%,,100.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Survival,%,UO_0000187,,100.0
66002,,,24389187,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5040846,Antibacterial activity against Escherichia coli ATCC25922 assessed as reduction in microbial growth after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5038623,Eur J Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3778749,=,1,1,=,,MIC,ug.mL-1,,2.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.5
66003,,,24389205,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5040847,Antibacterial activity against Staphylococcus aureus ATCC 6538 assessed as reduction in microbial growth after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5038623,Eur J Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3778749,=,1,1,=,,MIC,ug.mL-1,,1.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.25
66004,,,24389223,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5040848,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 assessed as reduction in microbial growth after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5038623,Eur J Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3778749,<,1,1,<,,MIC,ug.mL-1,,0.63,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.63
66005,,,24389241,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '12.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '12.0'}]",CHEMBL5040849,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as zone of inhibition incubated for 12 hrs by by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5038623,Eur J Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Millimeter,3778749,=,1,1,=,,IZ,mm,,1.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,1.25
66006,,,24390647,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '10.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5041089,Inhibition of biofilm formation in methicillin-resistant Staphylococcus aureus assessed as decrease in biofilm mass at 10 uM upon exposure to UV light irradiation and measured after 48 hrs by dilution plate coating method,F,,,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5038629,J Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,3778897,=,1,1,=,,Inhibition,%,,19.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,INH,%,UO_0000187,,19.0
66007,,,24390649,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '10.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '5.017', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '301.0'}]",CHEMBL5041091,Inhibition of biofilm formation in methicillin-resistant Staphylococcus aureus assessed as biofilm dispersal effect at 10 uM incubated for 5 hrs followed by exposure to UV light irradiation for 1 min by crystal violet staining based analysis,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5038629,J Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,3778897,=,1,0,=,,Activity,%,,15.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,15.0
66008,,,24664272,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5097919,Antibacterial activity against methicillin-resistant Staphylococcus aureus strains 15 1 to 4 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5096186,J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3843308,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
66009,,,24664310,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5097920,Antibacterial activity against methicillin-sensitive Staphylococcus aureus strains 15 1 to 4 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5096186,J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3843308,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
66010,,,24664348,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5097921,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis strains 15 1 to 4 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5096186,J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3843308,>,1,1,>,,MIC,ug.mL-1,,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,4.0
66011,,,24664386,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5097922,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis strains 15 1 to 4 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5096186,J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3843308,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.125
66012,,,24664424,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5097923,Antibacterial activity against ESBL-producing Escherichia coli ATCC 35218 strains 15 1 to 3 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5096186,J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3843308,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
66013,,,24664462,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5097924,Antibacterial activity against Escherichia coli ATCC 35218 strains 15 1 to 3 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5096186,J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3843308,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
66014,,,24664500,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5097925,Antibacterial activity against multidrug resistant Pseudomonas aeruginosa strains 15 1 to 3 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5096186,J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3843308,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
66015,,,24664567,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5097929,Antibacterial activity against ESBL-producing multidrug resistant Escherichia coli assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5096186,J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3843308,=,1,1,=,,MIC,nM,,8000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,8.0
66016,,,24664586,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5097930,Antibacterial activity against multidrug resistant wild type Escherichia coli ATCC BAA-2340 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5096186,J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3843308,=,1,1,=,,MIC,nM,,4000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,4.0
66017,,,24664605,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5097931,Antibacterial activity against multidrug resistant wild type Escherichia coli NCTC 13353 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5096186,J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3843308,=,1,1,=,,MIC,nM,,32000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,32.0
66018,,,24664624,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5097932,Antibacterial activity against KPC2-producing multidrug resistant Klebsiella pneumoniae assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5096186,J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3843308,>=,1,1,>=,,MIC,nM,,32000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,uM,UO_0000065,,32.0
66019,,,24664643,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5097933,Antibacterial activity agains wild type Klebsiella pneumoniae ATCC BAA-1705 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5096186,J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3843308,=,1,1,=,,MIC,nM,,64000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,uM,UO_0000065,,64.0
66020,,,24664662,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5097934,Antibacterial activity agains wild type Klebsiella pneumoniae ATCC BAA-2470 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5096186,J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3843308,=,1,1,=,,MIC,nM,,16000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,uM,UO_0000065,,16.0
66021,,,24664681,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5097935,Antibacterial activity agains OXA23-producing multidrug resistant Acinetobacter baumannii assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5096186,J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3843308,=,1,1,=,,MIC,nM,,4000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,uM,UO_0000065,,4.0
66022,,,24664700,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5097936,Antibacterial activity against wild type Acinetobacter baumannii NCTC 13304 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5096186,J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3843308,=,1,1,=,,MIC,nM,,4000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,uM,UO_0000065,,4.0
66023,,,24664719,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5097937,Antibacterial activity against IMP4-producing multidrug resistant Pseudomonas aeruginosa assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5096186,J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3843308,=,1,1,=,,MIC,nM,,4000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,4.0
66024,,,24664738,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5097938,Antibacterial activity against wild type Pseudomonas aeruginosa ATCC 27853 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5096186,J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3843308,=,1,1,=,,MIC,nM,,2000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,2.0
66025,,,24755727,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5122557,Antibacterial activity against multidrug resistant Helicobacter pylori G27 assessed as bacterial growth inhibition incubated for 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5120817,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862365,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug ml-1,UO_0000274,,0.25
66026,,,24755748,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5122558,Antibacterial activity against multidrug resistant Helicobacter pylori HP159 assessed as bacterial growth inhibition incubated for 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5120817,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862365,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug ml-1,UO_0000274,,8.0
66027,,,24755769,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5122559,Antibacterial activity against multidrug resistant Helicobacter pylori JRES00015 assessed as bacterial growth inhibition incubated for 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5120817,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862365,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug ml-1,UO_0000274,,16.0
66028,,,24764754,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5124835,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC29213 measured after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5120904,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864115,=,1,1,=,,MIC,ug.mL-1,,0.078,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.078
66029,,,24764765,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5124836,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC33591 measured after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5120904,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864115,=,1,1,=,,MIC,ug.mL-1,,0.078,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.078
66030,,,24764776,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5124837,Antibacterial activity against methicillin-resistant Staphylococcus aureus R6101 measured after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5120904,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864115,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,5.0
66031,,,24764787,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5124838,Antibacterial activity against Staphylococcus epidermidis ATCC12228 measured after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5120904,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864115,=,1,1,=,,MIC,ug.mL-1,,0.16,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.16
66032,,,24764798,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5124839,Antibacterial activity against Bacillus subtilis ATCC6633 measured after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5120904,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864115,<,1,1,<,,MIC,ug.mL-1,,0.078,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.078
66033,,,24764809,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5124840,Antibacterial activity against multidrug-resistant Morganella morganii KL-225 measured after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5120904,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864115,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,5.0
66034,,,24764820,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5124841,Antibacterial activity against beta-lactamase-producing Morganella morganii ATCC25830 measured after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5120904,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864115,<,1,1,<,,MIC,ug.mL-1,,0.078,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.078
66035,,,24833097,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5143414,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5137134,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3878482,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
66036,,,24833107,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5143415,Antibacterial activity against Enterococcus NR 31903 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5137134,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3878482,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC,ug ml-1,UO_0000274,,64.0
66037,,,24833109,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5143416,Antibacterial activity against Klebsiella pneumoniae BAA 1705 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5137134,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3878482,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,64.0
66038,,,24833111,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5143417,Antibacterial activity against Acinetobacter baumannii BAA 1605 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5137134,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3878482,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,8.0
66039,,,24833116,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5143418,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5137134,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3878482,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
66040,,,24833118,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5143419,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5137134,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3878482,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
66041,,,24833125,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5143422,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in bacterial growth incubated for 16 to 18 hrs in presence of PMBN by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5137134,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3878482,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
66042,,,24833129,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5143423,Antibacterial activity against Acinetobacter baumannii BAA 1605 assessed as reduction in bacterial growth incubated for 16 to 18 hrs in presence of PMBN by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5137134,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3878482,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,8.0
66043,,,24833160,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5143450,Antibiofilm activity against Staphylococcus aureus ATCC 29213 assessed as reduction in preformed bacterial biofilm mass at 1 time MIC incubated for 24 hrs by crystal violet staining based microtiter plate reader assay,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5137134,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,3878482,=,1,0,=,,Activity,%,,15.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,15.0
66044,,,24833163,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5143451,Antibacterial activity against Staphylococcus aureus ATCC 29213 infected in mouse J774A.1 cells assessed as reduction in intracellular bacterial cells at 5 times MIC incubated for 24 hrs followed by re-plating on TSA plate and measured after 18 to 24 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5137134,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,3878482,=,1,0,=,,Activity,log10CFU/ml,,0.45,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,log10CFU/ml,,,0.45
66045,,,24833174,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5143461,Synergistic antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as reduction in bacterial growth incubated for 24 hrs in presence of artocarpin by checkerboard method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5137134,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3878482,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
66046,,,24833189,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5143465,Post antibiotic effect against Staphylococcus aureus ATCC 29213 assessed as time required for 1 log10 increase in CFU at 1 time MIC incubated for 1 hr followed by replacement with drug free medium and measured every 1 hr (Rvb = 2 hrs),F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5137134,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,3878482,=,1,1,=,,TIME,hr,,2.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,2.5
66047,,,24833192,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5143466,Post antibiotic effect against Staphylococcus aureus ATCC 29213 assessed as time required for 1 log10 increase in CFU at 10 times MIC incubated for 1 hr followed by replacement with drug free medium and measured every 1 hr (Rvb = 2 hrs),F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5137134,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,3878482,=,1,1,=,,TIME,hr,,3.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,3.5
66048,,,24833195,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5143467,Post antibiotic effect against Staphylococcus aureus ATCC 29213 at 1 time MIC incubated for 1 hr followed by replacement with drug free medium and measured every 1 hr (Rvb = 0 hr),F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5137134,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,3878482,=,1,0,=,,PAE,hr,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,0.5
66049,,,24833198,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5143468,Post antibiotic effect against Staphylococcus aureus ATCC 29213 at 10 times MIC incubated for 1 hr followed by replacement with drug free medium and measured every 1 hr (Rvb = 0 hr),F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5137134,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,3878482,=,1,0,=,,PAE,hr,,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,1.5
66050,,,24833201,[],CHEMBL5143469,Induction of resistance in Staphylococcus aureus ATCC 29213 assessed as increase in MIC treated over 35 serial passages by resistant development assay,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5137134,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3878482,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612545,,Unchecked,,,,MIC,ug ml-1,UO_0000274,,32.0
66051,,,24833221,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5143489,Synergistic antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as fractional inhibitory concentration incubated for 24 hrs in presence of artocarpin by checkerboard method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5137134,J Nat Prod,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,3878482,=,1,0,=,,FIC,,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FIC,,,,1.0
66052,,,24844078,[],CHEMBL5146140,Antibacterial activity against Mycobacterium Acinetobacter baumannii clinical isolate 43 assessed as bacterial growth inhibition by CLSI protocol based assay,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880666,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC90,ug ml-1,UO_0000274,,16.0
66053,,,24844081,[],CHEMBL5146141,Antibacterial activity against Pseudomonas aeruginosa clinical isolate 42 assessed as bacterial growth inhibition by CLSI protocol based assay,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880666,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,32.0
66054,,,24844084,[],CHEMBL5146142,Antibacterial activity against Enterobacter cloacae clinical isolate 41 assessed as bacterial growth inhibition by CLSI protocol based assay,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880666,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC90,ug ml-1,UO_0000274,,32.0
66055,,,24844087,[],CHEMBL5146143,Antibacterial activity against Escherichia coli clinical isolate 42 assessed as bacterial growth inhibition by CLSI protocol based assay,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880666,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,16.0
66056,,,24844090,[],CHEMBL5146144,Antibacterial activity against Klebsiella pneumoniae clinical isolate 42 assessed as bacterial growth inhibition by CLSI protocol based assay,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880666,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,16.0
66057,,,24846048,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5146735,Antibacterial activity against methicillin resistant Staphylococcus aureus 032 assessed as inhibition of bacterial growth incubated for 18 hrs by CLSI based serial agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5143624,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881065,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,6.25
66058,,,24846063,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5146736,"Antibacterial activity against beta-lactams, macrolide and fluoroquinolone resistant Streptococcus pneumoniae 718 assessed as inhibition of bacterial growth incubated for 18 hrs by CLSI based serial agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5143624,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881065,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,12.5
66059,,,24846094,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'PO', 'standard_type': 'Route', 'standard_units': None, 'standard_value': None, 'text_value': 'PO', 'type': 'Route', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5146740,"Antibacterial activity against beta-lactams, macrolide and fluoroquinolone resistant Streptococcus pneumoniae 718 infected in po dosed Swiss mouse septicemia model assessed as protective dose administered on 1 and 5 hrs post infection and measured on day 7",F,,,BAO_0000188,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5143624,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,3881065,>,1,0,>,,EC50,mg kg-1,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,EC50,mg kg-1,UO_0000308,,100.0
66060,,,24852232,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5148042,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by microtiter plate assay,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5143690,Bioorg Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3882412,=,1,1,=,,MIC,ug.mL-1,,0.0078,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.0078
66061,,,24852269,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5148043,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by microtiter plate assay,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5143690,Bioorg Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3882412,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
66062,,,24852306,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5148044,Antibacterial activity against Klebsiella pneumoniae BAA 1705 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by microtiter plate assay,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5143690,Bioorg Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3882412,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,64.0
66063,,,24852343,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5148045,Antibacterial activity against Acinetobacter baumannii BAA 1605 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by microtiter plate assay,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5143690,Bioorg Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3882412,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,8.0
66064,,,24852380,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5148046,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by microtiter plate assay,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5143690,Bioorg Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3882412,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
66065,,,24871663,"[{'comments': None, 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microg/ml', 'standard_value': '256.0', 'text_value': None, 'type': 'Dose', 'units': 'microg/ml', 'value': '256.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '360.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '15.0'}]",CHEMBL5153123,Resistance development in methicillin-resistant Staphylococcus aureus 252 assessed as fold increase in resistance after 15 days serial passage upto 256 ug/ml,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5150045,J Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,3886721,=,1,0,=,,FC,,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FC,,,,64.0
66066,,,24890149,[],CHEMBL5158267,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv measured by MABA assay,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5154717,Eur J Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3890098,=,1,1,=,,MIC,ug.mL-1,,0.33,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.33
66067,,,24890247,[],CHEMBL5158272,Antimycobacterial activity against Mycobacterium tuberculosis 13946 clinical isolate measured by MABA assay,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5154717,Eur J Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3890098,=,1,1,=,,MIC,ug.mL-1,,1.94,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,1.94
66068,,,24890256,[],CHEMBL5158273,Antimycobacterial activity against Mycobacterium tuberculosis 14862 clinical isolate measured by MABA assay,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5154717,Eur J Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3890098,=,1,1,=,,MIC,ug.mL-1,,1.87,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,1.87
66069,,Active,24905879,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '100.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'IP', 'standard_type': 'Route', 'standard_units': None, 'standard_value': None, 'text_value': 'IP', 'type': 'Route', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5161824,"Invivo antibacterial activity against Staphylococcus aureus ATCC 25923 infected in BALB/c mouse model assessed as reduction of bacterial load in spleen at 100 mg/kg, ip administered as single dose measured after 24 hrs by colony counting based analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5154803,J Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,3892529,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
66070,,Active,24905880,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '100.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'IP', 'standard_type': 'Route', 'standard_units': None, 'standard_value': None, 'text_value': 'IP', 'type': 'Route', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5161825,"Invivo antibacterial activity against Staphylococcus aureus ATCC 25923 infected in BALB/c mouse model assessed as reduction of bacterial load in liver at 100 mg/kg, ip administered as single dose measured after 24 hrs by colony counting based analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5154803,J Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,3892529,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
66071,,Active,24905881,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '100.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'IP', 'standard_type': 'Route', 'standard_units': None, 'standard_value': None, 'text_value': 'IP', 'type': 'Route', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5161826,"Invivo antibacterial activity against Staphylococcus aureus ATCC 25923 infected in BALB/c mouse model assessed as reduction of bacterial load in kidney at 100 mg/kg, ip administered as single dose measured after 24 hrs by colony counting based analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5154803,J Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,3892529,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
66072,,,24909964,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5162990,Antibacterial activity against Methicillin resistant Staphylococcus aureus ATCC BAA -1556 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5154823,Eur J Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893127,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
66073,,,24909977,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5162991,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5154823,Eur J Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893127,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
66074,,,24909994,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5162993,Antibacterial activity against imipenem resistant Klebsiella pneumoniae ATCC BAA 1705 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5154823,Eur J Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893127,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,64.0
66075,,,24910007,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5162994,Antibacterial activity against Pseudomonas aeruginosa ATCC 27883 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5154823,Eur J Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893127,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
66076,,,24958680,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5215050,Antiproliferative activity against human A549 cells incubated for 72 hrs by CCK-8 assay,F,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5214883,Eur J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3898598,>,1,1,>,,IC50,nM,,70000.0,CHEMBL392,Homo sapiens,A549,9606.0,,,IC50,uM,UO_0000065,,70.0
66077,,,24958681,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5215051,Antiproliferative activity against human HepG2 cells incubated for 72 hrs by CCK-8 assay,F,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5214883,Eur J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3898598,>,1,1,>,,IC50,nM,,70000.0,CHEMBL395,Homo sapiens,HepG2,9606.0,,,IC50,uM,UO_0000065,,70.0
66078,,,24958682,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5215052,Antiproliferative activity against human MCF7 cells incubated for 72 hrs by CCK-8 assay,F,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5214883,Eur J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3898598,>,1,1,>,,IC50,nM,,70000.0,CHEMBL387,Homo sapiens,MCF7,9606.0,,,IC50,uM,UO_0000065,,70.0
66079,,,24958683,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5215053,Antiproliferative activity against human PC-3 cells incubated for 72 hrs by CCK-8 assay,F,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5214883,Eur J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3898598,>,1,1,>,,IC50,nM,,70000.0,CHEMBL390,Homo sapiens,PC-3,9606.0,,,IC50,uM,UO_0000065,,70.0
66080,,,24958684,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5215054,Antiproliferative activity against human HeLa cells incubated for 72 hrs by CCK-8 assay,F,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5214883,Eur J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3898598,>,1,1,>,,IC50,nM,,70000.0,CHEMBL399,Homo sapiens,HeLa,9606.0,,,IC50,uM,UO_0000065,,70.0
66081,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24958774,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.25', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '15.0'}]",CHEMBL5215087,Inhibition of tubulin polymerization (unknown origin) incubated for 15 mins in presence of GTP by fluorescence-based tubulin polymerization assay kit,B,,,BAO_0000190,BAO_0000223,protein complex format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5214883,Eur J Med Chem,2021.0,"{'bei': '13.69', 'le': '0.26', 'lle': '3.41', 'sei': '6.60'}",CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,4.95,0,http://www.openphacts.org/units/Nanomolar,3898598,=,1,1,=,,IC50,nM,,11270.0,CHEMBL2095182,Homo sapiens,Tubulin,9606.0,,,IC50,uM,UO_0000065,,11.27
66082,,,24976392,[],CHEMBL5224807,Antibacterial activity against methicillin sensitive Staphylococcus epidermidis ATCC 12228,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,,MIC,nM,,690.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,uM,UO_0000065,,0.69
66083,,,24976417,[],CHEMBL5224808,Antibacterial activity against methicillin sensitive Staphylococcus epidermidis 17-13,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,,MIC,nM,,690.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,uM,UO_0000065,,0.69
66084,,,24976442,[],CHEMBL5224809,Antibacterial activity against methicillin resistant Staphylococcus epidermidis 19-1,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,,MIC,nM,,11070.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,uM,UO_0000065,,11.07
66085,,,24976467,[],CHEMBL5224810,Antibacterial activity against methicillin resistant Staphylococcus epidermidis 19-2,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,,MIC,nM,,11070.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,uM,UO_0000065,,11.07
66086,,,24976492,[],CHEMBL5224811,Antibacterial activity against methicillin sensitive Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,,MIC,nM,,690.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,0.69
66087,,,24976517,[],CHEMBL5224812,Antibacterial activity against methicillin sensitive Staphylococcus aureus 15,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,,MIC,nM,,690.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,0.69
66088,,,24976542,[],CHEMBL5224813,Antibacterial activity against methicillin resistant Staphylococcus aureus 20-11,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,,MIC,nM,,1380.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,1.38
66089,,,24976567,[],CHEMBL5224814,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 43300,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,,MIC,nM,,1380.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,1.38
66090,,,24976592,[],CHEMBL5224815,Antibacterial activity against vancomycin intermediate and methicillin resistant Staphylococcus aureus ATCC 700698,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,,MIC,nM,,22140.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,22.14
66091,,,24976617,[],CHEMBL5224816,Antibacterial activity against vancomycin intermediate and methicillin resistant Staphylococcus aureus ATCC 700699,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,,MIC,nM,,22140.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,22.14
66092,,,24976635,[],CHEMBL5224817,Antibacterial activity against methicillin sensitive Staphylococcus aureus 20-12,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,,MIC,nM,,1380.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,1.38
66093,,,24976653,[],CHEMBL5224818,Antibacterial activity against methicillin sensitive Staphylococcus aureus ATCC 33591,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,,MIC,nM,,690.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,0.69
66094,,,24976671,[],CHEMBL5224819,Antibacterial activity against methicillin resistant Staphylococcus aureus 18-2,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,,MIC,nM,,177100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,177.1
66095,,,24976685,[],CHEMBL5224820,Antibacterial activity against Vanomycin-resistant Enterococcus faecalis ATCC 51299,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,,MIC,nM,,1380.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,uM,UO_0000065,,1.38
66096,,,24976699,[],CHEMBL5224821,Antibacterial activity against Vanomycin-resistant Enterococcus faecalis ATCC 51575,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,,MIC,nM,,2770.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,uM,UO_0000065,,2.77
66097,,,24976713,[],CHEMBL5224822,Antibacterial activity against Vanomycin-resistant Enterococcus faecium ATCC 700221,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,,MIC,nM,,177100.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,uM,UO_0000065,,177.1
66098,,,24976727,[],CHEMBL5224823,Antibacterial activity against Vanomycin-resistant Enterococcus faecium ATCC 51559,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,,MIC,nM,,88550.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,uM,UO_0000065,,88.55
66099,,,24976741,[],CHEMBL5224824,Antibacterial activity against Vanomycin-resistant Enterococcus faecium 15-6,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,,MIC,nM,,177100.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,uM,UO_0000065,,177.1
66100,,,24983353,[],CHEMBL5226740,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5226286,Eur J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905373,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
66101,,,24983357,[],CHEMBL5226741,Antibacterial activity against Pseudomonas aeruginosa No.010,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5226286,Eur J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905373,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
66102,,,24983361,[],CHEMBL5226742,Antibacterial activity against multidrug resistant Pseudomonas aeruginosa 025,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5226286,Eur J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905373,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
66103,,,24983365,[],CHEMBL5226743,Antibacterial activity against multidrug resistant Pseudomonas aeruginosa 034,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5226286,Eur J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905373,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
66104,,,24996143,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5231788,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth incubated for 24 hrs by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5230129,Eur J Med Chem,2020.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3909493,=,1,1,=,,MIC,ug.mL-1,,3.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,3.12
66105,,,25000635,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '2.0'}]",CHEMBL5232888,Antibacterial activity against Mycobacterium smegmatis ATCC 607 assessed as inhibition of bacterial growth incubated for 2 days by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5230166,RSC Med Chem,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911004,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,0.125
66106,,,25000664,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '2.0'}]",CHEMBL5232889,Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as inhibition of bacterial growth incubated for 2 days by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5230166,RSC Med Chem,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911004,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,2.0
66107,,,25000693,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '2.0'}]",CHEMBL5232890,Antibacterial activity multi-drug resistant Mycobacterium tuberculosis H37Rv ATCC 35822 assessed as inhibition of bacterial growth incubated for 2 days by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5230166,RSC Med Chem,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911004,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,4.0
66108,,,25019290,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5239023,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 incubated for 24 hrs by checkerboard assay,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5236607,J Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3916301,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
66109,,,25019301,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5239024,Antibacterial activity against Pseudomonas aeruginosa ATCC 27883 incubated for 24 hrs by checkerboard assay,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5236607,J Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3916301,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
66110,,,25019312,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5239025,Antibacterial activity against Escherichia coli ATCC 25922 incubated for 24 hrs by checkerboard assay,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5236607,J Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3916301,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
66111,,,25019323,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5239026,Antibacterial activity against Klebsiella pneumoniae ATCC BAA-1705 incubated for 24 hrs by checkerboard assay,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5236607,J Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3916301,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,64.0
66112,,,25029984,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5241345,Antimicrobial activity against Methicillin sensitive Staphylococcus aureus assessed as bacterial growth inhibition incubated for 18 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5241058,Eur J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3918735,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
66113,,,25032864,[],CHEMBL5242341,Antibacterial activity against quinolone susceptible Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919819,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.015
66114,,,25032868,[],CHEMBL5242342,Antibacterial activity against quinolone susceptible Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919819,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
66115,,,25032871,[],CHEMBL5242343,Antibacterial activity against quinolone resistant Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919819,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
66116,,,25032874,[],CHEMBL5242344,Antibacterial activity against quinolone resistant Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919819,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
66117,,,25032878,[],CHEMBL5242345,Antibacterial activity against quinolone resistant Acinetobacter baumannii,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919819,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,4.0
66118,,,25032957,[],CHEMBL5242368,Antibacterial activity against Clostridioides difficile,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919819,=,1,1,=,,MIC50,ug.mL-1,,128.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC50,ug ml-1,UO_0000274,,128.0
66119,,,25032958,[],CHEMBL5242368,Antibacterial activity against Clostridioides difficile,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919819,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC90,ug ml-1,UO_0000274,,128.0
66120,,,25035602,[],CHEMBL5243164,Antimicrobial activity against Escherichia coli assessed as diameter of inhibition zone by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5241112,RSC Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Millimeter,3920774,=,1,1,=,,IZ,mm,,29.35,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,29.35
66121,,,25035604,[],CHEMBL5243165,Antimicrobial activity against Bacillus subtilis assessed as diameter of inhibition zone by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5241112,RSC Med Chem,2022.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Millimeter,3920774,=,1,1,=,,IZ,mm,,26.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,DIZ,mm,UO_0000016,,26.0
66122,,,25040083,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5244529,Antimalarial activity against hepatic stage Plasmodium yoelii yoelii 265 BY for 48 hrs with media renew every 24 hrs,F,,,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922442,>,1,1,>,,IC50,ug.mL-1,,100.0,CHEMBL612328,Plasmodium yoelii yoelii,Plasmodium yoelii yoelii,73239.0,,,IC50,ug ml-1,UO_0000274,,100.0
66123,,,25040108,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '96.0'}]",CHEMBL5244530,Antimalarial activity against blood stage chloroquine-sensitive Plasmodium falciparum NF54-R infected in erythrocytes assessed as reduction in parasite growth preincubated for 72 hrs followed by addition of [3H]Hypoxanthine and measured after 24 hrs by liquid scintillation counting method,F,,,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922442,=,1,1,=,,IC50,ug.mL-1,,40.3,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,ug ml-1,UO_0000274,,40.3
66124,,,25040134,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '96.0'}]",CHEMBL5244531,Antimalarial activity against blood stage chloroquine-sensitive Plasmodium falciparum 3D7 infected in erythrocytes assessed as reduction in parasite growth preincubated for 72 hrs followed by addition of [3H]Hypoxanthine and measured after 24 hrs by liquid scintillation counting method,F,,,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922442,=,1,1,=,,IC50,ug.mL-1,,111.6,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,ug ml-1,UO_0000274,,111.6
66125,,,25040205,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5244554,Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human erythrocyte incubated for 72 hrs by SYBR green I staining based fluorescence assay,F,,,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3922442,>,1,1,>,,IC50,nM,,20000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,nM,UO_0000065,,20000.0
66126,,,25040701,[],CHEMBL5244788,Antimicrobial activity against methicillin-resistant Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5244218,Eur J Med Chem,2018.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922835,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
66127,,,25040712,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5244791,Antimicrobial activity against methicillin-resistant Staphylococcus aureus incubated for 18 hrs by Alamar blue staining based analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5244218,Eur J Med Chem,2018.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922835,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
66128,,,25040748,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5244793,Antimicrobial activity against methicillin-resistant Staphylococcus aureus incubated for 18 hrs by Agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5244218,Eur J Med Chem,2018.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922835,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
66129,,,25040775,[],CHEMBL5244797,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolates by two fold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5244218,Eur J Med Chem,2018.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922835,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.56
66130,,,25040865,[],CHEMBL5244812,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolates by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5244218,Eur J Med Chem,2018.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922835,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
66131,,,25041136,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5244855,Antibacterial activity against Escherichia coli 2010-05 assessed as bacterial growth inhibition measured after 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922898,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
66132,,,25041146,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5244856,Antibacterial activity against Escherichia coli 2010-29 assessed as bacterial growth inhibition measured after 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922898,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
66133,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25041153,[],CHEMBL5244860,Inhibition of Escherichia coli DNA gyrase,B,,,BAO_0000190,BAO_0000223,protein complex format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922898,=,1,1,=,,IC50,ug.mL-1,,3.2,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,ug ml-1,UO_0000274,,3.2
66134,,,25041321,[],CHEMBL5244893,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922898,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,4.0
66135,,,25041325,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5244894,Antibacterial activity against clinical isolate Escherichia coli assessed as bacterial growth inhibition incubated for 24 hrs by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922898,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,32.0
66136,,,25049782,[],CHEMBL5246946,Antibacterial activity against methicillin susceptible Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5244273,J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925677,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
66137,,,25049784,[],CHEMBL5246947,Antibacterial activity against ESBL negative Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5244273,J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925677,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
66138,,,25049786,[],CHEMBL5246948,Antibacterial activity against Staphylococcus epidermidis,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5244273,J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925677,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
66139,,,25049788,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '336.0', 'text_value': None, 'type': 'TIME', 'units': 'weeks', 'value': '2.0'}]",CHEMBL5246949,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 2 weeks,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5244273,J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925677,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
66140,,,25049811,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '504.0', 'text_value': None, 'type': 'TIME', 'units': 'weeks', 'value': '3.0'}]",CHEMBL5246950,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 3 weeks,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5244273,J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925677,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
66141,,,25049834,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '672.0', 'text_value': None, 'type': 'TIME', 'units': 'weeks', 'value': '4.0'}]",CHEMBL5246951,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 4 weeks,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5244273,J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925677,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
66142,,,25049857,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '840.0', 'text_value': None, 'type': 'TIME', 'units': 'weeks', 'value': '5.0'}]",CHEMBL5246952,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 5 weeks,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5244273,J Med Chem,2021.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925677,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
66143,,,25065675,[],CHEMBL5251416,Antibacterial activity against multi-drug resistant Acinetobacter baumannii assessed as bacterial growth inhibition by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5247650,J Med Chem,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3928733,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,16.0
66144,,,25065681,[],CHEMBL5251417,Antibacterial activity against non multi-drug resistant Acinetobacter baumannii assessed as bacterial growth inhibition by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5247650,J Med Chem,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3928733,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,16.0
66145,,,25065696,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'microg/ml', 'standard_value': '32.0', 'text_value': None, 'type': 'DOSE', 'units': 'microg/ml', 'value': '32.0'}]",CHEMBL5251425,Antibacterial activity against clinical isolate Acinetobacter baumannii assessed as bacterial growth inhibition at 32 ug/ml by CLSI based broth microdilution method relative to control,F,,,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5247650,J Med Chem,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,3928733,=,1,1,=,,Inhibition,%,,100.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,INH,%,UO_0000187,,100.0
66146,,,25072318,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5253313,Antibacterial activity against wild type Staphylococcus aureus incubated for 20 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5252521,Bioorg Med Chem,2016.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3929953,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
66147,,,25072323,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5253315,Antibacterial activity against methicillin-resistant Staphylococcus aureus incubated for 20 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5252521,Bioorg Med Chem,2016.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3929953,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
66148,,,25072326,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5253316,Antibacterial activity against wild type Streptococcus pneumoniae incubated for 20 hrs in presence of 2.5% lysed horse blood by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5252521,Bioorg Med Chem,2016.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3929953,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
66149,,,25072329,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5253317,Antibacterial activity against vancomycin-resistant Enterococcus faecium incubated for 20 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5252521,Bioorg Med Chem,2016.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3929953,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,4.0
66150,,,25072334,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5253320,Antibacterial activity against wild type Moraxella catarrhalis incubated for 20 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5252521,Bioorg Med Chem,2016.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3929953,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,1.0
66151,,,25072337,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5253321,Antibacterial activity against wild type Haemophilus influenzae incubated for 20 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5252521,Bioorg Med Chem,2016.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3929953,<,1,1,<,,MIC,ug.mL-1,,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.015
66152,,,25072340,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5253322,Antibacterial activity against wild type Escherichia coli incubated for 20 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5252521,Bioorg Med Chem,2016.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3929953,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.031
66153,,,25072343,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5253323,Antibacterial activity against wild type Pseudomonas aeruginosa incubated for 20 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5252521,Bioorg Med Chem,2016.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3929953,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
66154,,,25072346,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5253324,Antibacterial activity against wild type Acinetobacter baumannii incubated for 20 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5252521,Bioorg Med Chem,2016.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3929953,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.125
66155,,,25103808,[],CHEMBL5262789,Antimycobacterial activity against Mycobacterium tuberculosis Rv0005 harbouring gyrB gene,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5260811,Eur J Med Chem,2017.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3936459,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.5
66156,,,25103813,[],CHEMBL5262790,Antimycobacterial activity against Mycobacterium tuberculosis Rv0006 harbouring gyrA gene,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5260811,Eur J Med Chem,2017.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3936459,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.5
66157,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25118657,[],CHEMBL5291828,"Compound was evaluated for inhibition of human KCNH2 in an in vitro assay with cellular components measured by membrane filtration, radioactivity method",F,,,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,=,1,1,=,,AC50,nM,,739997.1,CHEMBL240,Homo sapiens,HERG,9606.0,,,AC50,uM,UO_0000065,,739.9971
66158,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25120019,[],CHEMBL5291755,Compound was evaluated for inhibition of rat Cacna1c in an in vitro assay with cellular components measured by membrane filtration,F,,,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL3762,Rattus norvegicus,Voltage-gated L-type calcium channel alpha-1C subunit,10116.0,,,AC50,uM,UO_0000065,,10.0
66159,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25121120,[],CHEMBL5291805,Binding affinity towards rat Grin1 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL330,Rattus norvegicus,Glutamate (NMDA) receptor subunit zeta 1,10116.0,,,AC50,uM,UO_0000065,,10.0
66160,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25122313,[],CHEMBL5291740,Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method,F,,,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL213,Homo sapiens,Beta-1 adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
66161,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25123314,[],CHEMBL5291742,Binding affinity towards human ADRB2 in an in vitro assay with cellular components measured by radioactivity method,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL210,Homo sapiens,Beta-2 adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
66162,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25124498,[],CHEMBL5291890,Binding affinity towards human SLC6A3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
66163,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25126624,[],CHEMBL5291770,Binding affinity towards human CHRNA4 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1882,Homo sapiens,Neuronal acetylcholine receptor protein alpha-4 subunit,9606.0,,,AC50,uM,UO_0000065,,10.0
66164,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25128521,[],CHEMBL5291798,Binding affinity towards rat Gabra1 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,,AC50,uM,UO_0000065,,10.0
66165,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25129936,[],CHEMBL5291853,"Binding affinity towards human OPRK1 in an in vitro assay with cellular components measured by membrane filtration, scintillation proximity assay",B,,,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL237,Homo sapiens,Kappa opioid receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
66166,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25131136,[],CHEMBL5291801,Compound was evaluated for inhibition of rat Gabra1 in an in vitro assay with cellular components measured by membrane filtration,F,,,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,,AC50,uM,UO_0000065,,10.0
66167,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25132344,[],CHEMBL5291823,Binding affinity towards human HTR2C in an in vitro assay with cellular components measured by radioactivity method,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL225,Homo sapiens,Serotonin 2c (5-HT2c) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
66168,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25133535,[],CHEMBL5291724,Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL226,Homo sapiens,Adenosine A1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
66169,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25134757,[],CHEMBL5291727,Binding affinity towards human ADORA3 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
66170,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25136020,[],CHEMBL5291763,Compound was evaluated for inhibition of human CHRM1 in an in vitro assay with cellular components measured by scintillation proximity assay,F,,,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,AC50,uM,UO_0000065,,10.0
66171,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25137224,[],CHEMBL5291767,Binding affinity towards human CHRM3 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,300000.0,CHEMBL245,Homo sapiens,Muscarinic acetylcholine receptor M3,9606.0,,,AC50,uM,UO_0000065,,300.0
66172,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25138236,[],CHEMBL5291732,Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
66173,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25140891,[],CHEMBL5291781,"Binding affinity towards human DRD2 in an in vitro assay with cellular components measured by membrane filtration, scintillation proximity assay",B,,,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
66174,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25142039,[],CHEMBL5291880,Binding affinity towards human SLC29A1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1997,Homo sapiens,Equilibrative nucleoside transporter 1,9606.0,,,AC50,uM,UO_0000065,,30.0
66175,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25144245,[],CHEMBL5291737,Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1942,Homo sapiens,Alpha-2b adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
66176,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25145542,[],CHEMBL5291891,Binding affinity towards human SLC6A2 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
66177,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25148439,[],CHEMBL5291738,Compound was evaluated for inhibition of human ADRA2C in an in vitro assay with cellular components measured by membrane filtration,F,,,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1916,Homo sapiens,Alpha-2c adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
66178,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25149667,[],CHEMBL5291824,"Compound was evaluated for inhibition of human HTR3A in an in vitro assay with cellular components measured by membrane filtration, radioactivity method",F,,,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1899,Homo sapiens,Serotonin 3a (5-HT3a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
66179,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25150871,[],CHEMBL5291892,Binding affinity towards human SLC6A4 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL228,Homo sapiens,Serotonin transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
66180,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25153019,[],CHEMBL5291726,Binding affinity towards human ADORA2A in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL251,Homo sapiens,Adenosine A2a receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
66181,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25154616,[],CHEMBL5291852,Binding affinity towards human OPRD1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,300000.0,CHEMBL236,Homo sapiens,Delta opioid receptor,9606.0,,,AC50,uM,UO_0000065,,300.0
66182,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25155677,[],CHEMBL5291889,Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2069,Homo sapiens,Thromboxane A2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
66183,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25157782,[],CHEMBL5291894,Binding affinity towards human OPRM1 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
66184,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25160229,[],CHEMBL5291895,Compound was evaluated for inhibition of human MAOA in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,AC50,uM,UO_0000065,,10.0
66185,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25162645,[],CHEMBL5291750,Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1889,Homo sapiens,Vasopressin V1a receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
66186,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25163760,[],CHEMBL5291751,Binding affinity towards human AVPR2 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1790,Homo sapiens,Vasopressin V2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
66187,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25166718,[],CHEMBL5291870,Compound was evaluated for inhibition of human PTGS2 in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,300000.0,CHEMBL230,Homo sapiens,Cyclooxygenase-2,9606.0,,,AC50,uM,UO_0000065,,300.0
66188,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25167776,[],CHEMBL5291791,Binding affinity towards human ESR1 in an in vitro cell free assay (NIBR assay) measured by fluorescence polarization method,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,AC50,uM,UO_0000065,,30.0
66189,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25169846,[],CHEMBL5291810,Agonist activity at human HRH2 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1941,Homo sapiens,Histamine H2 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
66190,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25170949,[],CHEMBL5291753,Binding affinity towards human BDKRB2 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL3157,Homo sapiens,Bradykinin B2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
66191,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25171829,[],CHEMBL5291758,Binding affinity towards human CCKBR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL298,Homo sapiens,Cholecystokinin B receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
66192,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25173283,[],CHEMBL5291803,Binding affinity towards human GHSR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4616,Homo sapiens,Ghrelin receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
66193,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25173794,[],CHEMBL5291818,Binding affinity towards human HTR2A in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
66194,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25174934,[],CHEMBL5291868,Compound was evaluated for inhibition of rat Ptgs1 in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4042,Rattus norvegicus,Cyclooxygenase-1,10116.0,,,AC50,uM,UO_0000065,,30.0
66195,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25176341,[],CHEMBL5291850,"Binding affinity towards human NR3C1 in an in vitro cell free assay measured by filtration, radioactivity method",B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2034,Homo sapiens,Glucocorticoid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
66196,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25177520,[],CHEMBL5291744,Binding affinity towards human AGTR1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL227,Homo sapiens,Type-1 angiotensin II receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
66197,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25178734,[],CHEMBL5291757,Binding affinity towards human CCKAR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1901,Homo sapiens,Cholecystokinin A receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
66198,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25179596,[],CHEMBL5291785,Binding affinity towards human EDNRA in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,300000.0,CHEMBL252,Homo sapiens,Endothelin receptor ET-A,9606.0,,,AC50,uM,UO_0000065,,300.0
66199,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25181060,[],CHEMBL5291777,Agonist activity at human DRD1 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
66200,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25181920,[],CHEMBL5291773,Binding affinity towards human CNR1 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
66201,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25183944,[],CHEMBL5291831,Binding affinity towards human MC3R in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4644,Homo sapiens,Melanocortin receptor 3,9606.0,,,AC50,uM,UO_0000065,,30.0
66202,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25184712,[],CHEMBL5291832,Binding affinity towards human MC4R in an in vitro assay with cellular components measured by scintillation proximity assay in vitro assay with cellular components,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL259,Homo sapiens,Melanocortin receptor 4,9606.0,,,AC50,uM,UO_0000065,,30.0
66203,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25185889,[],CHEMBL5291858,Compound was evaluated for inhibition of human PDE4D in an in vitro cell free assay measured by scintillation proximity assay,F,,,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL288,Homo sapiens,Phosphodiesterase 4D,9606.0,,,AC50,uM,UO_0000065,,30.0
66204,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25187017,[],CHEMBL5291834,Binding affinity towards human NPY1R in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4777,Homo sapiens,Neuropeptide Y receptor type 1,9606.0,,,AC50,uM,UO_0000065,,30.0
66205,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25187745,[],CHEMBL5291748,Binding affinity towards rat Ar in an in vitro cell free assay measured by fluorescence polarization method,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,,AC50,uM,UO_0000065,,30.0
66206,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25188568,[],CHEMBL5291846,Binding affinity towards human NR1I2 in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL3401,Homo sapiens,Pregnane X receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
66207,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25189712,[],CHEMBL5291833,Binding affinity towards human MLNR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL2203,Homo sapiens,Motilin receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
66208,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25191254,[],CHEMBL5291898,Compound was evaluated for inhibition of human PDE3A in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL241,Homo sapiens,Phosphodiesterase 3A,9606.0,,,AC50,uM,UO_0000065,,30.0
66209,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25192955,[],CHEMBL5291862,Binding affinity towards human PGR in an in vitro cell free assay measured by fluorescence polarization method in vitro cell free assay,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL208,Homo sapiens,Progesterone receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
66210,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25194075,[],CHEMBL5291899,Binding affinity towards human DRD3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
66211,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25201028,[],CHEMBL5291921,Binding affinity towards human HRH3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL264,Homo sapiens,Histamine H3 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
66212,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25210784,[],CHEMBL5291920,Antagonist activity human CHRM1 in an in vitro cell-based assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,=,1,1,=,,AC50,nM,,140000.6,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,AC50,uM,UO_0000065,,140.0006
66213,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25211969,[],CHEMBL5291760,Agonist activity at human CHRM1 in an in vitro cell-based assay (NIBR assay) measured by Hamamatsu Functional Drug Screening System,F,,,BAO_0000186,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,300000.0,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,AC50,uM,UO_0000065,,300.0
66214,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25213072,[],CHEMBL5291809,Binding affinity towards human HRH1 in an in vitro assay measured by filtration,B,,,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL231,Homo sapiens,Histamine H1 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
66215,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25214270,[],CHEMBL5291765,Antagonist activity at human CHRM2 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,AC50,uM,UO_0000065,,10.0
66216,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25215478,[],CHEMBL5291764,Agonist activity at human CHRM2 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,AC50,uM,UO_0000065,,10.0
66217,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25216403,[],CHEMBL5291814,Antagonist activity at human HTR1A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL214,Homo sapiens,Serotonin 1a (5-HT1a) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
66218,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25217551,[],CHEMBL5291813,Agonist activity at human HTR1A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL214,Homo sapiens,Serotonin 1a (5-HT1a) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
66219,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25218467,[],CHEMBL5291901,Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
66220,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25220421,[],CHEMBL5291735,Antagonist activity at human ADRA2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
66221,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25221625,[],CHEMBL5291734,Agonist activity at human ADRA2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
66222,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25225678,[],CHEMBL5291817,Antagonist activity at human HTR2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
66223,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25226868,[],CHEMBL5291816,Agonist activity at human HTR2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
66224,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25228049,[],CHEMBL5291821,Antagonist activity at human HTR2B in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
66225,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25229252,[],CHEMBL5291819,Agonist activity at human HTR2B in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
66226,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25230247,[],CHEMBL5291729,Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
66227,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25231131,[],CHEMBL5291772,Antagonist activity at human CNR1 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
66228,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25232030,[],CHEMBL5291771,Agonist activity at human CNR1 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
66229,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25233859,[],CHEMBL5291741,Agonist activity at human ADRB2 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL210,Homo sapiens,Beta-2 adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
66230,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25234203,[],CHEMBL5291796,Agonist activity at human GABRA1 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL5303741,Homo sapiens,Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2,9606.0,,,AC50,uM,UO_0000065,,30.0
66231,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25234502,[],CHEMBL5291797,Antagonist activity at human GABRA1 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,,AC50,nM,,30000.0,CHEMBL5303741,Homo sapiens,Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2,9606.0,,,AC50,uM,UO_0000065,,30.0
66232,,,78732,[],CHEMBL752926,Compound was tested for its binding affinity against nicotinic acetylcholine receptor by spectrometry assay,B,,,BAO_0000179,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1128936,Bioorg Med Chem Lett,1996.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Micromolar,175396,=,1,0,=,,Kd1,uM,,0.84,CHEMBL3916,Torpedo californica,Acetylcholine receptor protein delta chain,7787.0,,,Kd1,uM,UO_0000064,,0.84
66233,,,78733,[],CHEMBL752924,Compound was tested for its binding affinity against nicotinic acetylcholine receptor by spectrometry assay,B,,,BAO_0000033,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1128936,Bioorg Med Chem Lett,1996.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Micromolar,175396,=,1,0,=,,Bmax,uM,,2.14,CHEMBL3916,Torpedo californica,Acetylcholine receptor protein delta chain,7787.0,,,Bmax,uM,UO_0000064,,2.14
66234,,,78734,[],CHEMBL753095,Compound was tested for its binding affinity against nicotinic acetylcholine receptor by spectrometry assay,B,,,BAO_0000179,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1128936,Bioorg Med Chem Lett,1996.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Micromolar,175396,=,1,0,=,,Kd2,uM,,27.0,CHEMBL3916,Torpedo californica,Acetylcholine receptor protein delta chain,7787.0,,,Kd2,uM,UO_0000064,,27.0
66235,,,78735,[],CHEMBL752923,Compound was tested for its binding affinity against nicotinic acetylcholine receptor by fluorimetry assay,B,,,BAO_0000033,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1128936,Bioorg Med Chem Lett,1996.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Micromolar,175396,=,1,0,=,,Bmax,uM,,0.31,CHEMBL3916,Torpedo californica,Acetylcholine receptor protein delta chain,7787.0,,,Bmax,uM,UO_0000064,,0.31
66236,,,78736,[],CHEMBL752925,Compound was tested for its binding affinity against nicotinic acetylcholine receptor by fluorimetry assay,B,,,BAO_0000179,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1128936,Bioorg Med Chem Lett,1996.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Micromolar,175396,=,1,0,=,,Kd1,uM,,0.77,CHEMBL3916,Torpedo californica,Acetylcholine receptor protein delta chain,7787.0,,,Kd1,uM,UO_0000064,,0.77
66237,,,78737,[],CHEMBL753095,Compound was tested for its binding affinity against nicotinic acetylcholine receptor by spectrometry assay,B,,,BAO_0000179,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1128936,Bioorg Med Chem Lett,1996.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Micromolar,175396,=,1,0,=,,Kd2,uM,,34.0,CHEMBL3916,Torpedo californica,Acetylcholine receptor protein delta chain,7787.0,,,Kd2,uM,UO_0000064,,34.0
66238,,,383854,[],CHEMBL762013,In vitro inhibition of multidrug-resistant Plasmodium falciparum K1,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1152011,Bioorg Med Chem Lett,1994.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,73316,=,1,1,=,,IC50,ug.mL-1,,0.36,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,ug ml-1,UO_0000274,,0.36
66239,,,1251234,[],CHEMBL754059,In vitro antimalarial activity against Plasmodium falciparum D6,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1124122,J Med Chem,1988.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,9629,=,1,1,=,,IC50,ug.mL-1,,0.141,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,ng ml-1,UO_0000274,,141.0
66240,,,1251235,[],CHEMBL753350,In vitro antimalarial activity against Plasmodium falciparum W2,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1124122,J Med Chem,1988.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,9629,=,1,1,=,,IC50,ug.mL-1,,0.148,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,ng ml-1,UO_0000274,,148.0
66241,,,1251236,[],CHEMBL740591,In vivo Mean survival time of Plasmodium berghei parasitized mice dosed at 40 mg/kg,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1124122,J Med Chem,1988.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Day,9629,=,1,0,=,,T-C,day,,0.6,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,T-C,day,UO_0000033,,0.6
66242,,,1251237,[],CHEMBL740588,In vivo Mean survival time of Plasmodium berghei parasitized mice dosed at 160 mg/kg,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1124122,J Med Chem,1988.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Day,9629,=,1,0,=,,T-C,day,,1.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,T-C,day,UO_0000033,,1.0
66243,,Toxic,1251238,[],CHEMBL740595,In vivo Mean survival time of Plasmodium berghei parasitized mice dosed at 640 mg/kg; Toxic,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1124122,J Med Chem,1988.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,9629,,1,0,,,T-C,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,T-C,day,,,
66244,,,1472948,[],CHEMBL835973,Ratio of maximum concentration bound and specificity sum for triplex nucleic acids,B,,,BAO_0000179,BAO_0000225,nucleic acid format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1137982,J Med Chem,2004.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Micromolar,381032,=,1,0,=,,Cmax/SS,uM,,3.55,CHEMBL345,,Nucleic Acid,,,,Cmax/SS,uM,UO_0000064,,3.55
66245,,,1505879,[],CHEMBL826164,In vitro association constant for binding at d(AAGAATTCTT)2 done in 50 mM Tris-HCL in pH 6.35 at room temperature,B,,,BAO_0002809,BAO_0000225,nucleic acid format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1139560,Bioorg Med Chem Lett,2005.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,392417,=,1,0,=,,Ka,,,12400.0,CHEMBL345,,Nucleic Acid,,,,Ka,,,,12400.0
66246,,,1506046,[],CHEMBL827442,In vitro relative affinity for binding to d(AAGAATTCTT)2,B,,,BAO_0000179,BAO_0000225,nucleic acid format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1139560,Bioorg Med Chem Lett,2005.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,392417,=,1,0,=,,RA,,,1.0,CHEMBL345,,Nucleic Acid,,,,RA,,,,1.0
66247,,,1506305,[],CHEMBL826165,In vitro association constant for binding at d(TA AGAATTCTTA)2 done in 50 mM Tris-HCL in pH 6.35 at room temperature,B,,,BAO_0002809,BAO_0000225,nucleic acid format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1139560,Bioorg Med Chem Lett,2005.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,392417,=,1,0,=,,Ka,,,29300.0,CHEMBL345,,Nucleic Acid,,,,Ka,,,,29300.0
66248,,,1506306,[],CHEMBL828303,In vitro relative affinity for binding to d(TA AGAATTCTTA)2,B,,,BAO_0000179,BAO_0000225,nucleic acid format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1139560,Bioorg Med Chem Lett,2005.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,392417,=,1,0,=,,RA,,,1.0,CHEMBL345,,Nucleic Acid,,,,RA,,,,1.0
66249,,,1692676,[],CHEMBL868372,Reduction of blood glucose level in alloxan induced diabetic mice at 200 mg/kg,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1139034,Bioorg Med Chem Lett,2006.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MilligramPerDeciliter,440358,=,1,0,=,,Activity,mg/dl,,61.0,CHEMBL2071,Homo sapiens,Sulfonylurea receptor 1,9606.0,,,Activity,mg/dl,,,61.0
66250,,,1692684,[],CHEMBL868373,Antibacterial activity against Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1139034,Bioorg Med Chem Lett,2006.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,440358,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,5.0
66251,,Active,1692705,[],CHEMBL868377,Binding affinity to sulfonylurea receptor in pancreatic islet beta cell membranes,B,,,BAO_0000375,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1139034,Bioorg Med Chem Lett,2006.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,440358,,1,0,,,Activity,,,,CHEMBL2096972,Homo sapiens,"Sulfonylurea receptor 1, Kir6.2",9606.0,,,Activity,,,,
66252,,,1759174,[],CHEMBL866699,Antifungal activity against Cryptococcus neoformans ATCC 36556 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1146003,Bioorg Med Chem Lett,2006.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,536536,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,,MIC,ug ml-1,UO_0000274,,64.0
66253,,,1759175,[],CHEMBL866698,Antifungal activity against Aspergillus terreus ATCC 46941 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1146003,Bioorg Med Chem Lett,2006.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,536536,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612277,Aspergillus terreus,Aspergillus terreus,33178.0,,,MIC,ug ml-1,UO_0000274,,128.0
66254,,,1759176,[],CHEMBL866164,Antifungal activity against Aspergillus fumigatus ATCC 16424 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1146003,Bioorg Med Chem Lett,2006.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,536536,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL363,Aspergillus fumigatus,Aspergillus fumigatus,746128.0,,,MIC,ug ml-1,UO_0000274,,128.0
66255,,,1759177,[],CHEMBL866163,Antifungal activity against Candida krusei ATCC 6258 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1146003,Bioorg Med Chem Lett,2006.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,536536,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612841,Pichia kudriavzevii,Pichia kudriavzevii,4909.0,,,MIC,ug ml-1,UO_0000274,,32.0
66256,,,1759178,[],CHEMBL866162,Antifungal activity against Candida lusitaniae ATCC 42720 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1146003,Bioorg Med Chem Lett,2006.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,536536,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612362,Clavispora lusitaniae,Clavispora lusitaniae,36911.0,,,MIC,ug ml-1,UO_0000274,,128.0
66257,,,1759179,[],CHEMBL866161,Antifungal activity against Candida tropicalis ATCC 13803 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1146003,Bioorg Med Chem Lett,2006.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,536536,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL612870,Candida tropicalis,Candida tropicalis,5482.0,,,MIC,ug ml-1,UO_0000274,,16.0
66258,,,1759180,[],CHEMBL866160,Antifungal activity against Candida albicans ATCC 10231 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1146003,Bioorg Med Chem Lett,2006.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,536536,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,ug ml-1,UO_0000274,,128.0
66259,,,1958258,[],CHEMBL890912,Cytotoxicity against MRC5 cells,A,,,BAO_0000187,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1146376,Bioorg Med Chem Lett,2007.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,648146,=,1,1,=,,CC50,nM,,74000.0,CHEMBL614181,Homo sapiens,MRC5,9606.0,,,CC50,uM,UO_0000065,,74.0
66260,,,1958259,[],CHEMBL890913,Antiviral activity against HCMV in MRC5 cells by plaque reduction assay,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1146376,Bioorg Med Chem Lett,2007.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,6.17,0,http://www.openphacts.org/units/Nanomolar,648146,=,1,1,=,,IC50,nM,,680.0,CHEMBL371,Human betaherpesvirus 5,Human betaherpesvirus 5,10359.0,,,IC50,uM,UO_0000065,,0.68
66261,,,1958264,[],CHEMBL890914,"Selectivity index, ratio of CC50 for MRC5 cells to IC50 for HCMV",F,,,BAO_0000179,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1146376,Bioorg Med Chem Lett,2007.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,648146,=,1,0,=,,Ratio CC50/IC50,,,110.0,CHEMBL612545,,Unchecked,,,,Ratio CC50/IC50,,,,110.0
66262,,Active,1958363,[],CHEMBL890915,Inhibition of HCMV proliferation in MRC5 cells after 54 hrs post-infection at 10 uM by plaque assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1146376,Bioorg Med Chem Lett,2007.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,648146,,1,0,,,Activity,,,,CHEMBL371,Human betaherpesvirus 5,Human betaherpesvirus 5,10359.0,,,Activity,,,,
66263,,Active,1958364,[],CHEMBL890916,Inhibition of HCMV proliferation in MRC5 cells after 24 hrs post-infection at 10 uM by plaque assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1146376,Bioorg Med Chem Lett,2007.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,648146,,1,0,,,Activity,,,,CHEMBL371,Human betaherpesvirus 5,Human betaherpesvirus 5,10359.0,,,Activity,,,,
66264,,Not Active,1958365,[],CHEMBL890917,Inhibition of HCMV adsorption to MRC5 cells at 0.2 to 2 uM by infectious centre assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1146376,Bioorg Med Chem Lett,2007.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,648146,,1,0,,,Activity,,,,CHEMBL371,Human betaherpesvirus 5,Human betaherpesvirus 5,10359.0,,,Activity,,,,
66265,,Not Active,1958366,[],CHEMBL890918,Inhibition of HCMV penetration to MRC5 cells at 0.2 to 2 uM,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1146376,Bioorg Med Chem Lett,2007.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,648146,,1,0,,,Activity,,,,CHEMBL371,Human betaherpesvirus 5,Human betaherpesvirus 5,10359.0,,,Activity,,,,
66266,,,1974818,[],CHEMBL898570,Binding affinity to human telo21 G-quadruplex DNA assessed as thermal stability in tris-HCl buffer at pH 7.4,B,,,BAO_0000581,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1149624,Bioorg Med Chem,2007.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#DegreeCelsius,659677,=,1,0,=,,Tm,degrees C,,44.0,CHEMBL612545,,Unchecked,,,,Tm,degrees C,UO_0000027,,44.0
66267,,,1974826,[],CHEMBL898571,Binding affinity to human telo21 G-quadruplex DNA assessed as change in thermal stability in tris-HCl buffer at pH 7.4,B,,,BAO_0000179,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1149624,Bioorg Med Chem,2007.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#DegreeCelsius,659677,=,1,1,=,,Delta Tm,degrees C,,3.9,CHEMBL612545,,Unchecked,,,,deltaTm,degrees C,UO_0000027,,3.9
66268,,,1974834,[],CHEMBL898573,Inhibition of amplification in human telo21 G-quadruplex DNA by PCR stop assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1149624,Bioorg Med Chem,2007.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.68,0,http://www.openphacts.org/units/Nanomolar,659677,=,1,1,=,,IC50,nM,,2100.0,CHEMBL612545,,Unchecked,,,,IC50,umol/L,UO_0000065,,2.1
66269,,,1974842,[],CHEMBL898574,Inhibition of telomerase expressed in MCF7 cells by TRAP assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1149624,Bioorg Med Chem,2007.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.12,0,http://www.openphacts.org/units/Nanomolar,659677,=,1,1,=,,IC50,nM,,75000.0,CHEMBL612545,,Unchecked,,,,IC50,umol/L,UO_0000065,,75.0
66270,,,1974850,[],CHEMBL898572,Binding affinity to human telo21 G-quadruplex DNA at 1 uM after 5 mins,B,,,BAO_0000192,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1149624,Bioorg Med Chem,2007.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.75,0,http://www.openphacts.org/units/Nanomolar,659677,=,1,1,=,,Ki,nM,,1790.0,CHEMBL612545,,Unchecked,,,,Ki,10^-6/M,UO_0000065,,1.79
66271,,,1981662,[],CHEMBL899225,Inhibition of SrtA,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1149701,Bioorg Med Chem Lett,2007.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,661495,=,1,1,=,,IC50,ug.mL-1,,8.7,CHEMBL5362,Staphylococcus aureus,Sortase A,1280.0,,,IC50,ug ml-1,UO_0000274,,8.7
66272,,,1981667,[],CHEMBL899226,Antimicrobial activity against Staphylococcus aureus Newman,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1149701,Bioorg Med Chem Lett,2007.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,661495,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
66273,,Active,2178422,[],CHEMBL966379,Antimicrobial activity against Staphylococcus aureus 4222 with norA KLE mutation at 120 to 140 ug/ml,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1155570,J Nat Prod,2000.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,712189,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
66274,,,2191325,[],CHEMBL975031,Cytotoxicity against Sprague-Dawley rat primary hepatocytes after 24 hrs by MTT assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1157160,Bioorg Med Chem,2008.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,741418,=,1,1,=,,IC50,ug.mL-1,,26.5,CHEMBL613362,Rattus norvegicus,Hepatocyte,10116.0,,,IC50,ug ml-1,UO_0000274,,26.5
66275,,,2191326,[],CHEMBL975032,Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1157160,Bioorg Med Chem,2008.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,741418,=,1,1,=,,IC50,ug.mL-1,,146200000.0,CHEMBL395,Homo sapiens,HepG2,9606.0,,,IC50,g/ml,UO_0000274,,146.2
66276,,,2191327,[],CHEMBL975033,Cytotoxicity against human HeLa cells after 24 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1157160,Bioorg Med Chem,2008.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,741418,=,1,1,=,,IC50,ug.mL-1,,138400000.0,CHEMBL399,Homo sapiens,HeLa,9606.0,,,IC50,g/ml,UO_0000274,,138.4
66277,,,2227574,[],CHEMBL1008167,Binding affinity to human c-myc G-quadruplex Pu18 DNA assessed as melting temperature at 2.0 uM by FRET melting assay,B,,,BAO_0000581,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1156609,Bioorg Med Chem,2008.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#DegreeCelsius,797226,=,1,0,=,,Tm,degrees C,,55.0,CHEMBL612545,,Unchecked,,,,Tm,degrees C,UO_0000027,,55.0
66278,,,2227584,[],CHEMBL1008168,Binding affinity to human c-myc G-quadruplex Pu18 DNA assessed as change melting temperature at 2.0 uM by FRET melting assay,B,,,BAO_0000179,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1156609,Bioorg Med Chem,2008.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#DegreeCelsius,797226,=,1,1,=,,Delta Tm,degrees C,,1.0,CHEMBL612545,,Unchecked,,,,deltaTm,degrees C,UO_0000027,,1.0
66279,,,2227594,[],CHEMBL1008169,Binding affinity to human c-myc G-quadruplex F10T DNA assessed as melting temperature at 2.0 uM by FRET melting assay,B,,,BAO_0000581,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1156609,Bioorg Med Chem,2008.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#DegreeCelsius,797226,=,1,0,=,,Tm,degrees C,,60.0,CHEMBL612545,,Unchecked,,,,Tm,degrees C,UO_0000027,,60.0
66280,,,2227604,[],CHEMBL1008170,Binding affinity to human c-myc G-quadruplex F10T DNA assessed as change melting temperature at 2.0 uM by FRET melting assay,B,,,BAO_0000179,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1156609,Bioorg Med Chem,2008.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#DegreeCelsius,797226,=,1,1,=,,Delta Tm,degrees C,,2.0,CHEMBL612545,,Unchecked,,,,deltaTm,degrees C,UO_0000027,,2.0
66281,,,2274072,[],CHEMBL1030753,Inhibition of 6-His tagged Staphylococcus aureus recombinant sortase delta N24 expressed in Escherichia coli BL21 (DE3),B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1153353,Bioorg Med Chem,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,1,http://www.openphacts.org/units/MicrogramPerMilliliter,755347,=,1,1,=,,IC50,ug.mL-1,,8.7,CHEMBL5362,Staphylococcus aureus,Sortase A,1280.0,,,IC50,ug ml-1,UO_0000274,,8.7
66282,,,2297763,[],CHEMBL1018093,Inhibition of HIV1 RT,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1137798,J Nat Prod,1991.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,811338,=,1,1,=,,IC50,ug.mL-1,,100.0,CHEMBL247,Human immunodeficiency virus 1,Human immunodeficiency virus type 1 reverse transcriptase,11676.0,,,IC50,ug ml-1,UO_0000274,,100.0
66283,,,2322510,[],CHEMBL1004277,Antifungal activity against Candida albicans IFO 1061 after 48 hrs by serial broth dilution test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1150950,J Nat Prod,1998.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,787654,=,1,1,=,,MIC,ug.mL-1,,500.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,ug ml-1,UO_0000274,,500.0
66284,,,2322523,[],CHEMBL1004276,Antibacterial activity against Escherichia coli IFO 026 after 24 hrs by serial broth dilution test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1150950,J Nat Prod,1998.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,787654,>,1,1,>,,MIC,ug.mL-1,,2000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2000.0
66285,,,2322536,[],CHEMBL1004275,Antibacterial activity against Salmonella enteritidis after 24 hrs by serial broth dilution test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1150950,J Nat Prod,1998.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,787654,=,1,1,=,,MIC,ug.mL-1,,500.0,CHEMBL614447,Salmonella enterica subsp. enterica serovar Enteritidis,Salmonella enteritidis,149539.0,,,MIC,ug ml-1,UO_0000274,,500.0
66286,,,2322549,[],CHEMBL1004274,Antibacterial activity against Bacillus subtilis after 24 hrs by serial broth dilution test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1150950,J Nat Prod,1998.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,787654,=,1,1,=,,MIC,ug.mL-1,,1000.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,1000.0
66287,,,2322562,[],CHEMBL1004273,Antibacterial activity against Staphylococcus aureus after 24 hrs by serial broth dilution test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1150950,J Nat Prod,1998.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,787654,=,1,1,=,,MIC,ug.mL-1,,250.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,250.0
66288,,,2322589,[],CHEMBL1003436,Antimicrobial activity against recombinant Mycobacterium bovis BCG expressing pMV361 lux after 5 days by luciferase assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1150956,J Nat Prod,1998.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,787822,=,1,1,=,,MIC,ug.mL-1,,200.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,200.0
66289,,,2322597,[],CHEMBL1003437,Antimicrobial activity against recombinant Mycobacterium intracellular expressing pMV361 lux after 3 days by luciferase assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1150956,J Nat Prod,1998.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,787822,=,1,1,=,,MIC,ug.mL-1,,200.0,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,MIC,ug ml-1,UO_0000274,,200.0
66290,,,2322635,[],CHEMBL1003429,Antimicrobial activity against Staphylococcus aureus ATCC 13709,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1150956,J Nat Prod,1998.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,787822,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,50.0
66291,,,2322636,[],CHEMBL1003432,Antimicrobial activity against Klebsiella pneumoniae ATCC 10031,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1150956,J Nat Prod,1998.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,787822,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,100.0
66292,,,2322637,[],CHEMBL1003433,Antimicrobial activity against Mycobacterium smegmatis ATCC 607,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1150956,J Nat Prod,1998.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,787822,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,25.0
66293,,,2322638,[],CHEMBL1003434,Antimicrobial activity against Candida albicans ATCC 10231,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1150956,J Nat Prod,1998.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,787822,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,ug ml-1,UO_0000274,,100.0
66294,,,2389877,[],CHEMBL940345,Induction of LDLR mRNA expression in human HepG2 cells after 12 hrs by RT-PCR assay relative to untreated control,F,,,BAO_0000179,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1140862,J Med Chem,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,729195,=,1,0,=,,FC,,,2.2,CHEMBL395,Homo sapiens,HepG2,9606.0,,,FC,,,,2.2
66295,,,2389908,[],CHEMBL951496,Elimination half life in po dosed human,A,,,BAO_0002115,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1140862,J Med Chem,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Hour,729195,=,1,1,=,,T1/2,hr,,2.94,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,beta t1/2,hr,UO_0000032,,2.94
66296,,Active,2389910,[],CHEMBL950527,Induction of LDLR protein expression in human HepG2 cells at 10 ug/mL after 12 hrs by flow cytometry,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1140862,J Med Chem,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,729195,,1,0,,,Activity,,,,CHEMBL395,Homo sapiens,HepG2,9606.0,,,Activity,,,,
66297,,Active,2389911,[],CHEMBL950526,Induction of LDLR protein in human Bel7402 cells after 12 hrs by RT-PCR assay relative to control,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1140862,J Med Chem,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,729195,,1,0,,,Activity,,,,CHEMBL614279,Homo sapiens,Bel-7402,9606.0,,,Activity,,,,
66298,,,2389912,[],CHEMBL950528,"Reduction of blood cholesterol level in hyperlipidemic Sprague-Dawley rat at 100 mg/kg, po daily twice for 30 days relative to control",F,,,BAO_0001103,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1140862,J Med Chem,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,729195,=,1,0,=,,Activity,%,,27.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Activity,%,UO_0000187,,27.4
66299,,,2389913,[],CHEMBL950529,"Reduction of blood low density lipoprotein cholesterol level in hyperlipidemic Sprague-Dawley rat at 100 mg/kg, po daily twice for 30 days relative to control",F,,,BAO_0001103,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1140862,J Med Chem,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,729195,=,1,0,=,,Activity,%,,31.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Activity,%,UO_0000187,,31.6
66300,,tde,2389918,[],CHEMBL950530,"Reduction of blood cholesterol level in hyperlipidemic Sprague-Dawley rat at 100 mg/kg, po daily twice",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1140862,J Med Chem,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,729195,,1,0,,,Activity,,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Activity,,,,
66301,,tde,2389919,[],CHEMBL950531,"Reduction of blood low density lipoprotein cholesterol level in hyperlipidemic Sprague-Dawley rat at 100 mg/kg, po daily twice",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1140862,J Med Chem,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,729195,,1,0,,,Activity,,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Activity,,,,
66302,,,2389921,[],CHEMBL950532,"Induction of LDLR mRNA expression in hyperlipidemic Sprague-Dawley rat liver at 100 mg/kg, po daily twice for 30 days by RT-PCR relative to control",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1140862,J Med Chem,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,729195,=,1,0,=,,FC,,,1.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,FC,,,,1.5
66303,,Not Active,2389922,[],CHEMBL951473,"Induction of HMG-CoA reductase mRNA expression in hyperlipidemic Sprague-Dawley rat liver at 100 mg/kg, po daily twice for 30 days by RT-PCR",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1140862,J Med Chem,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,729195,,1,0,,,Activity,,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Activity,,,,
66304,,,2389934,[],CHEMBL951483,"Reduction of blood cholesterol level in hyperlipidemic C57BL/6J mouse at 100 mg/kg, po daily twice for 21 days relative to control",F,,,BAO_0001103,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1140862,J Med Chem,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,729195,=,1,0,=,,Activity,%,,16.7,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,%,UO_0000187,,16.7
66305,,,2389936,[],CHEMBL951485,"Induction of LDLR mRNA expression in hyperlipidemic C57BL/6J mouse liver at 100 mg/kg, po daily twice for 21 days by RT-PCR relative to control",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1140862,J Med Chem,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,729195,=,1,0,=,,FC,,,1.5,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,FC,,,,1.5
66306,,,2389947,[],CHEMBL951484,"Reduction of blood low density lipoprotein cholesterol level in hyperlipidemic C57BL/6J mouse at 100 mg/kg, po daily twice for 21 days relative to control",F,,,BAO_0001103,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1140862,J Med Chem,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,729195,=,1,0,=,,Activity,%,,23.9,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,%,UO_0000187,,23.9
66307,,,2429808,[],CHEMBL998453,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 1126 after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1148941,J Nat Prod,2004.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,762102,=,1,1,=,,MIC,ug.mL-1,,60.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/ml,UO_0000274,,0.06
66308,,,2442182,[],CHEMBL989438,Toxicity against brine shrimp,A,,,BAO_0002117,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1146568,J Nat Prod,2003.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Micromolar,715571,=,1,0,=,,LD50,uM,,67.0,CHEMBL613459,Artemia,Artemia,6660.0,,,LD50,uM,UO_0000064,,67.0
66309,,Not Determined,2442188,[],CHEMBL989439,Antioxidant activity assessed as DPPH radical scavenging activity,F,,,BAO_0000190,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1146568,J Nat Prod,2003.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,715571,,1,0,,,IC50,,,,CHEMBL613712,,Radical scavenging activity,,,,IC50,,,,
66310,,,2488803,[],CHEMBL1028043,Antagonist activity at human P2X7 receptor expressed in HEK293 cells assessed as inhibition of BzATP-induced fluorescent ethidium accumulation at 8 uM,F,,,BAO_0000201,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1143291,Bioorg Med Chem Lett,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,753069,=,1,1,=,,Inhibition,%,,7.03,CHEMBL4805,Homo sapiens,P2X purinoceptor 7,9606.0,,,INH,%,UO_0000187,,7.03
66311,,,2546143,[],CHEMBL968123,Antiplasmodial activity against multi drug-resistant Plasmodium falciparum K1 in erythrocytes by [3H]hypoxanthine uptake,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1155642,J Nat Prod,2000.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,6.01,0,http://www.openphacts.org/units/Nanomolar,736158,=,1,1,=,,IC50,nM,,968.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,0.968
66312,,,2546165,[],CHEMBL968124,Antiamnesic activity against Entamoeba histolytica NIH 200 after 72 hrs by microdilution technique,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1155642,J Nat Prod,2000.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,736158,=,1,1,=,,IC50,nM,,111000.0,CHEMBL612853,Entamoeba histolytica,Entamoeba histolytica,5759.0,,,IC50,uM,UO_0000065,,111.0
66313,,,2546187,[],CHEMBL968125,Cytotoxicity against human KB cells after 72 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1155642,J Nat Prod,2000.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.13,0,http://www.openphacts.org/units/Nanomolar,736158,=,1,1,=,,IC50,nM,,7320.0,CHEMBL398,Homo sapiens,KB,9606.0,,,IC50,uM,UO_0000065,,7.32
66314,,,2549652,[],CHEMBL977556,Antifungal activity against wild type Candida albicans Al-1 after 48 hrs by NCCLS M27A method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1142598,J Nat Prod,2006.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,786871,=,1,1,=,,MIC,ug.mL-1,,31.3,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,ug ml-1,UO_0000274,,31.3
66315,,,2549655,[],CHEMBL977557,Antifungal activity against azole-resistant Candida albicans D10 after 48 hrs by NCCLS M27A method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1142598,J Nat Prod,2006.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,786871,=,1,1,=,,MIC,ug.mL-1,,31.3,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,ug ml-1,UO_0000274,,31.3
66316,,,2549659,[],CHEMBL977558,Antifungal activity against azole-resistant Candida albicans CN1A after 48 hrs by NCCLS M27A method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1142598,J Nat Prod,2006.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,786871,=,1,1,=,,MIC,ug.mL-1,,15.6,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,ug ml-1,UO_0000274,,15.6
66317,,,2549663,[],CHEMBL977560,Antifungal activity against Candida shehatae after 48 hrs by NCCLS M27A method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1142598,J Nat Prod,2006.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,786871,=,1,1,=,,MIC,ug.mL-1,,7.8,CHEMBL613933,Scheffersomyces shehatae,Scheffersomyces shehatae,45589.0,,,MIC,ug ml-1,UO_0000274,,7.8
66318,,,2549664,[],CHEMBL977559,Antifungal activity against Cryptococcus neoformans after 48 hrs by NCCLS M27A method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1142598,J Nat Prod,2006.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,786871,=,1,1,=,,MIC,ug.mL-1,,31.3,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,,MIC,ug ml-1,UO_0000274,,31.3
66319,,,2549665,[],CHEMBL966449,Antifungal activity against Saccharomyces cerevisiae after 48 hrs by NCCLS M27A method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1142598,J Nat Prod,2006.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,786871,=,1,1,=,,MIC,ug.mL-1,,78.1,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,,MIC,ug ml-1,UO_0000274,,78.1
66320,,,2549666,[],CHEMBL980221,Antifungal activity against filamentous Wangiella dermatitidis after 48 hrs by NCCLS M27A method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1142598,J Nat Prod,2006.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,786871,=,1,1,=,,MIC,ug.mL-1,,31.3,CHEMBL612740,Exophiala dermatitidis,Exophiala dermatitidis,5970.0,,,MIC,ug ml-1,UO_0000274,,31.3
66321,,,2549667,[],CHEMBL980222,Antifungal activity against Pseudallescheria boydii after 48 hrs by NCCLS M27A method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1142598,J Nat Prod,2006.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,786871,=,1,1,=,,MIC,ug.mL-1,,62.5,CHEMBL612876,Scedosporium boydii,Scedosporium boydii,5597.0,,,MIC,ug ml-1,UO_0000274,,62.5
66322,,,2549668,[],CHEMBL980223,Antifungal activity against Alternaria alternata after 48 hrs by NCCLS M27A method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1142598,J Nat Prod,2006.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,786871,=,1,1,=,,MIC,ug.mL-1,,125.0,CHEMBL613794,Alternaria alternata,Alternaria alternata,5599.0,,,MIC,ug ml-1,UO_0000274,,125.0
66323,,,2549669,[],CHEMBL980224,Antifungal activity against wild type Candida albicans Al-1 in presence of dillapiol,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1142598,J Nat Prod,2006.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,786871,=,1,1,=,,MIC,ug.mL-1,,15.6,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,ug ml-1,UO_0000274,,15.6
66324,,,2549670,[],CHEMBL980225,Potentiation of drimane-type sesquiterpene-induced antifungal activity against wild type Candida albicans Al-1 assessed as fractional inhibition concentration index,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1142598,J Nat Prod,2006.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,786871,=,1,0,=,,FICI,,,0.5,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,FICI,,,,0.5
66325,,,2551022,[],CHEMBL967270,Toxicity in brine shrimp,A,,,BAO_0002117,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1142611,J Nat Prod,2006.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Micromolar,787173,=,1,0,=,,LD50,uM,,66.9,CHEMBL613459,Artemia,Artemia,6660.0,,,LD50,uM,UO_0000064,,66.9
66326,,,2551628,[],CHEMBL969218,Antimicrobial activity against wild-type Staphylococcus aureus 8325-4,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1157254,J Nat Prod,2006.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,759759,=,1,1,=,,MIC,nM,,372000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,372.0
66327,,,2551629,[],CHEMBL969217,Antimicrobial activity against NorA knockout Staphylococcus aureus K1758 mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1157254,J Nat Prod,2006.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,759759,=,1,1,=,,MIC,nM,,89000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,89.0
66328,,,2551630,[],CHEMBL969220,Antimicrobial activity against Staphylococcus aureus K2361 mutant overexpressing NorA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1157254,J Nat Prod,2006.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,759759,=,1,1,=,,MIC,nM,,1488000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,1488.0
66329,,,2571351,[],CHEMBL996994,Antibacterial activity against NorA knockout Staphylococcus aureus K1758 after 18 to 20 hrs by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1155887,Bioorg Med Chem Lett,2008.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,769608,=,1,1,=,,MIC,nM,,67000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,67.0
66330,,,2571352,[],CHEMBL996995,Antibacterial activity against wild type Staphylococcus aureus 8325-4 after 18 to 20 hrs by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1155887,Bioorg Med Chem Lett,2008.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,769608,=,1,1,=,,MIC,nM,,269000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,269.0
66331,,,2571353,[],CHEMBL996996,Antibacterial activity against Staphylococcus aureus K2378 overexpressing NorA after 18 to 20 hrs by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1155887,Bioorg Med Chem Lett,2008.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,769608,=,1,1,=,,MIC,nM,,2152000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,2152.0
66332,,,2571686,[],CHEMBL1001377,Upregulation of LDLR mRNA expression in human HepG2 cells after 8 hrs by RT-PCR relative to control,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1155928,Bioorg Med Chem Lett,2008.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,769016,=,1,0,=,,Activity,,,5.3,CHEMBL395,Homo sapiens,HepG2,9606.0,,,Activity,,,,5.3
66333,,,2627419,[],CHEMBL1004977,Binding affinity to human telomeric G-quadruplex F21T DNA assessed as change in melting temperature at 2.0 uM by FRET assay,B,,,BAO_0000179,BAO_0000225,nucleic acid format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1137001,Bioorg Med Chem Lett,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#DegreeCelsius,784632,=,1,1,=,,Delta Tm,degrees C,,4.0,CHEMBL345,,Nucleic Acid,,,,deltaTm,degrees C,UO_0000027,,4.0
66334,,,2627430,[],CHEMBL1004978,Binding affinity to human telomeric G-quadruplex F10T DNA assessed as change in melting temperature at 2.0 uM by FRET assay,B,,,BAO_0000179,BAO_0000225,nucleic acid format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1137001,Bioorg Med Chem Lett,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#DegreeCelsius,784632,=,1,1,=,,Delta Tm,degrees C,,1.0,CHEMBL345,,Nucleic Acid,,,,deltaTm,degrees C,UO_0000027,,1.0
66335,,,2628146,[],CHEMBL1004979,Selectivity for human telomeric G-quadruplex F21T DNA to ds26 duplex DNA,B,,,BAO_0002136,BAO_0000225,nucleic acid format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1137001,Bioorg Med Chem Lett,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,784632,=,1,0,=,,Selectivity ratio,,,50.0,CHEMBL345,,Nucleic Acid,,,,Selectivity ratio,,,,50.0
66336,,,2628147,[],CHEMBL1004980,Binding affinity to G-quadruplex HTG21 oligomer by fluorescence titration experiment,B,,,BAO_0000587,BAO_0000225,nucleic acid format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1137001,Bioorg Med Chem Lett,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,784632,=,1,1,=,,Kb,nM,,2000.0,CHEMBL345,,Nucleic Acid,,,,Kb,10'-6/M,UO_0000065,,2.0
66337,,,2655868,[],CHEMBL1032727,Antibacterial activity against Staphylococcus aureus K1758 NorA efflux pump-deficient mutant after 18 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1158423,Bioorg Med Chem,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,816041,=,1,1,=,,MIC,nM,,40000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,40.0
66338,,,2655875,[],CHEMBL1032728,Antibacterial activity against wild type Staphylococcus aureus 8325-4 after 18 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1158423,Bioorg Med Chem,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,816041,=,1,1,=,,MIC,nM,,325000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,325.0
66339,,,2655882,[],CHEMBL1032729,Antibacterial activity against Staphylococcus aureus K2378 overexpressing NorA efflux pump after 18 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1158423,Bioorg Med Chem,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,816041,>,1,1,>,,MIC,nM,,650000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,650.0
66340,,,2655889,[],CHEMBL1032730,Antibacterial activity against Escherichia coli BW-25116 TolC-deficient mutant after 18 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1158423,Bioorg Med Chem,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,816041,=,1,1,=,,MIC,nM,,325000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,325.0
66341,,,2655896,[],CHEMBL1032731,Antibacterial activity against Escherichia coli ECM116 mar1642 overexpressing ArcAB pump after 18 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1158423,Bioorg Med Chem,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,816041,=,1,1,=,,MIC,nM,,325000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,325.0
66342,,,2655903,[],CHEMBL1032732,Antibacterial activity against Escherichia coli K-12 after 18 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1158423,Bioorg Med Chem,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,816041,>,1,1,>,,MIC,nM,,2600000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,2600.0
66343,,,2655910,[],CHEMBL1032733,Antibacterial activity against Escherichia coli ECM1642 after 18 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1158423,Bioorg Med Chem,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,816041,>,1,1,>,,MIC,nM,,2600000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,2600.0
66344,,,2655917,[],CHEMBL1032734,Antibacterial activity against Enterococcus faecalis OG1RF after 18 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1158423,Bioorg Med Chem,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,816041,=,1,1,=,,MIC,nM,,650000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,uM,UO_0000065,,650.0
66345,,,2655924,[],CHEMBL1032735,Antibacterial activity against Enterococcus faecalis MMH594 after 18 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1158423,Bioorg Med Chem,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,816041,>,1,1,>,,MIC,nM,,650000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,uM,UO_0000065,,650.0
66346,,,2655931,[],CHEMBL1032736,Antibacterial activity against Enterococcus faecalis V583 after 18 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1158423,Bioorg Med Chem,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,816041,>,1,1,>,,MIC,nM,,650000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,uM,UO_0000065,,650.0
66347,,,2925129,[],CHEMBL1053693,Inhibition of Rac1b GTPase activity assessed as incorporation of BODIPY-GTP at 50 uM after 40 mins by nucleotide binding competition assay,B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1155205,Bioorg Med Chem Lett,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,850043,=,1,1,=,,Inhibition,%,,23.0,CHEMBL6094,Homo sapiens,Ras-related C3 botulinum toxin substrate 1,9606.0,,,INH,%,UO_0000187,,23.0
66348,,,2925167,[],CHEMBL1053689,Inhibition of Cdc42 GTPase activity assessed as incorporation of BODIPY-GTP at 50 uM after 40 mins by nucleotide binding competition assay,B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1155205,Bioorg Med Chem Lett,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,850043,=,1,1,=,,Inhibition,%,,8.0,CHEMBL6088,Homo sapiens,Cell division control protein 42 homolog,9606.0,,,INH,%,UO_0000187,,8.0
66349,,,2925192,[],CHEMBL1051382,Inhibition of Rac1 GTPase activity assessed as incorporation of BODIPY-GTP at 50 uM after 40 mins by nucleotide binding competition assay,B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1155205,Bioorg Med Chem Lett,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,850043,=,1,1,=,,Inhibition,%,,14.0,CHEMBL6094,Homo sapiens,Ras-related C3 botulinum toxin substrate 1,9606.0,,,INH,%,UO_0000187,,14.0
66350,,,2944591,[],CHEMBL1059294,Upregulation of LDLR mRNA expression in human liver HepG2 at 10 ug/mL after 8 hrs by RT-PCR relative to control,F,,,BAO_0000179,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1154197,Bioorg Med Chem Lett,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,850480,=,1,0,=,,FC,,,1.9,CHEMBL395,Homo sapiens,HepG2,9606.0,,,FC,,,,1.9
66351,,,2944592,[],CHEMBL1059295,Upregulation of InsR mRNA expression in human liver HepG2 at 10 ug/mL after 8 hrs by RT-PCR relative to control,F,,,BAO_0000179,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1154197,Bioorg Med Chem Lett,2009.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,850480,=,1,0,=,,FC,,,2.3,CHEMBL395,Homo sapiens,HepG2,9606.0,,,FC,,,,2.3
66352,,,3037915,[],CHEMBL1040694,"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.",F,,,BAO_0000179,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1156829,Proc Natl Acad Sci U S A,2008.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,865461,=,3,1,=,,IFI,%,,1.84,CHEMBL612545,,Unchecked,,,,IFI,,UO_0000187,,0.018404908
66353,,,3040297,[],CHEMBL1040693,NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7),T,,,BAO_0000187,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1156829,Proc Natl Acad Sci U S A,2008.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,865461,>,3,1,>,,CC50,nM,,100000.0,CHEMBL614039,Homo sapiens,Huh-7,9606.0,,,CC50,uM,UO_0000065,,100.0
66354,,,3042798,[],CHEMBL1040692,NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay,F,,,BAO_0000188,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1156829,Proc Natl Acad Sci U S A,2008.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,6.36,0,http://www.openphacts.org/units/Nanomolar,865461,=,3,1,=,,EC50,nM,,442.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,EC50,uM,UO_0000065,,0.442
66355,,,3043651,[],CHEMBL1040691,NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ,F,,,BAO_0000188,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1156829,Proc Natl Acad Sci U S A,2008.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,6.66,0,http://www.openphacts.org/units/Nanomolar,865461,=,3,1,=,,EC50,nM,,218.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,EC50,uM,UO_0000065,,0.218
66356,,,3103971,[],CHEMBL1071733,Inhibition of electric eel AChE by modified Ellman method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1159112,Bioorg Med Chem,2010.0,"{'bei': '19.11', 'le': '0.35', 'lle': '3.33', 'sei': '15.75'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,6.43,0,http://www.openphacts.org/units/Nanomolar,885080,=,1,1,=,,IC50,nM,,374.0,CHEMBL4078,Electrophorus electricus,Acetylcholinesterase,8005.0,,,IC50,uM,UO_0000065,,0.374
66357,,,3105075,[],CHEMBL1071734,Inhibition of horse serum BChE by Ellman's method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1159112,Bioorg Med Chem,2010.0,"{'bei': '14.09', 'le': '0.26', 'lle': '1.64', 'sei': '11.62'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.74,0,http://www.openphacts.org/units/Nanomolar,885080,=,1,1,=,,IC50,nM,,18200.0,CHEMBL5763,Equus caballus,Cholinesterase,9796.0,,,IC50,uM,UO_0000065,,18.2
66358,,,3105077,[],CHEMBL1071735,Selectivity for electric eel AChE over horse serum BChE,B,,,BAO_0000179,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1159112,Bioorg Med Chem,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,885080,=,1,0,=,,Ratio IC50,,,48.6,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,48.6
66359,,,3105094,[],CHEMBL1071736,Inhibition of electric eel AChE by enzyme kinetics assay,B,,,BAO_0000192,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1159112,Bioorg Med Chem,2010.0,"{'bei': '19.44', 'le': '0.36', 'lle': '3.44', 'sei': '16.03'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,6.54,0,http://www.openphacts.org/units/Nanomolar,885080,=,1,1,=,,Ki,nM,,289.0,CHEMBL4078,Electrophorus electricus,Acetylcholinesterase,8005.0,,,Ki,uM,UO_0000065,,0.289
66360,,,3105096,[],CHEMBL1071737,Inhibition of horse serum BChE by enzyme kinetics assay,B,,,BAO_0000192,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1159112,Bioorg Med Chem,2010.0,"{'bei': '14.97', 'le': '0.28', 'lle': '1.94', 'sei': '12.34'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.04,0,http://www.openphacts.org/units/Nanomolar,885080,=,1,1,=,,Ki,nM,,9200.0,CHEMBL5763,Equus caballus,Cholinesterase,9796.0,,,Ki,uM,UO_0000065,,9.2
66361,,Active,3105098,[],CHEMBL1071738,Non-competitive inhibition of electric eel AChE by Lineweaver-Burke plot,B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1159112,Bioorg Med Chem,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,885080,,1,0,,,Inhibition,%,,,CHEMBL4078,Electrophorus electricus,Acetylcholinesterase,8005.0,,,INH,,UO_0000187,,
66362,,Active,3105100,[],CHEMBL1071740,Non-competitive inhibition of horse serum BChE by Lineweaver-Burke plot,B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1159112,Bioorg Med Chem,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,885080,,1,0,,,Inhibition,%,,,CHEMBL5763,Equus caballus,Cholinesterase,9796.0,,,INH,,UO_0000187,,
66363,,,3272092,[],CHEMBL1110126,Inhibition of human recombinant POP,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1157839,J Med Chem,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,912890,=,1,1,=,,IC50,nM,,145000.0,CHEMBL3202,Homo sapiens,Prolyl endopeptidase,9606.0,,,IC50,nM,UO_0000065,,145000.0
66364,,Active,3329685,[],CHEMBL1168947,Induction of apoptosis in human HL60 cells after 48 hrs using annexin V-propidium iodide staining by FACS analysis,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1165893,Eur J Med Chem,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,920893,,1,0,,,Activity,,,,CHEMBL383,Homo sapiens,HL-60,9606.0,,,Activity,,,,
66365,,,3334442,[],CHEMBL1167959,Inhibition of electric eel AChE by Ellman's assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1165944,Bioorg Med Chem,2010.0,"{'bei': '19.11', 'le': '0.35', 'lle': '3.33', 'sei': '15.75'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,6.43,1,http://www.openphacts.org/units/Nanomolar,919653,=,1,1,=,,IC50,nM,,374.0,CHEMBL4078,Electrophorus electricus,Acetylcholinesterase,8005.0,,,IC50,uM,UO_0000065,,0.374
66366,,,3334472,[],CHEMBL1167960,Inhibition of equine serum BuChE by Ellman's method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1165944,Bioorg Med Chem,2010.0,"{'bei': '14.09', 'le': '0.26', 'lle': '1.64', 'sei': '11.62'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.74,1,http://www.openphacts.org/units/Nanomolar,919653,=,1,1,=,,IC50,nM,,18200.0,CHEMBL5763,Equus caballus,Cholinesterase,9796.0,,,IC50,uM,UO_0000065,,18.2
66367,,,3334502,[],CHEMBL1167961,Selectivity ratio of IC50 for equine serum BuChE to IC50 for electric eel AChE,U,,,BAO_0000179,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1165944,Bioorg Med Chem,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,919653,=,1,0,=,,Ratio IC50,,,48.6,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,48.6
66368,,,3375613,[],CHEMBL1212609,Cytotoxicity against human A549 cells by SRB assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1208733,Bioorg Med Chem Lett,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.2,0,http://www.openphacts.org/units/Nanomolar,927349,=,1,1,=,,IC50,nM,,6270.0,CHEMBL392,Homo sapiens,A549,9606.0,,,IC50,uM,UO_0000065,,6.27
66369,,,3375628,[],CHEMBL1212610,Cytotoxicity against human SKOV3 cells by SRB assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1208733,Bioorg Med Chem Lett,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.78,0,http://www.openphacts.org/units/Nanomolar,927349,=,1,1,=,,IC50,nM,,16440.0,CHEMBL614925,Homo sapiens,SK-OV-3,9606.0,,,IC50,uM,UO_0000065,,16.44
66370,,,3375643,[],CHEMBL1212611,Cytotoxicity against human SK-MEL-2 cells by SRB assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1208733,Bioorg Med Chem Lett,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.86,0,http://www.openphacts.org/units/Nanomolar,927349,=,1,1,=,,IC50,nM,,13760.0,CHEMBL614917,Homo sapiens,SK-MEL-2,9606.0,,,IC50,uM,UO_0000065,,13.76
66371,,,3375658,[],CHEMBL1212612,Cytotoxicity against human HCT15 cells by SRB assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1208733,Bioorg Med Chem Lett,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.78,0,http://www.openphacts.org/units/Nanomolar,927349,=,1,1,=,,IC50,nM,,16590.0,CHEMBL612263,Homo sapiens,HCT-15,9606.0,,,IC50,uM,UO_0000065,,16.59
66372,,,3425941,[],CHEMBL1225424,"Hypolipidemic activity in high fat high cholesterol diet fed Wistar rat hyperlipidemic model assessed as reduction in total cholesterol 100 mg/kg, po qd for 28 days",F,,,BAO_0001103,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1221278,Bioorg Med Chem,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,936699,=,1,0,=,,Activity,%,,27.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Activity,%,UO_0000187,,27.4
66373,,,3425942,[],CHEMBL1225420,"Lipophilicity, log P of the compound",P,,,BAO_0002130,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1221278,Bioorg Med Chem,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,936699,=,1,1,=,,LogP,,,-0.92,CHEMBL2362975,,No relevant target,,,,logP,,,,-0.92
66374,,,3425962,[],CHEMBL1225423,"Hypolipidemic activity in high fat high cholesterol diet fed Wistar rat hyperlipidemic model assessed as reduction in LDL cholesterol 100 mg/kg, po qd for 28 days",F,,,BAO_0001103,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1221278,Bioorg Med Chem,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,936699,=,1,0,=,,Activity,%,,38.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Activity,%,UO_0000187,,38.0
66375,,,3529668,[],CHEMBL1273968,Selectivity ratio of IC50 for equine BChE to IC50 for electric eel AChE,B,,,BAO_0000179,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1268919,Bioorg Med Chem Lett,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,967109,=,1,0,=,,Ratio IC50,,,48.6,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,48.6
66376,,Not Determined,3529681,[],CHEMBL1273967,Inhibition of equine BChE after 15 mins by Ellman's method using butyrylcholine as substrate,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1268919,Bioorg Med Chem Lett,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,967109,,1,0,,,IC50,,,,CHEMBL5077,Equus caballus,Butyrylcholinesterase,9796.0,,,IC50,,,,
66377,,,3529694,[],CHEMBL1273966,Inhibition of equine BChE after 15 mins by Ellman's method using acetylcholine as substrate,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1268919,Bioorg Med Chem Lett,2010.0,"{'bei': '14.09', 'le': '0.26', 'lle': '1.64', 'sei': '11.62'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.74,0,http://www.openphacts.org/units/Nanomolar,967109,=,1,1,=,,IC50,nM,,18200.0,CHEMBL5077,Equus caballus,Butyrylcholinesterase,9796.0,,,IC50,uM,UO_0000065,,18.2
66378,,,3529707,[],CHEMBL1273965,Inhibition of electric eel AChE after 15 mins by Ellman's method using acetylcholine as substrate,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1268919,Bioorg Med Chem Lett,2010.0,"{'bei': '19.11', 'le': '0.35', 'lle': '3.33', 'sei': '15.75'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,6.43,1,http://www.openphacts.org/units/Nanomolar,967109,=,1,1,=,,IC50,nM,,374.0,CHEMBL4078,Electrophorus electricus,Acetylcholinesterase,8005.0,,,IC50,uM,UO_0000065,,0.374
66379,,Active,3539286,[],CHEMBL1285392,Binding affinity to Candida albicans CaCdr1p expressed in yeast AD1-8u,B,,,BAO_0000375,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1275276,Eur J Med Chem,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,970247,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
66380,,Not Active,3539352,[],CHEMBL1285394,Binding affinity to Candida albicans CaMdr1p expressed in yeast AD1-8u,B,,,BAO_0000375,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1275276,Eur J Med Chem,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,970247,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
66381,,,3539418,[],CHEMBL1285395,Antifungal activity against yeast AD1-8u expressing Candida albicans CaCdr1p by agar disk diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1275276,Eur J Med Chem,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Millimeter,970247,=,1,1,=,,IZ,mm,,5.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,,IZ,cm,UO_0000016,,0.5
66382,,,3539484,[],CHEMBL1285393,Antifungal activity against yeast AD1-8u expressing Candida albicans CaMdr1p by agar disk diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1275276,Eur J Med Chem,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Millimeter,970247,=,1,1,=,,IZ,mm,,0.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,,IZ,cm,UO_0000016,,0.0
66383,,Inconclusive,3627951,[],CHEMBL1614544,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.15,0,http://www.openphacts.org/units/Nanomolar,1042837,=,7,1,=,,Potency,nM,,7079.5,CHEMBL1293235,Homo sapiens,Prelamin-A/C,9606.0,,,Potency,um,UO_0000065,,7.0795
66384,,Inconclusive,3656654,[],CHEMBL1614544,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.95,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,11220.2,CHEMBL1293235,Homo sapiens,Prelamin-A/C,9606.0,,,Potency,um,UO_0000065,,11.2202
66385,,Active,3658616,[],CHEMBL1613813,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-022. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.5,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,31622.8,CHEMBL614696,Homo sapiens,Lymphoblastoid cell,9606.0,,,Potency,um,UO_0000065,,31.6228
66386,,Inconclusive,3698502,[],CHEMBL1613904,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-026. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.2,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,63095.7,CHEMBL614696,Homo sapiens,Lymphoblastoid cell,9606.0,,,Potency,um,UO_0000065,,63.0957
66387,,Inconclusive,3755775,[],CHEMBL1613918,"PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ]",F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.0,0,http://www.openphacts.org/units/Nanomolar,1042837,=,7,1,=,,Potency,nM,,10000.0,CHEMBL5514,Homo sapiens,Huntingtin,9606.0,,,Potency,um,UO_0000065,,10.0
66388,,Inconclusive,3773642,[],CHEMBL1613947,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-009. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.3,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,50118.7,CHEMBL614696,Homo sapiens,Lymphoblastoid cell,9606.0,,,Potency,um,UO_0000065,,50.1187
66389,,Inconclusive,3775664,[],CHEMBL1613950,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-015. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.3,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,50118.7,CHEMBL614696,Homo sapiens,Lymphoblastoid cell,9606.0,,,Potency,um,UO_0000065,,50.1187
66390,,Inconclusive,3778981,[],CHEMBL1613967,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-020. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.3,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,50118.7,CHEMBL614696,Homo sapiens,Lymphoblastoid cell,9606.0,,,Potency,um,UO_0000065,,50.1187
66391,,Not Active,3874536,[],CHEMBL1613842,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.35,0,http://www.openphacts.org/units/Nanomolar,1042837,=,7,1,=,,Potency,nM,,4466.8,CHEMBL1293232,Homo sapiens,Survival motor neuron protein,9606.0,,,Potency,um,UO_0000065,,4.4668
66392,,Not Active,3878006,[],CHEMBL1613842,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.2,0,http://www.openphacts.org/units/Nanomolar,1157909,=,7,1,=,,Potency,nM,,6309.6,CHEMBL1293232,Homo sapiens,Survival motor neuron protein,9606.0,,,Potency,um,UO_0000065,,6.3096
66393,,Inconclusive,3894660,[],CHEMBL1613853,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-016. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.3,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,50118.7,CHEMBL614696,Homo sapiens,Lymphoblastoid cell,9606.0,,,Potency,um,UO_0000065,,50.1187
66394,,Inconclusive,3902942,[],CHEMBL1613876,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-005. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.5,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,31622.8,CHEMBL614696,Homo sapiens,Lymphoblastoid cell,9606.0,,,Potency,um,UO_0000065,,31.6228
66395,,Not Active,3906611,[],CHEMBL1613842,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.1,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,7943.3,CHEMBL1293232,Homo sapiens,Survival motor neuron protein,9606.0,,,Potency,um,UO_0000065,,7.9433
66396,,Inconclusive,3920558,[],CHEMBL1614356,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-017. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.4,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,39810.7,CHEMBL614696,Homo sapiens,Lymphoblastoid cell,9606.0,,,Potency,um,UO_0000065,,39.8107
66397,,Inconclusive,3939356,[],CHEMBL1614361,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.1,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,7943.3,CHEMBL1963,Homo sapiens,Thyroid stimulating hormone receptor,9606.0,,,Potency,um,UO_0000065,,7.9433
66398,,Inconclusive,3951414,[],CHEMBL1614492,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-008. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.4,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,39810.7,CHEMBL614696,Homo sapiens,Lymphoblastoid cell,9606.0,,,Potency,um,UO_0000065,,39.8107
66399,,Inconclusive,4032894,[],CHEMBL1614421,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",B,,,BAO_0000186,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,"{'bei': '13.68', 'le': '0.25', 'lle': '1.50', 'sei': '11.27'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.6,0,http://www.openphacts.org/units/Nanomolar,1042837,=,7,1,=,,Potency,nM,,25118.9,CHEMBL1293224,Homo sapiens,Microtubule-associated protein tau,9606.0,,,Potency,um,UO_0000065,,25.1189
66400,,Active,4046548,[],CHEMBL1614421,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",B,,,BAO_0000186,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,"{'bei': '14.12', 'le': '0.26', 'lle': '1.65', 'sei': '11.64'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.75,0,http://www.openphacts.org/units/Nanomolar,1157909,=,7,1,=,,Potency,nM,,17782.8,CHEMBL1293224,Homo sapiens,Microtubule-associated protein tau,9606.0,,,Potency,um,UO_0000065,,17.7828
66401,,Inconclusive,4057310,[],CHEMBL1614425,PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Live Cells. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.4,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,39810.7,CHEMBL614696,Homo sapiens,Lymphoblastoid cell,9606.0,,,Potency,um,UO_0000065,,39.8107
66402,,Inconclusive,4076419,[],CHEMBL1614441,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.45,0,http://www.openphacts.org/units/Nanomolar,1042837,=,7,1,=,,Potency,nM,,35481.3,CHEMBL1293231,Mus musculus,Nuclear receptor ROR-gamma,10090.0,,,Potency,um,UO_0000065,,35.4813
66403,,Inconclusive,4098963,[],CHEMBL1614441,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.8,0,http://www.openphacts.org/units/Nanomolar,1157909,=,7,1,=,,Potency,nM,,15848.9,CHEMBL1293231,Mus musculus,Nuclear receptor ROR-gamma,10090.0,,,Potency,um,UO_0000065,,15.8489
66404,,Inconclusive,4106464,[],CHEMBL1614393,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-012. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.4,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,39810.7,CHEMBL614696,Homo sapiens,Lymphoblastoid cell,9606.0,,,Potency,um,UO_0000065,,39.8107
66405,,Inconclusive,4188783,[],CHEMBL1614458,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.6,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,25118.9,CHEMBL3577,Homo sapiens,Aldehyde dehydrogenase 1A1,9606.0,,,Potency,um,UO_0000065,,25.1189
66406,,Inconclusive,4201622,[],CHEMBL1614459,PUBCHEM_BIOASSAY: qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,7.09,0,http://www.openphacts.org/units/Nanomolar,1042837,=,7,1,=,,Potency,nM,,82.0,CHEMBL612545,,Unchecked,,,,Potency,um,UO_0000065,,0.082
66407,,Inconclusive,4287370,[],CHEMBL1614459,PUBCHEM_BIOASSAY: qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,6.64,0,http://www.openphacts.org/units/Nanomolar,1264003,=,7,1,=,,Potency,nM,,231.1,CHEMBL612545,,Unchecked,,,,Potency,um,UO_0000065,,0.2311
66408,,Inconclusive,4292343,[],CHEMBL1614132,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-021. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.1,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,79432.8,CHEMBL614696,Homo sapiens,Lymphoblastoid cell,9606.0,,,Potency,um,UO_0000065,,79.4328
66409,,Not Active,4411266,[],CHEMBL1614234,PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium. (Class of assay: confirmatory) [Related pubchem assays: 901 ],F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.4,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,3981.1,CHEMBL1293238,Rattus norvegicus,Inositol monophosphatase 1,10116.0,,,Potency,um,UO_0000065,,3.9811
66410,,Inconclusive,4588688,[],CHEMBL1614275,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ]",F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.75,0,http://www.openphacts.org/units/Nanomolar,1042837,=,7,1,=,,Potency,nM,,17740.7,CHEMBL1293234,Giardia intestinalis,"Putative fructose-1,6-bisphosphate aldolase",5741.0,,,Potency,um,UO_0000065,,17.7407
66411,,Inconclusive,4605453,[],CHEMBL1614275,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ]",F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.35,0,http://www.openphacts.org/units/Nanomolar,1157909,=,7,1,=,,Potency,nM,,4456.3,CHEMBL1293234,Giardia intestinalis,"Putative fructose-1,6-bisphosphate aldolase",5741.0,,,Potency,um,UO_0000065,,4.4563
66412,,Inconclusive,4635124,[],CHEMBL1613797,PUBCHEM_BIOASSAY: qHTS Assay for Anthrax Lethal Toxin Internalization. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.7,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,19952.6,CHEMBL4372,Bacillus anthracis,Anthrax lethal factor,1392.0,,,Potency,um,UO_0000065,,19.9526
66413,,Inconclusive,4647033,[],CHEMBL1614530,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.95,0,http://www.openphacts.org/units/Nanomolar,1264003,=,7,1,=,,Potency,nM,,11220.2,CHEMBL2026,Escherichia coli K-12,Beta-lactamase AmpC,83333.0,,,Potency,um,UO_0000065,,11.2202
66414,,Inconclusive,4674534,[],CHEMBL1613785,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-010. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.4,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,39810.7,CHEMBL614696,Homo sapiens,Lymphoblastoid cell,9606.0,,,Potency,um,UO_0000065,,39.8107
66415,,Not Active,4711357,[],CHEMBL1614281,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.1,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,7943.3,CHEMBL1963,Homo sapiens,Thyroid stimulating hormone receptor,9606.0,,,Potency,um,UO_0000065,,7.9433
66416,,Inconclusive,4717930,[],CHEMBL1614528,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-018. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.5,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,31622.8,CHEMBL614696,Homo sapiens,Lymphoblastoid cell,9606.0,,,Potency,um,UO_0000065,,31.6228
66417,,Inconclusive,4723568,[],CHEMBL1614329,"PUBCHEM_BIOASSAY: Cell Viability - LYMP1-003 - Assay at 40 hr. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.7,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,19952.6,CHEMBL614696,Homo sapiens,Lymphoblastoid cell,9606.0,,,Potency,um,UO_0000065,,19.9526
66418,,Inconclusive,4818018,[],CHEMBL1614087,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.1,0,http://www.openphacts.org/units/Nanomolar,1042837,=,7,1,=,,Potency,nM,,7943.3,CHEMBL1293231,Mus musculus,Nuclear receptor ROR-gamma,10090.0,,,Potency,um,UO_0000065,,7.9433
66419,,Inconclusive,4868954,[],CHEMBL1614218,PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.4,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,3981.1,CHEMBL612545,,Unchecked,,,,Potency,um,UO_0000065,,3.9811
66420,,Active,4876690,[],CHEMBL1614216,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-001. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.4,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,39810.7,CHEMBL614696,Homo sapiens,Lymphoblastoid cell,9606.0,,,Potency,um,UO_0000065,,39.8107
66421,,Inconclusive,4896490,[],CHEMBL1614049,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-007. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.4,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,39810.7,CHEMBL614696,Homo sapiens,Lymphoblastoid cell,9606.0,,,Potency,um,UO_0000065,,39.8107
66422,,Inconclusive,4902149,[],CHEMBL1614072,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-014. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.4,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,39810.7,CHEMBL614696,Homo sapiens,Lymphoblastoid cell,9606.0,,,Potency,um,UO_0000065,,39.8107
66423,,Inconclusive,4905430,[],CHEMBL1614053,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-013. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.1,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,79432.8,CHEMBL614696,Homo sapiens,Lymphoblastoid cell,9606.0,,,Potency,um,UO_0000065,,79.4328
66424,,Not Active,4949625,[],CHEMBL1614108,PUBCHEM_BIOASSAY: qHTS Assay for Activators of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ],A,,,BAO_0000186,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.9,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,12589.3,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,Potency,um,UO_0000065,,12.5893
66425,,Not Active,4961324,[],CHEMBL1614108,PUBCHEM_BIOASSAY: qHTS Assay for Activators of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ],A,,,BAO_0000186,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.8,0,http://www.openphacts.org/units/Nanomolar,1157909,=,7,1,=,,Potency,nM,,15848.9,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,Potency,um,UO_0000065,,15.8489
66426,,Inconclusive,4976581,[],CHEMBL1614092,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-019. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.4,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,39810.7,CHEMBL614696,Homo sapiens,Lymphoblastoid cell,9606.0,,,Potency,um,UO_0000065,,39.8107
66427,,Active,4984518,[],CHEMBL1614097,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-024. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.4,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,39810.7,CHEMBL614696,Homo sapiens,Lymphoblastoid cell,9606.0,,,Potency,um,UO_0000065,,39.8107
66428,,Active,5018546,[],CHEMBL1613886,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ],A,,,BAO_0000186,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.9,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,12589.3,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,Potency,um,UO_0000065,,12.5893
66429,,Active,5026813,[],CHEMBL1613886,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ],A,,,BAO_0000186,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.8,0,http://www.openphacts.org/units/Nanomolar,1157909,=,7,1,=,,Potency,nM,,15848.9,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,Potency,um,UO_0000065,,15.8489
66430,,Inconclusive,5069076,[],CHEMBL1613942,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-006. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.4,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,,Potency,nM,,39810.7,CHEMBL614696,Homo sapiens,Lymphoblastoid cell,9606.0,,,Potency,um,UO_0000065,,39.8107
66431,,,5119563,[],CHEMBL1638723,Antibacterial activity against wild-type Staphylococcus aureus 8325-4 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1629702,Antimicrob Agents Chemother,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1313080,=,1,1,=,,MIC,nM,,325000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,325.0
66432,,,5119564,[],CHEMBL1638724,Antibacterial activity against NorA-deficient Staphylococcus aureus K1758 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1629702,Antimicrob Agents Chemother,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1313080,=,1,1,=,,MIC,nM,,40000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,40.0
66433,,,5119565,[],CHEMBL1638725,Antibacterial activity against Staphylococcus aureus K2378 overexpressing NorA after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1629702,Antimicrob Agents Chemother,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1313080,>,1,1,>,,MIC,nM,,650000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,650.0
66434,,Active,5119575,[],CHEMBL1638738,Antibacterial activity against NorA-deficient Staphylococcus aureus K1758 after 18 hrs by two fold serial dilution method in presence of INF55,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1629702,Antimicrob Agents Chemother,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1313080,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
66435,,Active,5119576,[],CHEMBL1638739,Inhibition of NorA in Staphylococcus aureus 8325-4 assessed as decrease in Berberine MIC,B,,,BAO_0000375,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1629702,Antimicrob Agents Chemother,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1313080,,1,0,,,Activity,,,,CHEMBL5114,Staphylococcus aureus,Quinolone resistance protein norA,1280.0,,,Activity,,,,
66436,,Active,5119577,[],CHEMBL1638740,Inhibition of NorA in Staphylococcus aureus K2378 overexpressing NorA assessed as decrease in Berberine MIC,B,,,BAO_0000375,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1629702,Antimicrob Agents Chemother,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1313080,,1,0,,,Activity,,,,CHEMBL5114,Staphylococcus aureus,Quinolone resistance protein norA,1280.0,,,Activity,,,,
66437,,Not Active,5119581,[],CHEMBL1638728,Inhibition of NorA in Staphylococcus aureus 8325-4 assessed as accumulation of compound at 3 uM by fluorescence assay,B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1629702,Antimicrob Agents Chemother,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1313080,,1,0,,,Inhibition,%,,,CHEMBL5114,Staphylococcus aureus,Quinolone resistance protein norA,1280.0,,,INH,,UO_0000187,,
66438,,Not Active,5119582,[],CHEMBL1638729,Inhibition of NorA in Staphylococcus aureus K2378 overexpressing NorA assessed as accumulation of compound at 3 uM by fluorescence assay,B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1629702,Antimicrob Agents Chemother,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1313080,,1,0,,,Inhibition,%,,,CHEMBL5114,Staphylococcus aureus,Quinolone resistance protein norA,1280.0,,,INH,,UO_0000187,,
66439,,Active,5119583,[],CHEMBL1638730,Inhibition of NorA in Staphylococcus aureus 8325-4 assessed as accumulation of Berberine at 3 uM by fluorescence assay in presence of INF55,B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1629702,Antimicrob Agents Chemother,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1313080,,1,0,,,Inhibition,%,,,CHEMBL5114,Staphylococcus aureus,Quinolone resistance protein norA,1280.0,,,INH,,UO_0000187,,
66440,,Active,5119584,[],CHEMBL1638731,Inhibition of NorA in Staphylococcus aureus K2378 overexpressing NorA assessed as accumulation of Berberine at 3 uM by fluorescence assay in presence of INF55,B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1629702,Antimicrob Agents Chemother,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1313080,,1,0,,,Inhibition,%,,,CHEMBL5114,Staphylococcus aureus,Quinolone resistance protein norA,1280.0,,,INH,,UO_0000187,,
66441,,Active,5119585,[],CHEMBL1638732,Inhibition of NorA in Staphylococcus aureus 8325-4 assessed as assessed as accumulation of compound at 3 uM by fluorescence assay,B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1629702,Antimicrob Agents Chemother,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1313080,,1,0,,,Inhibition,%,,,CHEMBL5114,Staphylococcus aureus,Quinolone resistance protein norA,1280.0,,,INH,,UO_0000187,,
66442,,Active,5119586,[],CHEMBL1638741,Cellular uptake in NorA-deficient Staphylococcus aureus K1758 assessed as accumulation of compound at 3 uM by fluorescence assay,A,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1629702,Antimicrob Agents Chemother,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1313080,,1,0,,,Drug uptake,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Drug uptake,,,,
66443,,,5212450,[],CHEMBL1680768,Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBADomeganorM plasmid containing Neisseria gonorrhoeae multidrug efflux pump NorM after 18 to 24 hrs by two fold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1671618,Antimicrob Agents Chemother,2008.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331765,=,1,1,=,,MIC,ug.mL-1,,250.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,250.0
66444,,,5212451,[],CHEMBL1680772,Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBADomegaydhE plasmid containing Escherichia coli multidrug efflux pump YdhE after 18 to 24 hrs by two fold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1671618,Antimicrob Agents Chemother,2008.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331765,=,1,1,=,,MIC,ug.mL-1,,250.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,250.0
66445,,,5212452,[],CHEMBL1680771,Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBAD plasmid after 18 to 24 hrs by two fold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1671618,Antimicrob Agents Chemother,2008.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331765,=,1,1,=,,MIC,ug.mL-1,,31.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,31.25
66446,,inconclusive,5396415,[],CHEMBL1737994,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504444]",F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,,Potency,nM,,25929.0,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,25.929
66447,,inconclusive,5405362,[],CHEMBL1737994,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504444]",F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,,Potency,nM,,16360.1,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,16.3601
66448,,inconclusive,5474350,[],CHEMBL1738184,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,,Potency,nM,,9200.0,CHEMBL1075094,Homo sapiens,Nuclear factor erythroid 2-related factor 2,9606.0,,,Potency,uM,UO_0000065,,9.2
66449,,inconclusive,5477573,[],CHEMBL1738184,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,,Potency,nM,,29092.9,CHEMBL1075094,Homo sapiens,Nuclear factor erythroid 2-related factor 2,9606.0,,,Potency,uM,UO_0000065,,29.0929
66450,,inconclusive,5745533,[],CHEMBL1738442,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,,Potency,nM,,10000.0,CHEMBL6032,Homo sapiens,"Histone-lysine N-methyltransferase, H3 lysine-9 specific 3",9606.0,,,Potency,uM,UO_0000065,,10.0
66451,,inconclusive,5934495,[],CHEMBL1738588,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,,Potency,nM,,231.1,CHEMBL1741209,Homo sapiens,ATPase family AAA domain-containing protein 5,9606.0,,,Potency,uM,UO_0000065,,0.2311
66452,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",transporter substrate,6073652,[],CHEMBL1743157,"Substrates of transporters of clinical importance in the absorption and disposition of drugs, MDR1",A,,,BAO_0000375,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1743141,Nat Rev Drug Discov,2010.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1393588,,1,0,,,Activity,,,,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,Activity,,,,
66453,,,6149679,[],CHEMBL1764320,Antiviral activity against 0.05 MOI Human immunodeficiency virus 1 NL4.3 infected in human CEM cells expressing green fluorescent protein assessed as p24 antigen production at 0.29 uM measured 7 days post infection by ELISA,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1759861,Eur J Med Chem,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1413335,=,1,1,=,,Inhibition,%,,66.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676.0,,,INH,%,UO_0000187,,66.0
66454,,,6149698,[],CHEMBL1764652,Inhibition of Human immunodeficiency virus 1 NL4.3 reverse transcriptase activity at 20 ug/ml,B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1759861,Eur J Med Chem,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1413335,=,1,1,=,,Inhibition,%,,94.0,CHEMBL247,Human immunodeficiency virus 1,Human immunodeficiency virus type 1 reverse transcriptase,11676.0,,,INH,%,UO_0000187,,94.0
66455,,,6149702,[],CHEMBL1764653,Inhibition of Human immunodeficiency virus 1 NL4.3 reverse transcriptase activity,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1759861,Eur J Med Chem,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,1,http://www.openphacts.org/units/MicrogramPerMilliliter,1413335,=,1,1,=,,IC50,ug.mL-1,,100.0,CHEMBL247,Human immunodeficiency virus 1,Human immunodeficiency virus type 1 reverse transcriptase,11676.0,,,IC50,ug ml-1,UO_0000274,,100.0
66456,,,6155554,[],CHEMBL1764262,Cytotoxicity against human CEM cells expressing green fluorescent protein after 48 hrs by MTT assay,A,,,BAO_0000187,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1759861,Eur J Med Chem,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1413335,=,1,1,=,,CC50,nM,,2090.0,CHEMBL382,Homo sapiens,CCRF-CEM,9606.0,,,CC50,uM,UO_0000065,,2.09
66457,,,6155573,[],CHEMBL1764263,Antiviral activity against 0.05 MOI Human immunodeficiency virus 1 NL4.3 infected in human CEM cells expressing green fluorescent protein assessed as p24 antigen production measured 7 days post infection by ELISA,F,,,BAO_0000188,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1759861,Eur J Med Chem,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,6.89,0,http://www.openphacts.org/units/Nanomolar,1413335,=,1,1,=,,EC50,nM,,130.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676.0,,,EC50,uM,UO_0000065,,0.13
66458,,,6155592,[],CHEMBL1764264,"Therapeutic index, ratio of CC50 for human CEM cells expressing green fluorescent protein to EC50 for Human immunodeficiency virus 1 NL4.3",A,,,BAO_0000179,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1759861,Eur J Med Chem,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1413335,=,1,0,=,,TI,,,16.07,CHEMBL612558,,ADMET,,,,TI,,,,16.07
66459,,,6168791,[],CHEMBL1767832,Inhibition of electric eel Acetylcholinesterase,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1765080,Bioorg Med Chem,2011.0,"{'bei': '19.11', 'le': '0.35', 'lle': '3.33', 'sei': '15.75'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,6.43,1,http://www.openphacts.org/units/Nanomolar,1416884,=,1,1,=,,IC50,nM,,374.0,CHEMBL4078,Electrophorus electricus,Acetylcholinesterase,8005.0,,,IC50,uM,UO_0000065,,0.374
66460,,,6168809,[],CHEMBL1767833,Inhibition of equine serum Butyrylcholinesterase,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1765080,Bioorg Med Chem,2011.0,"{'bei': '14.09', 'le': '0.26', 'lle': '1.64', 'sei': '11.62'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.74,1,http://www.openphacts.org/units/Nanomolar,1416884,=,1,1,=,,IC50,nM,,18200.0,CHEMBL5077,Equus caballus,Butyrylcholinesterase,9796.0,,,IC50,uM,UO_0000065,,18.2
66461,,,6168827,[],CHEMBL1767831,Ratio of IC50 for equine serum Butyrylcholinesterase to IC50 for electric eel Acetylcholinesterase,B,,,BAO_0000179,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1765080,Bioorg Med Chem,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1416884,=,1,0,=,,Ratio IC50,,,48.6,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,48.6
66462,,,6168846,[],CHEMBL1767829,Inhibition of amyloid-beta (1 to 42) aggregation at 20 uM after 48 hrs by fluorescence analysis using thioflavin T,B,,,BAO_0000201,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1765080,Bioorg Med Chem,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1416884,=,1,1,=,,Inhibition,%,,36.3,CHEMBL612545,,Unchecked,,,,INH,%,UO_0000187,,36.3
66463,,,6177731,[],CHEMBL1772625,Thermal stability of c-MYC FPu18T G-quadruplex DNA assessed as stabilization temperature at 2 uM by FRET assay,B,,,BAO_0000179,BAO_0000225,nucleic acid format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1770141,Eur J Med Chem,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#DegreeCelsius,1419134,=,1,1,=,,Delta Tm,degrees C,,1.0,CHEMBL345,,Nucleic Acid,,,,deltaTm,degrees C,UO_0000027,,1.0
66464,,,6177740,[],CHEMBL1772626,Thermal stability of F10T duplex DNA assessed as stabilization temperature at 2 uM by FRET assay,B,,,BAO_0000179,BAO_0000225,nucleic acid format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1770141,Eur J Med Chem,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#DegreeCelsius,1419134,=,1,1,=,,Delta Tm,degrees C,,2.0,CHEMBL345,,Nucleic Acid,,,,deltaTm,degrees C,UO_0000027,,2.0
66465,,,6195967,[],CHEMBL1775670,Antiproliferative activity against rat VSMC assessed as cell growth inhibition,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1772972,J Nat Prod,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1421166,=,1,1,=,,GI50,nM,,95100.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,GI50,uM,UO_0000065,,95.1
66466,,,6195969,[],CHEMBL1775671,Growth inhibition against rat VSMC after 72 hrs by MTT assay,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1772972,J Nat Prod,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1421166,=,1,1,=,,GI50,nM,,95140.0,CHEMBL612545,,Unchecked,,,,GI50,uM,UO_0000065,,95.14
66467,,,6195971,[],CHEMBL1775672,Growth inhibition against rat A10 cells after 72 hrs by MTT assay,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1772972,J Nat Prod,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1421166,=,1,1,=,,GI50,nM,,101620.0,CHEMBL614513,Rattus norvegicus,A10,10116.0,,,GI50,uM,UO_0000065,,101.62
66468,,,6195974,[],CHEMBL1775674,Growth inhibition against human SKN cells after 72 hrs by MTT assay,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1772972,J Nat Prod,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1421166,=,1,1,=,,GI50,nM,,15880.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,GI50,uM,UO_0000065,,15.88
66469,,,6195977,[],CHEMBL1775675,Growth inhibition against human RKN cells after 48 hrs by MTT assay,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1772972,J Nat Prod,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1421166,=,1,1,=,,GI50,nM,,49600.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,GI50,uM,UO_0000065,,49.6
66470,,,6195979,[],CHEMBL1775676,Growth inhibition against human G402 cells after 48 hrs by MTT assay,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1772972,J Nat Prod,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1421166,=,1,1,=,,GI50,nM,,11870.0,CHEMBL1075446,Homo sapiens,G-402,9606.0,,,GI50,uM,UO_0000065,,11.87
66471,,Active,6195984,[],CHEMBL1775679,Downregulation of Scd2 mRNA expression in rat A10 cells at 30 uM after 24 hrs by quantitative RT-PCR analysis,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1772972,J Nat Prod,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1421166,,1,0,,,Activity,,,,CHEMBL614513,Rattus norvegicus,A10,10116.0,,,Activity,,,,
66472,,Active,6195987,[],CHEMBL1775680,Down regulation of Prim2 mRNA expression in rat A10 cells at 30 uM after 24 hrs by quantitative RT-PCR analysis,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1772972,J Nat Prod,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1421166,,1,0,,,Activity,,,,CHEMBL614513,Rattus norvegicus,A10,10116.0,,,Activity,,,,
66473,,Active,6195990,[],CHEMBL1775681,Downregulation of Impk mRNA expression in rat A10 cells at 30 uM after 24 hrs by quantitative RT-PCR analysis,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1772972,J Nat Prod,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1421166,,1,0,,,Activity,,,,CHEMBL614513,Rattus norvegicus,A10,10116.0,,,Activity,,,,
66474,,Not Active,6196001,[],CHEMBL1775739,Upregulation of Rgc32 mRNA expression in rat A10 cells at 3 to 30 uM after 12 hrs by quantitative RT-PCR analysis,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1772972,J Nat Prod,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1421166,,1,0,,,Activity,,,,CHEMBL614513,Rattus norvegicus,A10,10116.0,,,Activity,,,,
66475,,Active,6233969,[],CHEMBL1789905,"NOVARTIS: Antimalarial liver stage activity measured as a greater than 50% reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells at 10uM compound concentration, determined by immuno-fluorescence.",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1789904,Science,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1432136,,3,0,,,Activity,,,,CHEMBL612889,Plasmodium yoelii,Plasmodium yoelii,5861.0,,,Activity,,,,
66476,,,6234139,[],CHEMBL1789906,"NOVARTIS: Antimalarial liver stage activity measured as reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells by immuno-fluorescence, and median schizont size at 10uM compound concentration",F,,,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1789904,Science,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,6.26,0,http://www.openphacts.org/units/Nanomolar,1432136,=,3,1,=,,IC50,nM,,548.0,CHEMBL612889,Plasmodium yoelii,Plasmodium yoelii,5861.0,,,IC50,uM,UO_0000065,,0.548
66477,,163.00 pixels,6234772,[],CHEMBL1789906,"NOVARTIS: Antimalarial liver stage activity measured as reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells by immuno-fluorescence, and median schizont size at 10uM compound concentration",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1789904,Science,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Micrometer,1432136,=,3,0,=,,Schizont size,um,,102.08,CHEMBL612889,Plasmodium yoelii,Plasmodium yoelii,5861.0,,,Schizont size,um,UO_0000017,,102.08
66478,,inconclusive,6469917,[],CHEMBL1794364,PUBCHEM_BIOASSAY: qHTS assay for small molecule agonists of estrogen receptor alpha signaling. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1010458,,7,1,,,Potency,nM,,11220.2,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,Potency,uM,UO_0000065,,11.2202
66479,,active,6550855,[],CHEMBL1794345,"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]",F,,,BAO_0000186,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,,Potency,nM,,65.7,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Potency,uM,UO_0000065,,0.0657
66480,,active,6707035,[],CHEMBL1794345,"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]",F,,,BAO_0000186,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,,Potency,nM,,147.2,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Potency,uM,UO_0000065,,0.1472
66481,,inconclusive,6816502,[],CHEMBL1794424,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,,Potency,nM,,79432.8,CHEMBL6035,Rattus norvegicus,"Thioredoxin reductase 1, cytoplasmic",10116.0,,,Potency,uM,UO_0000065,,79.4328
66482,,active,6851299,[],CHEMBL1794496,"PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435005, AID435007]",F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.49,0,http://www.openphacts.org/units/Nanomolar,1264003,=,7,1,=,,AC50,nM,,3252.0,CHEMBL613545,Rattus norvegicus,INS1,10116.0,,,AC50,uM,UO_0000065,,3.252
66483,,inconclusive,6868869,[],CHEMBL1794486,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813],F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,,Potency,nM,,19952.6,CHEMBL5027,Homo sapiens,Flap endonuclease 1,9606.0,,,Potency,uM,UO_0000065,,19.9526
66484,,inconclusive,6885566,[],CHEMBL1794483,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,,Potency,nM,,8912.5,CHEMBL5391,Homo sapiens,DNA polymerase iota,9606.0,,,Potency,uM,UO_0000065,,8.9125
66485,,inconclusive,6890568,[],CHEMBL1794486,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813],F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,,Potency,nM,,44668.4,CHEMBL5027,Homo sapiens,Flap endonuclease 1,9606.0,,,Potency,uM,UO_0000065,,44.6684
66486,,inconclusive,6926269,[],CHEMBL1794483,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,,Potency,nM,,39810.7,CHEMBL5391,Homo sapiens,DNA polymerase iota,9606.0,,,Potency,uM,UO_0000065,,39.8107
66487,,inconclusive,6958508,[],CHEMBL1794560,PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of androgen receptor signaling. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1010458,,7,1,,,Potency,nM,,31622.8,CHEMBL1871,Homo sapiens,Androgen Receptor,9606.0,,,Potency,uM,UO_0000065,,31.6228
66488,,inconclusive,7029822,[],CHEMBL1794552,PUBCHEM_BIOASSAY: qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1010458,,7,1,,,Potency,nM,,19952.6,CHEMBL3979,Homo sapiens,Peroxisome proliferator-activated receptor delta,9606.0,,,Potency,uM,UO_0000065,,19.9526
66489,,inconclusive,7043979,[],CHEMBL1794512,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Cell Surface uPA Generation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493178],F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,,Potency,nM,,6309.6,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,6.3096
66490,,inconclusive,7054771,[],CHEMBL1794512,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Cell Surface uPA Generation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493178],F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,,Potency,nM,,4466.8,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,4.4668
66491,,inconclusive,7066530,[],CHEMBL1794524,PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1010458,,7,1,,,Potency,nM,,44668.4,CHEMBL3979,Homo sapiens,Peroxisome proliferator-activated receptor delta,9606.0,,,Potency,uM,UO_0000065,,44.6684
66492,,active,7135343,[],CHEMBL1794580,"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]",F,,,BAO_0000186,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,,Potency,nM,,233.2,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Potency,uM,UO_0000065,,0.2332
66493,,active,7138137,[],CHEMBL1794580,"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]",F,,,BAO_0000186,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,,Potency,nM,,207.9,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Potency,uM,UO_0000065,,0.2079
66494,,inconclusive,7371331,[],CHEMBL1794308,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]",F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,,Potency,nM,,11582.1,CHEMBL614818,Homo sapiens,HEK293,9606.0,,,Potency,uM,UO_0000065,,11.5821
66495,,inconclusive,7438164,[],CHEMBL1794375,"PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",B,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,,Potency,nM,,14581.0,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,14.581
66496,,inconclusive,7464485,[],CHEMBL1794382,PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of glucocorticoid receptor signaling. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1010458,,7,1,,,Potency,nM,,3162.3,CHEMBL2034,Homo sapiens,Glucocorticoid receptor,9606.0,,,Potency,uM,UO_0000065,,3.1623
66497,,inconclusive,7527924,[],CHEMBL1794375,"PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",B,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,,Potency,nM,,14581.0,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,14.581
66498,,inactive,7553661,[],CHEMBL1794467,PUBCHEM_BIOASSAY: Inhibitors of USP1/UAF1: Pilot qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504878],F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1157909,,7,1,,,Potency,nM,,50118.7,CHEMBL1795087,Homo sapiens,Ubiquitin carboxyl-terminal hydrolase 1,9606.0,,,Potency,uM,UO_0000065,,50.1187
66499,,inconclusive,7557516,[],CHEMBL1794440,PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,,Potency,nM,,89125.1,CHEMBL6035,Rattus norvegicus,"Thioredoxin reductase 1, cytoplasmic",10116.0,,,Potency,uM,UO_0000065,,89.1251
66500,,,7599389,[],CHEMBL1909212,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,"{'bei': '18.17', 'le': '0.33', 'lle': '3.01', 'sei': '14.98'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,6.11,0,http://www.openphacts.org/units/Nanomolar,1539543,=,15,1,=,,IC50,nM,,774.0,CHEMBL220,Homo sapiens,Acetylcholinesterase,9606.0,,,IC50,uM,UO_0000065,,0.774
66501,,Note: corresponding IC50 reported as Active,7599390,[],CHEMBL1909212,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),B,,,BAO_0000192,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL220,Homo sapiens,Acetylcholinesterase,9606.0,,,Ki,,,,
66502,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599391,[],CHEMBL1909213,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL226,Homo sapiens,Adenosine A1 receptor,9606.0,,,IC50,,,,
66503,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599392,[],CHEMBL1909213,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL226,Homo sapiens,Adenosine A1 receptor,9606.0,,,Ki,,,,
66504,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599393,[],CHEMBL1909214,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL251,Homo sapiens,Adenosine A2a receptor,9606.0,,,IC50,,,,
66505,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599394,[],CHEMBL1909214,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL251,Homo sapiens,Adenosine A2a receptor,9606.0,,,Ki,,,,
66506,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599395,[],CHEMBL1909215,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,IC50,,,,
66507,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599396,[],CHEMBL1909215,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,Ki,,,,
66508,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599397,[],CHEMBL1909084,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66509,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599398,[],CHEMBL1909084,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66510,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599399,[],CHEMBL1909085,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL319,Rattus norvegicus,Alpha-1a adrenergic receptor,10116.0,,,IC50,,,,
66511,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599400,[],CHEMBL1909085,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL319,Rattus norvegicus,Alpha-1a adrenergic receptor,10116.0,,,Ki,,,,
66512,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599401,[],CHEMBL1909086,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL315,Rattus norvegicus,Alpha-1b adrenergic receptor,10116.0,,,IC50,,,,
66513,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599402,[],CHEMBL1909086,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL315,Rattus norvegicus,Alpha-1b adrenergic receptor,10116.0,,,Ki,,,,
66514,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599403,[],CHEMBL1909087,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL223,Homo sapiens,Alpha-1d adrenergic receptor,9606.0,,,IC50,,,,
66515,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599404,[],CHEMBL1909087,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL223,Homo sapiens,Alpha-1d adrenergic receptor,9606.0,,,Ki,,,,
66516,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599405,[],CHEMBL1909088,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,IC50,,,,
66517,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599406,[],CHEMBL1909088,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,Ki,,,,
66518,,,7599407,[],CHEMBL1909089,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,"{'bei': '18.49', 'le': '0.34', 'lle': '3.12', 'sei': '15.25'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,6.22,0,http://www.openphacts.org/units/Nanomolar,1539543,=,15,1,=,,IC50,nM,,601.0,CHEMBL1942,Homo sapiens,Alpha-2b adrenergic receptor,9606.0,,,IC50,uM,UO_0000065,,0.601
66519,,,7599408,[],CHEMBL1909089,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,"{'bei': '19.51', 'le': '0.36', 'lle': '3.46', 'sei': '16.08'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,6.56,0,http://www.openphacts.org/units/Nanomolar,1539543,=,15,1,=,,Ki,nM,,274.0,CHEMBL1942,Homo sapiens,Alpha-2b adrenergic receptor,9606.0,,,Ki,uM,UO_0000065,,0.274
66520,,,7599409,[],CHEMBL1909090,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,"{'bei': '16.49', 'le': '0.30', 'lle': '2.45', 'sei': '13.60'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.55,0,http://www.openphacts.org/units/Nanomolar,1539543,=,15,1,=,,IC50,nM,,2837.0,CHEMBL1916,Homo sapiens,Alpha-2c adrenergic receptor,9606.0,,,IC50,uM,UO_0000065,,2.837
66521,,,7599410,[],CHEMBL1909090,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,"{'bei': '18.98', 'le': '0.35', 'lle': '3.29', 'sei': '15.65'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,6.38,0,http://www.openphacts.org/units/Nanomolar,1539543,=,15,1,=,,Ki,nM,,412.0,CHEMBL1916,Homo sapiens,Alpha-2c adrenergic receptor,9606.0,,,Ki,uM,UO_0000065,,0.412
66522,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599411,[],CHEMBL1909091,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL213,Homo sapiens,Beta-1 adrenergic receptor,9606.0,,,IC50,,,,
66523,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599412,[],CHEMBL1909091,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL213,Homo sapiens,Beta-1 adrenergic receptor,9606.0,,,Ki,,,,
66524,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599413,[],CHEMBL1909092,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL210,Homo sapiens,Beta-2 adrenergic receptor,9606.0,,,IC50,,,,
66525,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599414,[],CHEMBL1909092,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL210,Homo sapiens,Beta-2 adrenergic receptor,9606.0,,,Ki,,,,
66526,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599415,[],CHEMBL1909093,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL246,Homo sapiens,Beta-3 adrenergic receptor,9606.0,,,IC50,,,,
66527,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599416,[],CHEMBL1909093,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL246,Homo sapiens,Beta-3 adrenergic receptor,9606.0,,,Ki,,,,
66528,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599417,[],CHEMBL1909094,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,IC50,,,,
66529,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599418,[],CHEMBL1909094,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,Ki,,,,
66530,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599419,[],CHEMBL1909095,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),B,,,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL2622,Rattus norvegicus,Aldose reductase,10116.0,,,IC50,,,,
66531,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599420,[],CHEMBL1909095,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),B,,,BAO_0000192,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL2622,Rattus norvegicus,Aldose reductase,10116.0,,,Ki,,,,
66532,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599421,[],CHEMBL1909096,DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A),B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL4607,Homo sapiens,Angiotensin II type 2 (AT-2) receptor,9606.0,,,IC50,,,,
66533,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599422,[],CHEMBL1909096,DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A),B,,,BAO_0000192,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL4607,Homo sapiens,Angiotensin II type 2 (AT-2) receptor,9606.0,,,Ki,,,,
66534,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599423,[],CHEMBL1909097,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",B,,,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66535,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599424,[],CHEMBL1909097,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",B,,,BAO_0000192,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66536,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599425,[],CHEMBL1909098,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66537,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599426,[],CHEMBL1909098,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66538,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599427,[],CHEMBL1909099,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66539,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599428,[],CHEMBL1909099,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),B,,,BAO_0000192,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66540,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599429,[],CHEMBL1909100,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL3157,Homo sapiens,Bradykinin B2 receptor,9606.0,,,IC50,,,,
66541,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599430,[],CHEMBL1909100,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL3157,Homo sapiens,Bradykinin B2 receptor,9606.0,,,Ki,,,,
66542,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599431,[],CHEMBL1909101,DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon)),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL1832,Homo sapiens,Calcitonin receptor,9606.0,,,IC50,,,,
66543,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599432,[],CHEMBL1909101,DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon)),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL1832,Homo sapiens,Calcitonin receptor,9606.0,,,Ki,,,,
66544,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599433,[],CHEMBL1909102,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66545,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599434,[],CHEMBL1909102,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66546,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599435,[],CHEMBL1909103,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66547,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599436,[],CHEMBL1909103,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66548,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599437,[],CHEMBL1909121,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66549,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599438,[],CHEMBL1909121,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66550,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599439,[],CHEMBL1909122,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,IC50,,,,
66551,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599440,[],CHEMBL1909122,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,Ki,,,,
66552,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599441,[],CHEMBL1909123,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),B,,,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL205,Homo sapiens,Carbonic anhydrase II,9606.0,,,IC50,,,,
66553,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599442,[],CHEMBL1909123,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),B,,,BAO_0000192,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL205,Homo sapiens,Carbonic anhydrase II,9606.0,,,Ki,,,,
66554,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599443,[],CHEMBL1909124,DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL4015,Homo sapiens,C-C chemokine receptor type 2,9606.0,,,IC50,,,,
66555,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599444,[],CHEMBL1909124,DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL4015,Homo sapiens,C-C chemokine receptor type 2,9606.0,,,Ki,,,,
66556,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599445,[],CHEMBL1909125,DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL2414,Homo sapiens,C-C chemokine receptor type 4,9606.0,,,IC50,,,,
66557,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599446,[],CHEMBL1909125,DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL2414,Homo sapiens,C-C chemokine receptor type 4,9606.0,,,Ki,,,,
66558,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599447,[],CHEMBL1909126,DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL274,Homo sapiens,C-C chemokine receptor type 5,9606.0,,,IC50,,,,
66559,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599448,[],CHEMBL1909126,DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL274,Homo sapiens,C-C chemokine receptor type 5,9606.0,,,Ki,,,,
66560,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599449,[],CHEMBL1909127,DRUGMATRIX: Chemokine CXCR1 (IL-8A),B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL4029,Homo sapiens,Interleukin-8 receptor A,9606.0,,,IC50,,,,
66561,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599450,[],CHEMBL1909127,DRUGMATRIX: Chemokine CXCR1 (IL-8A),B,,,BAO_0000192,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL4029,Homo sapiens,Interleukin-8 receptor A,9606.0,,,Ki,,,,
66562,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599451,[],CHEMBL1909128,DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL2434,Homo sapiens,Interleukin-8 receptor B,9606.0,,,IC50,,,,
66563,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599452,[],CHEMBL1909128,DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL2434,Homo sapiens,Interleukin-8 receptor B,9606.0,,,Ki,,,,
66564,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599453,[],CHEMBL1909129,"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL1901,Homo sapiens,Cholecystokinin A receptor,9606.0,,,IC50,,,,
66565,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599454,[],CHEMBL1909129,"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL1901,Homo sapiens,Cholecystokinin A receptor,9606.0,,,Ki,,,,
66566,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599455,[],CHEMBL1909130,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL221,Homo sapiens,Cyclooxygenase-1,9606.0,,,IC50,,,,
66567,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599456,[],CHEMBL1909130,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000192,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL221,Homo sapiens,Cyclooxygenase-1,9606.0,,,Ki,,,,
66568,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599457,[],CHEMBL1909131,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL230,Homo sapiens,Cyclooxygenase-2,9606.0,,,IC50,,,,
66569,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599458,[],CHEMBL1909131,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000192,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL230,Homo sapiens,Cyclooxygenase-2,9606.0,,,Ki,,,,
66570,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599459,[],CHEMBL1909132,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL3356,Homo sapiens,Cytochrome P450 1A2,9606.0,,,IC50,,,,
66571,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599460,[],CHEMBL1909132,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL3356,Homo sapiens,Cytochrome P450 1A2,9606.0,,,Ki,,,,
66572,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599461,[],CHEMBL1909133,"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL5282,Homo sapiens,Cytochrome P450 2A6,9606.0,,,IC50,,,,
66573,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599462,[],CHEMBL1909133,"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL5282,Homo sapiens,Cytochrome P450 2A6,9606.0,,,Ki,,,,
66574,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599463,[],CHEMBL1909134,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL3622,Homo sapiens,Cytochrome P450 2C19,9606.0,,,IC50,,,,
66575,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599464,[],CHEMBL1909134,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL3622,Homo sapiens,Cytochrome P450 2C19,9606.0,,,Ki,,,,
66576,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599465,[],CHEMBL1909135,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL3397,Homo sapiens,Cytochrome P450 2C9,9606.0,,,IC50,,,,
66577,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599466,[],CHEMBL1909135,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL3397,Homo sapiens,Cytochrome P450 2C9,9606.0,,,Ki,,,,
66578,,,7599467,[],CHEMBL1909136,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,"{'bei': '15.89', 'le': '0.29', 'lle': '2.25', 'sei': '13.10'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.35,0,http://www.openphacts.org/units/Nanomolar,1539543,=,15,1,=,,IC50,nM,,4504.2,CHEMBL289,Homo sapiens,Cytochrome P450 2D6,9606.0,,,IC50,uM,UO_0000065,,4.5042
66579,,Note: corresponding IC50 reported as Active,7599468,[],CHEMBL1909136,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL289,Homo sapiens,Cytochrome P450 2D6,9606.0,,,Ki,,,,
66580,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599469,[],CHEMBL1909137,"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL5281,Homo sapiens,Cytochrome P450 2E1,9606.0,,,IC50,,,,
66581,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599470,[],CHEMBL1909137,"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL5281,Homo sapiens,Cytochrome P450 2E1,9606.0,,,Ki,,,,
66582,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599471,[],CHEMBL1909138,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,IC50,,,,
66583,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599472,[],CHEMBL1909138,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,Ki,,,,
66584,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600807,[],CHEMBL1909139,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,IC50,,,,
66585,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600808,[],CHEMBL1909139,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,Ki,,,,
66586,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600809,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606.0,,,IC50,,,,
66587,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600810,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606.0,,,Ki,,,,
66588,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600811,[],CHEMBL1909141,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,IC50,,,,
66589,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600812,[],CHEMBL1909141,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,Ki,,,,
66590,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600813,[],CHEMBL1909142,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL219,Homo sapiens,Dopamine D4 receptor,9606.0,,,IC50,,,,
66591,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600814,[],CHEMBL1909142,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL219,Homo sapiens,Dopamine D4 receptor,9606.0,,,Ki,,,,
66592,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600815,[],CHEMBL1909143,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,IC50,,,,
66593,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600816,[],CHEMBL1909143,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,Ki,,,,
66594,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600817,[],CHEMBL1909144,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL252,Homo sapiens,Endothelin receptor ET-A,9606.0,,,IC50,,,,
66595,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600818,[],CHEMBL1909144,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL252,Homo sapiens,Endothelin receptor ET-A,9606.0,,,Ki,,,,
66596,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600819,[],CHEMBL1909145,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,IC50,,,,
66597,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600820,[],CHEMBL1909145,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000192,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,Ki,,,,
66598,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600821,[],CHEMBL1909146,DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL242,Homo sapiens,Estrogen receptor beta,9606.0,,,IC50,,,,
66599,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600822,[],CHEMBL1909146,DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000192,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL242,Homo sapiens,Estrogen receptor beta,9606.0,,,Ki,,,,
66600,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600823,[],CHEMBL1909147,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66601,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600824,[],CHEMBL1909147,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66602,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600825,[],CHEMBL1909148,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66603,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600826,[],CHEMBL1909148,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66604,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600827,[],CHEMBL1909149,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66605,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600828,[],CHEMBL1909149,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66606,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600829,[],CHEMBL1909150,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL2034,Homo sapiens,Glucocorticoid receptor,9606.0,,,IC50,,,,
66607,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600830,[],CHEMBL1909150,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),B,,,BAO_0000192,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL2034,Homo sapiens,Glucocorticoid receptor,9606.0,,,Ki,,,,
66608,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600831,[],CHEMBL1909151,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66609,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600832,[],CHEMBL1909151,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66610,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600833,[],CHEMBL1909152,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66611,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600834,[],CHEMBL1909152,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66612,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600835,[],CHEMBL1909153,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66613,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600836,[],CHEMBL1909153,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66614,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600837,[],CHEMBL1909154,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66615,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600838,[],CHEMBL1909154,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66616,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600839,[],CHEMBL1909155,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL3392921,Rattus norvegicus,Glycine receptor,10116.0,,,IC50,,,,
66617,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600840,[],CHEMBL1909155,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL3392921,Rattus norvegicus,Glycine receptor,10116.0,,,Ki,,,,
66618,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600841,[],CHEMBL1909156,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL231,Homo sapiens,Histamine H1 receptor,9606.0,,,IC50,,,,
66619,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600842,[],CHEMBL1909156,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL231,Homo sapiens,Histamine H1 receptor,9606.0,,,Ki,,,,
66620,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600843,[],CHEMBL1909157,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL1941,Homo sapiens,Histamine H2 receptor,9606.0,,,IC50,,,,
66621,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600844,[],CHEMBL1909157,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL1941,Homo sapiens,Histamine H2 receptor,9606.0,,,Ki,,,,
66622,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600845,[],CHEMBL1909158,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL402,Homo sapiens,HMG-CoA reductase,9606.0,,,IC50,,,,
66623,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600846,[],CHEMBL1909158,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),B,,,BAO_0000192,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL402,Homo sapiens,HMG-CoA reductase,9606.0,,,Ki,,,,
66624,,,7600847,[],CHEMBL1909159,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.89,0,http://www.openphacts.org/units/Nanomolar,1539543,=,15,1,=,,IC50,nM,,1278.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,1.278
66625,,,7600848,[],CHEMBL1909159,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,6.07,0,http://www.openphacts.org/units/Nanomolar,1539543,=,15,1,=,,Ki,nM,,852.0,CHEMBL612545,,Unchecked,,,,Ki,uM,UO_0000065,,0.852
66626,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600849,[],CHEMBL1909160,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL5486,Rattus norvegicus,Insulin receptor,10116.0,,,IC50,,,,
66627,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600850,[],CHEMBL1909160,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL5486,Rattus norvegicus,Insulin receptor,10116.0,,,Ki,,,,
66628,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600851,[],CHEMBL1909161,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66629,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600852,[],CHEMBL1909161,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66630,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600853,[],CHEMBL1909162,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66631,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600854,[],CHEMBL1909162,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66632,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600855,[],CHEMBL1909163,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),B,,,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL1909043,Cavia porcellus,Leukotriene C4 synthase,10141.0,,,IC50,,,,
66633,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600856,[],CHEMBL1909163,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),B,,,BAO_0000192,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL1909043,Cavia porcellus,Leukotriene C4 synthase,10141.0,,,Ki,,,,
66634,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600857,[],CHEMBL1909164,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL1798,Homo sapiens,Cysteinyl leukotriene receptor 1,9606.0,,,IC50,,,,
66635,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600858,[],CHEMBL1909164,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL1798,Homo sapiens,Cysteinyl leukotriene receptor 1,9606.0,,,Ki,,,,
66636,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600859,[],CHEMBL1909165,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),B,,,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL4358,Oryctolagus cuniculus,Arachidonate 15-lipoxygenase,9986.0,,,IC50,,,,
66637,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600860,[],CHEMBL1909165,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),B,,,BAO_0000192,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL4358,Oryctolagus cuniculus,Arachidonate 15-lipoxygenase,9986.0,,,Ki,,,,
66638,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600861,[],CHEMBL1909166,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL4644,Homo sapiens,Melanocortin receptor 3,9606.0,,,IC50,,,,
66639,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600862,[],CHEMBL1909166,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL4644,Homo sapiens,Melanocortin receptor 3,9606.0,,,Ki,,,,
66640,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600863,[],CHEMBL1909167,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL259,Homo sapiens,Melanocortin receptor 4,9606.0,,,IC50,,,,
66641,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600864,[],CHEMBL1909167,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL259,Homo sapiens,Melanocortin receptor 4,9606.0,,,Ki,,,,
66642,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600865,[],CHEMBL1909168,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL4608,Homo sapiens,Melanocortin receptor 5,9606.0,,,IC50,,,,
66643,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600866,[],CHEMBL1909168,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL4608,Homo sapiens,Melanocortin receptor 5,9606.0,,,Ki,,,,
66644,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600867,[],CHEMBL1909169,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,IC50,,,,
66645,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600868,[],CHEMBL1909169,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),B,,,BAO_0000192,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,Ki,,,,
66646,,,7600869,[],CHEMBL1909170,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,"{'bei': '16.39', 'le': '0.30', 'lle': '2.41', 'sei': '13.51'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.51,0,http://www.openphacts.org/units/Nanomolar,1539543,=,15,1,=,,IC50,nM,,3080.0,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,IC50,uM,UO_0000065,,3.08
66647,,,7600870,[],CHEMBL1909170,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,"{'bei': '18.22', 'le': '0.33', 'lle': '3.03', 'sei': '15.02'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,6.13,0,http://www.openphacts.org/units/Nanomolar,1539543,=,15,1,=,,Ki,nM,,742.0,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,Ki,uM,UO_0000065,,0.742
66648,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600871,[],CHEMBL1909171,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,IC50,,,,
66649,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600872,[],CHEMBL1909171,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,Ki,,,,
66650,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600873,[],CHEMBL1909172,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL245,Homo sapiens,Muscarinic acetylcholine receptor M3,9606.0,,,IC50,,,,
66651,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600874,[],CHEMBL1909172,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL245,Homo sapiens,Muscarinic acetylcholine receptor M3,9606.0,,,Ki,,,,
66652,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600875,[],CHEMBL1909173,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL1821,Homo sapiens,Muscarinic acetylcholine receptor M4,9606.0,,,IC50,,,,
66653,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600876,[],CHEMBL1909173,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL1821,Homo sapiens,Muscarinic acetylcholine receptor M4,9606.0,,,Ki,,,,
66654,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600877,[],CHEMBL1909174,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL2035,Homo sapiens,Muscarinic acetylcholine receptor M5,9606.0,,,IC50,,,,
66655,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600878,[],CHEMBL1909174,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL2035,Homo sapiens,Muscarinic acetylcholine receptor M5,9606.0,,,Ki,,,,
66656,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600879,[],CHEMBL1909175,DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL4777,Homo sapiens,Neuropeptide Y receptor type 1,9606.0,,,IC50,,,,
66657,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600880,[],CHEMBL1909175,DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL4777,Homo sapiens,Neuropeptide Y receptor type 1,9606.0,,,Ki,,,,
66658,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600881,[],CHEMBL1909176,DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL4018,Homo sapiens,Neuropeptide Y receptor type 2,9606.0,,,IC50,,,,
66659,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600882,[],CHEMBL1909176,DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL4018,Homo sapiens,Neuropeptide Y receptor type 2,9606.0,,,Ki,,,,
66660,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600883,[],CHEMBL1909177,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66661,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600884,[],CHEMBL1909177,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66662,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600885,[],CHEMBL1909178,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",B,,,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL3048,Rattus norvegicus,"Nitric-oxide synthase, brain",10116.0,,,IC50,,,,
66663,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600886,[],CHEMBL1909178,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",B,,,BAO_0000192,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL3048,Rattus norvegicus,"Nitric-oxide synthase, brain",10116.0,,,Ki,,,,
66664,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600887,[],CHEMBL1909179,"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL3464,Mus musculus,"Nitric oxide synthase, inducible",10090.0,,,IC50,,,,
66665,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600888,[],CHEMBL1909179,"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)",B,,,BAO_0000192,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL3464,Mus musculus,"Nitric oxide synthase, inducible",10090.0,,,Ki,,,,
66666,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600889,[],CHEMBL1909180,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL236,Homo sapiens,Delta opioid receptor,9606.0,,,IC50,,,,
66667,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600890,[],CHEMBL1909180,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL236,Homo sapiens,Delta opioid receptor,9606.0,,,Ki,,,,
66668,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600891,[],CHEMBL1909181,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL237,Homo sapiens,Kappa opioid receptor,9606.0,,,IC50,,,,
66669,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600892,[],CHEMBL1909181,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL237,Homo sapiens,Kappa opioid receptor,9606.0,,,Ki,,,,
66670,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600893,[],CHEMBL1909182,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,IC50,,,,
66671,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600894,[],CHEMBL1909182,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,Ki,,,,
66672,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600895,[],CHEMBL1909183,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66673,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600896,[],CHEMBL1909183,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66674,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600897,[],CHEMBL1909184,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,,,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66675,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600898,[],CHEMBL1909184,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,,,BAO_0000192,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66676,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600899,[],CHEMBL1909185,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66677,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600900,[],CHEMBL1909185,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,,,BAO_0000192,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66678,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600901,[],CHEMBL1909186,DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP),B,,,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL1827,Homo sapiens,Phosphodiesterase 5A,9606.0,,,IC50,,,,
66679,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600902,[],CHEMBL1909186,DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP),B,,,BAO_0000192,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL1827,Homo sapiens,Phosphodiesterase 5A,9606.0,,,Ki,,,,
66680,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600903,[],CHEMBL1909187,DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF),B,,,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL250,Homo sapiens,Platelet activating factor receptor,9606.0,,,IC50,,,,
66681,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600904,[],CHEMBL1909187,DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF),B,,,BAO_0000192,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL250,Homo sapiens,Platelet activating factor receptor,9606.0,,,Ki,,,,
66682,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600905,[],CHEMBL1909188,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66683,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600906,[],CHEMBL1909188,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),B,,,BAO_0000192,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66684,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600907,[],CHEMBL1909189,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66685,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600908,[],CHEMBL1909189,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66686,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600909,[],CHEMBL1909190,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL240,Homo sapiens,HERG,9606.0,,,IC50,,,,
66687,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600910,[],CHEMBL1909190,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL240,Homo sapiens,HERG,9606.0,,,Ki,,,,
66688,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600911,[],CHEMBL1909191,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),B,,,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL1909044,Bos taurus,Progesterone receptor,9913.0,,,IC50,,,,
66689,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600912,[],CHEMBL1909191,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),B,,,BAO_0000192,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL1909044,Bos taurus,Progesterone receptor,9913.0,,,Ki,,,,
66690,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600913,[],CHEMBL1909192,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",B,,,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL4074,Oryctolagus cuniculus,Angiotensin-converting enzyme,9986.0,,,IC50,,,,
66691,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600914,[],CHEMBL1909192,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",B,,,BAO_0000192,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL4074,Oryctolagus cuniculus,Angiotensin-converting enzyme,9986.0,,,Ki,,,,
66692,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600915,[],CHEMBL1909193,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL4801,Homo sapiens,Caspase-1,9606.0,,,IC50,,,,
66693,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600916,[],CHEMBL1909193,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",B,,,BAO_0000192,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL4801,Homo sapiens,Caspase-1,9606.0,,,Ki,,,,
66694,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600917,[],CHEMBL1909194,"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)",B,,,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL4071,Homo sapiens,Cathepsin G,9606.0,,,IC50,,,,
66695,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600918,[],CHEMBL1909194,"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)",B,,,BAO_0000192,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL4071,Homo sapiens,Cathepsin G,9606.0,,,Ki,,,,
66696,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600919,[],CHEMBL1909195,"DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)",B,,,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL248,Homo sapiens,Leukocyte elastase,9606.0,,,IC50,,,,
66697,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600920,[],CHEMBL1909195,"DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)",B,,,BAO_0000192,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL248,Homo sapiens,Leukocyte elastase,9606.0,,,Ki,,,,
66698,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600921,[],CHEMBL1909196,"DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",B,,,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL332,Homo sapiens,Matrix metalloproteinase-1,9606.0,,,IC50,,,,
66699,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600922,[],CHEMBL1909196,"DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",B,,,BAO_0000192,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL332,Homo sapiens,Matrix metalloproteinase-1,9606.0,,,Ki,,,,
66700,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600923,[],CHEMBL1909197,"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL321,Homo sapiens,Matrix metalloproteinase 9,9606.0,,,IC50,,,,
66701,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600924,[],CHEMBL1909197,"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",B,,,BAO_0000192,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL321,Homo sapiens,Matrix metalloproteinase 9,9606.0,,,Ki,,,,
66702,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600925,[],CHEMBL1909198,DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone),B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL299,Homo sapiens,Protein kinase C alpha,9606.0,,,IC50,,,,
66703,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600926,[],CHEMBL1909198,DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone),B,,,BAO_0000192,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL299,Homo sapiens,Protein kinase C alpha,9606.0,,,Ki,,,,
66704,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600927,[],CHEMBL1909199,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL3385,Homo sapiens,MAP kinase ERK1,9606.0,,,IC50,,,,
66705,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600928,[],CHEMBL1909199,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000192,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL3385,Homo sapiens,MAP kinase ERK1,9606.0,,,Ki,,,,
66706,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600929,[],CHEMBL1909200,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL4040,Homo sapiens,MAP kinase ERK2,9606.0,,,IC50,,,,
66707,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600930,[],CHEMBL1909200,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000192,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL4040,Homo sapiens,MAP kinase ERK2,9606.0,,,Ki,,,,
66708,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600931,[],CHEMBL1909201,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL260,Homo sapiens,MAP kinase p38 alpha,9606.0,,,IC50,,,,
66709,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600932,[],CHEMBL1909201,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000192,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL260,Homo sapiens,MAP kinase p38 alpha,9606.0,,,Ki,,,,
66710,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600933,[],CHEMBL1909202,"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL4445,Homo sapiens,"Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform",9606.0,,,IC50,,,,
66711,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600934,[],CHEMBL1909202,"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)",B,,,BAO_0000192,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL4445,Homo sapiens,"Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform",9606.0,,,Ki,,,,
66712,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600935,[],CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL203,Homo sapiens,Epidermal growth factor receptor erbB1,9606.0,,,IC50,,,,
66713,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600936,[],CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000192,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL203,Homo sapiens,Epidermal growth factor receptor erbB1,9606.0,,,Ki,,,,
66714,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600937,[],CHEMBL1909204,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL1841,Homo sapiens,Tyrosine-protein kinase FYN,9606.0,,,IC50,,,,
66715,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600938,[],CHEMBL1909204,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000192,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL1841,Homo sapiens,Tyrosine-protein kinase FYN,9606.0,,,Ki,,,,
66716,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600939,[],CHEMBL1909205,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL1824,Homo sapiens,Receptor protein-tyrosine kinase erbB-2,9606.0,,,IC50,,,,
66717,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600940,[],CHEMBL1909205,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000192,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL1824,Homo sapiens,Receptor protein-tyrosine kinase erbB-2,9606.0,,,Ki,,,,
66718,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602274,[],CHEMBL1909206,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL258,Homo sapiens,Tyrosine-protein kinase LCK,9606.0,,,IC50,,,,
66719,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602275,[],CHEMBL1909206,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000192,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL258,Homo sapiens,Tyrosine-protein kinase LCK,9606.0,,,Ki,,,,
66720,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602276,[],CHEMBL1909207,"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL3243,Homo sapiens,Leukocyte common antigen,9606.0,,,IC50,,,,
66721,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602277,[],CHEMBL1909207,"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)",B,,,BAO_0000192,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL3243,Homo sapiens,Leukocyte common antigen,9606.0,,,Ki,,,,
66722,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602278,[],CHEMBL1909208,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66723,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602279,[],CHEMBL1909208,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66724,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602280,[],CHEMBL1909209,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL273,Rattus norvegicus,Serotonin 1a (5-HT1a) receptor,10116.0,,,IC50,,,,
66725,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602281,[],CHEMBL1909209,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL273,Rattus norvegicus,Serotonin 1a (5-HT1a) receptor,10116.0,,,Ki,,,,
66726,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602282,[],CHEMBL1909210,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL3459,Rattus norvegicus,Serotonin 1b (5-HT1b) receptor,10116.0,,,IC50,,,,
66727,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602283,[],CHEMBL1909210,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL3459,Rattus norvegicus,Serotonin 1b (5-HT1b) receptor,10116.0,,,Ki,,,,
66728,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602284,[],CHEMBL1909211,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,IC50,,,,
66729,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602285,[],CHEMBL1909211,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,Ki,,,,
66730,,,7602286,[],CHEMBL1909104,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,"{'bei': '16.24', 'le': '0.30', 'lle': '2.36', 'sei': '13.39'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.46,0,http://www.openphacts.org/units/Nanomolar,1539543,=,15,1,=,,IC50,nM,,3437.0,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,IC50,uM,UO_0000065,,3.437
66731,,,7602287,[],CHEMBL1909104,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,"{'bei': '16.83', 'le': '0.31', 'lle': '2.56', 'sei': '13.87'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.66,0,http://www.openphacts.org/units/Nanomolar,1539543,=,15,1,=,,Ki,nM,,2187.0,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,Ki,uM,UO_0000065,,2.187
66732,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602288,[],CHEMBL1909105,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL225,Homo sapiens,Serotonin 2c (5-HT2c) receptor,9606.0,,,IC50,,,,
66733,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602289,[],CHEMBL1909105,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL225,Homo sapiens,Serotonin 2c (5-HT2c) receptor,9606.0,,,Ki,,,,
66734,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602290,[],CHEMBL1909106,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66735,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602291,[],CHEMBL1909106,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66736,,,7602292,[],CHEMBL1909107,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,"{'bei': '16.81', 'le': '0.31', 'lle': '2.55', 'sei': '13.86'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.65,0,http://www.openphacts.org/units/Nanomolar,1539543,=,15,1,=,,IC50,nM,,2222.0,CHEMBL5017,Cavia porcellus,Serotonin 4 (5-HT4) receptor,10141.0,,,IC50,uM,UO_0000065,,2.222
66737,,,7602293,[],CHEMBL1909107,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,"{'bei': '19.12', 'le': '0.35', 'lle': '3.33', 'sei': '15.76'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,6.43,0,http://www.openphacts.org/units/Nanomolar,1539543,=,15,1,=,,Ki,nM,,370.0,CHEMBL5017,Cavia porcellus,Serotonin 4 (5-HT4) receptor,10141.0,,,Ki,uM,UO_0000065,,0.37
66738,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602294,[],CHEMBL1909108,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL3371,Homo sapiens,Serotonin 6 (5-HT6) receptor,9606.0,,,IC50,,,,
66739,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602295,[],CHEMBL1909108,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL3371,Homo sapiens,Serotonin 6 (5-HT6) receptor,9606.0,,,Ki,,,,
66740,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602296,[],CHEMBL1909109,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL228,Homo sapiens,Serotonin transporter,9606.0,,,IC50,,,,
66741,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602297,[],CHEMBL1909109,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL228,Homo sapiens,Serotonin transporter,9606.0,,,Ki,,,,
66742,,,7602298,[],CHEMBL1909110,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,"{'bei': '17.51', 'le': '0.32', 'lle': '2.79', 'sei': '14.44'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.89,0,http://www.openphacts.org/units/Nanomolar,1539543,=,15,1,=,,IC50,nM,,1289.0,CHEMBL287,Homo sapiens,Sigma opioid receptor,9606.0,,,IC50,uM,UO_0000065,,1.289
66743,,,7602299,[],CHEMBL1909110,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,"{'bei': '18.63', 'le': '0.34', 'lle': '3.17', 'sei': '15.36'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,6.27,0,http://www.openphacts.org/units/Nanomolar,1539543,=,15,1,=,,Ki,nM,,542.0,CHEMBL287,Homo sapiens,Sigma opioid receptor,9606.0,,,Ki,uM,UO_0000065,,0.542
66744,,,7602300,[],CHEMBL1909111,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,7.02,0,http://www.openphacts.org/units/Nanomolar,1539543,=,15,1,=,,IC50,nM,,95.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,0.095
66745,,,7602301,[],CHEMBL1909111,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,7.23,0,http://www.openphacts.org/units/Nanomolar,1539543,=,15,1,=,,Ki,nM,,59.0,CHEMBL612545,,Unchecked,,,,Ki,uM,UO_0000065,,0.059
66746,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602302,[],CHEMBL1909112,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66747,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602303,[],CHEMBL1909112,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66748,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602304,[],CHEMBL1909113,DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL249,Homo sapiens,Neurokinin 1 receptor,9606.0,,,IC50,,,,
66749,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602305,[],CHEMBL1909113,DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL249,Homo sapiens,Neurokinin 1 receptor,9606.0,,,Ki,,,,
66750,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602306,[],CHEMBL1909114,DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL2327,Homo sapiens,Neurokinin 2 receptor,9606.0,,,IC50,,,,
66751,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602307,[],CHEMBL1909114,DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL2327,Homo sapiens,Neurokinin 2 receptor,9606.0,,,Ki,,,,
66752,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602308,[],CHEMBL1909115,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,,IC50,,,,
66753,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602309,[],CHEMBL1909115,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,,Ki,,,,
66754,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602310,[],CHEMBL1909116,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),B,,,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL1835,Homo sapiens,Thromboxane-A synthase,9606.0,,,IC50,,,,
66755,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602311,[],CHEMBL1909116,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),B,,,BAO_0000192,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL1835,Homo sapiens,Thromboxane-A synthase,9606.0,,,Ki,,,,
66756,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602312,[],CHEMBL1909117,"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)",B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
66757,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602313,[],CHEMBL1909117,"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)",B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
66758,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602314,[],CHEMBL1909118,DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF),B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL1868,Homo sapiens,Vascular endothelial growth factor receptor 1,9606.0,,,IC50,,,,
66759,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602315,[],CHEMBL1909118,DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF),B,,,BAO_0000192,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL1868,Homo sapiens,Vascular endothelial growth factor receptor 1,9606.0,,,Ki,,,,
66760,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602316,[],CHEMBL1909119,DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL5144,Homo sapiens,Vasoactive intestinal polypeptide receptor 1,9606.0,,,IC50,,,,
66761,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602317,[],CHEMBL1909119,DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL5144,Homo sapiens,Vasoactive intestinal polypeptide receptor 1,9606.0,,,Ki,,,,
66762,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602318,[],CHEMBL1909120,DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL1889,Homo sapiens,Vasopressin V1a receptor,9606.0,,,IC50,,,,
66763,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602319,[],CHEMBL1909120,DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr),B,,,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,Ki,,,,CHEMBL1889,Homo sapiens,Vasopressin V1a receptor,9606.0,,,Ki,,,,
66764,,,7928075,[],CHEMBL1918466,Inhibition of AChE assessed as hydrolysis of acetylcholine preincubated for 15 mins measured after 15 mins by colorimetric Ellman assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1914414,Bioorg Med Chem Lett,2011.0,"{'bei': '21.99', 'le': '0.40', 'lle': '4.30', 'sei': '18.13'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,7.4,0,http://www.openphacts.org/units/Nanomolar,1558070,=,1,1,=,,IC50,nM,,40.0,CHEMBL220,Homo sapiens,Acetylcholinesterase,9606.0,,,IC50,uM,UO_0000065,,0.04
66765,,,7928968,[],CHEMBL1918467,Inhibition of BChE assessed as hydrolysis of butrylcholine preincubated for 15 mins measured after 15 mins by colorimetric Ellman assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1914414,Bioorg Med Chem Lett,2011.0,"{'bei': '14.04', 'le': '0.26', 'lle': '1.62', 'sei': '11.57'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.72,0,http://www.openphacts.org/units/Nanomolar,1558070,=,1,1,=,,IC50,nM,,18970.0,CHEMBL1914,Homo sapiens,Butyrylcholinesterase,9606.0,,,IC50,uM,UO_0000065,,18.97
66766,,,7968898,[],CHEMBL1931047,Inhibition of electric eel AChE using acetylcholine chloride as substrate preincubated for 15 mins by Ellman's method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1926506,Bioorg Med Chem,2011.0,"{'bei': '19.11', 'le': '0.35', 'lle': '3.33', 'sei': '15.75'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,6.43,1,http://www.openphacts.org/units/Nanomolar,1563712,=,1,1,=,,IC50,nM,,374.0,CHEMBL4078,Electrophorus electricus,Acetylcholinesterase,8005.0,,,IC50,uM,UO_0000065,,0.374
66767,,,7968915,[],CHEMBL1931048,Inhibition of equine serum BuChE using butyrylthiocholine chloride as substrate preincubated for 15 mins by Ellman's method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1926506,Bioorg Med Chem,2011.0,"{'bei': '14.09', 'le': '0.26', 'lle': '1.64', 'sei': '11.62'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.74,1,http://www.openphacts.org/units/Nanomolar,1563712,=,1,1,=,,IC50,nM,,18200.0,CHEMBL5077,Equus caballus,Butyrylcholinesterase,9796.0,,,IC50,uM,UO_0000065,,18.2
66768,,,7968932,[],CHEMBL1931049,Selectivity ratio of IC50 for equine serum BuChE to IC50 for electric eel AChE,B,,,BAO_0000179,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1926506,Bioorg Med Chem,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1563712,=,1,0,=,,Ratio IC50,,,48.6,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,48.6
66769,,Not Determined,7968946,[],CHEMBL1931050,Inhibition of equine serum BuChE using acetylcholine as substrate preincubated for 15 mins by Ellman's method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1926506,Bioorg Med Chem,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1563712,,1,0,,,IC50,,,,CHEMBL5077,Equus caballus,Butyrylcholinesterase,9796.0,,,IC50,,,,
66770,,,7969853,[],CHEMBL1931051,Antioxidant activity assessed as trolox equivalent of APPH-induced radical scavenging activity at 0.5 to 10 uM measured every 60 sec for 4 hrs by ORAC fluorescence assay relative to trolox,F,,,BAO_0000193,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1926506,Bioorg Med Chem,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1563712,=,1,0,=,,Ratio,,,0.4,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Ratio,,,,0.4
66771,,,7969868,[],CHEMBL1931052,Inhibition of self-mediated amyloid beta (1 to 42) aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay,B,,,BAO_0000201,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1926506,Bioorg Med Chem,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1563712,=,1,1,=,,Inhibition,%,,36.3,CHEMBL612545,,Unchecked,,,,INH,%,UO_0000187,,36.3
66772,,,8002403,[],CHEMBL1941568,Estrogenic activity at ERalpha in human MVLN cells at 100 ug/mL after 24 hrs by luciferase reporter gene assay relative to E2,B,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1938229,Bioorg Med Chem Lett,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1571695,=,1,0,=,,Activity,%,,51.41,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,Activity,%,UO_0000187,,51.41
66773,,,8003024,[],CHEMBL1941569,Estrogenic activity at ERalpha in human MVLN cells at 20 ug/mL after 24 hrs by luciferase reporter gene assay relative to E2,B,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1938229,Bioorg Med Chem Lett,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1571695,=,1,0,=,,Activity,%,,58.49,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,Activity,%,UO_0000187,,58.49
66774,,inactive,8235302,[],CHEMBL1963976,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,17660.38,CHEMBL614078,Homo sapiens,MDA-N,9606.0,,,log GI50 (M),,UO_0000065,,-4.753
66775,,inactive,8269055,[],CHEMBL1963981,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,10327.61,CHEMBL614054,Homo sapiens,SN12C,9606.0,,,log GI50 (M),,UO_0000065,,-4.986
66776,,inactive,8316016,[],CHEMBL1963985,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,7345.14,CHEMBL614997,Homo sapiens,NCI-H23,9606.0,,,log GI50 (M),,UO_0000065,,-5.134
66777,,inactive,8386064,[],CHEMBL1963989,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,100000.0,CHEMBL614519,Homo sapiens,ACHN,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
66778,,inactive,8419493,[],CHEMBL1963990,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,133967.67,CHEMBL614388,Homo sapiens,UO-31,9606.0,,,log GI50 (M),,UO_0000065,,-3.873
66779,,inactive,8456805,[],CHEMBL1963991,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,36728.23,CHEMBL613889,Homo sapiens,HOP-92,9606.0,,,log GI50 (M),,UO_0000065,,-4.435
66780,,inactive,8490238,[],CHEMBL1963994,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,13645.83,CHEMBL383,Homo sapiens,HL-60,9606.0,,,log GI50 (M),,UO_0000065,,-4.865
66781,,inactive,8563988,[],CHEMBL1964017,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,44463.13,CHEMBL613508,Homo sapiens,DU-145,9606.0,,,log GI50 (M),,UO_0000065,,-4.352
66782,,inactive,8579711,[],CHEMBL1964018,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,35318.32,CHEMBL614860,Homo sapiens,SF-539,9606.0,,,log GI50 (M),,UO_0000065,,-4.452
66783,,inactive,8584549,[],CHEMBL1964025,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,6683.44,CHEMBL614021,Homo sapiens,Malme-3M,9606.0,,,log GI50 (M),,UO_0000065,,-5.175
66784,,inactive,8653687,[],CHEMBL1964021,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,4954.5,CHEMBL614922,Homo sapiens,SK-MEL-5,9606.0,,,log GI50 (M),,UO_0000065,,-5.305
66785,,inactive,8672392,[],CHEMBL1964030,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,16634.13,CHEMBL385,Homo sapiens,K562,9606.0,,,log GI50 (M),,UO_0000065,,-4.779
66786,,inactive,8709846,[],CHEMBL1964034,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the A498 Renal cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,95940.06,CHEMBL614516,Homo sapiens,A498,9606.0,,,log GI50 (M),,UO_0000065,,-4.018
66787,,inactive,8765383,[],CHEMBL1964037,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,5284.45,CHEMBL614213,Homo sapiens,OVCAR-3,9606.0,,,log GI50 (M),,UO_0000065,,-5.277
66788,,inactive,8797376,[],CHEMBL1964043,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,11246.05,CHEMBL614643,Homo sapiens,HOP-62,9606.0,,,log GI50 (M),,UO_0000065,,-4.949
66789,,inactive,8862711,[],CHEMBL1964040,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,7533.56,CHEMBL614177,Homo sapiens,MOLT-4,9606.0,,,log GI50 (M),,UO_0000065,,-5.123
66790,,inactive,8871321,[],CHEMBL1964045,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI/ADR-RES Breast cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,323593.66,CHEMBL613829,Homo sapiens,NCI/ADR-RES,9606.0,,,log GI50 (M),,UO_0000065,,-3.49
66791,,inactive,8914039,[],CHEMBL1964047,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,5767.66,CHEMBL615022,Homo sapiens,U-251,9606.0,,,log GI50 (M),,UO_0000065,,-5.239
66792,,inactive,8952513,[],CHEMBL1964048,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,12676.52,CHEMBL612555,Homo sapiens,OVCAR-8,9606.0,,,log GI50 (M),,UO_0000065,,-4.897
66793,,inactive,8977350,[],CHEMBL1964049,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,58344.51,CHEMBL614214,Homo sapiens,OVCAR-5,9606.0,,,log GI50 (M),,UO_0000065,,-4.234
66794,,inactive,9047641,[],CHEMBL1964062,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DMS 273 Small Cell Lung cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,10303.86,CHEMBL614034,Homo sapiens,DMS-273,9606.0,,,log GI50 (M),,UO_0000065,,-4.987
66795,,inactive,9073575,[],CHEMBL1964059,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,8375.29,CHEMBL614164,Homo sapiens,SNB-19,9606.0,,,log GI50 (M),,UO_0000065,,-5.077
66796,,inactive,9114018,[],CHEMBL1964065,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,30690.22,CHEMBL614300,Homo sapiens,SR,9606.0,,,log GI50 (M),,UO_0000065,,-4.513
66797,,inactive,9147410,[],CHEMBL1964063,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-231/ATCC Breast cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,36140.99,CHEMBL400,Homo sapiens,MDA-MB-231,9606.0,,,log GI50 (M),,UO_0000065,,-4.442
66798,,inactive,9174081,[],CHEMBL1964066,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,100000.0,CHEMBL614056,Homo sapiens,TK-10,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
66799,,inactive,9186977,[],CHEMBL1964074,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the M19-MEL Melanoma cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,5559.04,CHEMBL614019,Homo sapiens,M19-MEL,9606.0,,,log GI50 (M),,UO_0000065,,-5.255
66800,,inactive,9198978,[],CHEMBL1964072,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,40644.33,CHEMBL612262,Homo sapiens,SW-620,9606.0,,,log GI50 (M),,UO_0000065,,-4.391
66801,,inactive,9249826,[],CHEMBL1964077,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,7709.03,CHEMBL614709,Homo sapiens,KM12,9606.0,,,log GI50 (M),,UO_0000065,,-5.113
66802,,inactive,9286842,[],CHEMBL1964075,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,2223.31,CHEMBL614387,Homo sapiens,NCI-H522,9606.0,,,log GI50 (M),,UO_0000065,,-5.653
66803,,inactive,9300418,[],CHEMBL1964085,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,22803.42,CHEMBL614317,Homo sapiens,M14,9606.0,,,log GI50 (M),,UO_0000065,,-4.642
66804,,inactive,9328201,[],CHEMBL1964086,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the XF 498 Central Nervous System cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,7816.28,CHEMBL613533,Homo sapiens,XF498,9606.0,,,log GI50 (M),,UO_0000065,,-5.107
66805,,inactive,9365629,[],CHEMBL1964087,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,36559.48,CHEMBL614803,Homo sapiens,NCI-H322M,9606.0,,,log GI50 (M),,UO_0000065,,-4.437
66806,,inactive,9434349,[],CHEMBL1964088,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,7345.14,CHEMBL614882,Homo sapiens,RPMI-8226,9606.0,,,log GI50 (M),,UO_0000065,,-5.134
66807,,inactive,9445116,[],CHEMBL1964091,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,9660.51,CHEMBL614051,Homo sapiens,OVCAR-4,9606.0,,,log GI50 (M),,UO_0000065,,-5.015
66808,,inactive,9510630,[],CHEMBL1964099,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the BT-549 Breast cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,5382.7,CHEMBL614072,Homo sapiens,BT-549,9606.0,,,log GI50 (M),,UO_0000065,,-5.269
66809,,inactive,9512790,[],CHEMBL1964092,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,77090.35,CHEMBL614096,Homo sapiens,LOX IMVI,9606.0,,,log GI50 (M),,UO_0000065,,-4.113
66810,,inactive,9538150,[],CHEMBL1964095,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the P388 Leukemia cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,1874.99,CHEMBL389,Mus musculus,P388,10090.0,,,log GI50 (M),,UO_0000065,,-5.727
66811,,inactive,9684713,[],CHEMBL1963844,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,25292.98,CHEMBL614917,Homo sapiens,SK-MEL-2,9606.0,,,log GI50 (M),,UO_0000065,,-4.597
66812,,inactive,9728935,[],CHEMBL1963848,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the KM20L2 Colon cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,28183.83,CHEMBL614791,Homo sapiens,KM-20L2,9606.0,,,log GI50 (M),,UO_0000065,,-4.55
66813,,inactive,9735509,[],CHEMBL1963854,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,62517.27,CHEMBL392,Homo sapiens,A549,9606.0,,,log GI50 (M),,UO_0000065,,-4.204
66814,,inactive,9785066,[],CHEMBL1963866,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,36475.39,CHEMBL614451,Homo sapiens,SNB-75,9606.0,,,log GI50 (M),,UO_0000065,,-4.438
66815,,inactive,9816045,[],CHEMBL1963860,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,9057.33,CHEMBL613855,Homo sapiens,HCC 2998,9606.0,,,log GI50 (M),,UO_0000065,,-5.043
66816,,inactive,9877744,[],CHEMBL1963868,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,216271.85,CHEMBL612263,Homo sapiens,HCT-15,9606.0,,,log GI50 (M),,UO_0000065,,-3.665
66817,,inactive,9911551,[],CHEMBL1963874,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,15031.42,CHEMBL394,Homo sapiens,HCT-116,9606.0,,,log GI50 (M),,UO_0000065,,-4.823
66818,,inactive,9949257,[],CHEMBL1963876,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,5199.96,CHEMBL613977,Homo sapiens,SF-268,9606.0,,,log GI50 (M),,UO_0000065,,-5.284
66819,,inactive,9993085,[],CHEMBL1963882,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MCF7 Breast cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,15066.07,CHEMBL387,Homo sapiens,MCF7,9606.0,,,log GI50 (M),,UO_0000065,,-4.822
66820,,inactive,10043847,[],CHEMBL1963880,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,46238.1,CHEMBL614487,Homo sapiens,EKVX,9606.0,,,log GI50 (M),,UO_0000065,,-4.335
66821,,inactive,10061963,[],CHEMBL1963887,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DMS 114 Small Cell Lung cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,4226.69,CHEMBL614642,Homo sapiens,DMS-114,9606.0,,,log GI50 (M),,UO_0000065,,-5.374
66822,,inactive,10116889,[],CHEMBL1963885,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the PC-3 Prostate cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,26853.44,CHEMBL390,Homo sapiens,PC-3,9606.0,,,log GI50 (M),,UO_0000065,,-4.571
66823,,inactive,10149619,[],CHEMBL1963900,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the T-47D Breast cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,10256.52,CHEMBL614361,Homo sapiens,T47D,9606.0,,,log GI50 (M),,UO_0000065,,-4.989
66824,,inactive,10156523,[],CHEMBL1963895,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,84527.88,CHEMBL614925,Homo sapiens,SK-OV-3,9606.0,,,log GI50 (M),,UO_0000065,,-4.073
66825,,inactive,10198628,[],CHEMBL1963903,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,29922.65,CHEMBL614610,Homo sapiens,UACC-62,9606.0,,,log GI50 (M),,UO_0000065,,-4.524
66826,,inactive,10244554,[],CHEMBL1963901,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,12218.0,CHEMBL396,Homo sapiens,NCI-H460,9606.0,,,log GI50 (M),,UO_0000065,,-4.913
66827,,inactive,10284318,[],CHEMBL1963911,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,65012.97,CHEMBL614067,Homo sapiens,CAKI-1,9606.0,,,log GI50 (M),,UO_0000065,,-4.187
66828,,inactive,10293828,[],CHEMBL1963918,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the P388/ADR Leukemia cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,101624.87,CHEMBL614218,Mus musculus,P388/ADR,10090.0,,,log GI50 (M),,UO_0000065,,-3.993
66829,,inactive,10295082,[],CHEMBL1963921,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-435 Breast cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,12793.81,CHEMBL614697,Homo sapiens,MDA-MB-435,9606.0,,,log GI50 (M),,UO_0000065,,-4.893
66830,,inactive,10350183,[],CHEMBL1963922,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,8452.79,CHEMBL614908,Homo sapiens,SF-295,9606.0,,,log GI50 (M),,UO_0000065,,-5.073
66831,,inactive,10396242,[],CHEMBL1963929,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,40644.33,CHEMBL613984,Homo sapiens,IGROV-1,9606.0,,,log GI50 (M),,UO_0000065,,-4.391
66832,,inactive,10399100,[],CHEMBL1963945,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HS 578T Breast cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,10046.16,CHEMBL614645,Homo sapiens,Hs-578T,9606.0,,,log GI50 (M),,UO_0000065,,-4.998
66833,,inactive,10513167,[],CHEMBL1963960,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,14588.14,CHEMBL612796,Homo sapiens,UACC-257,9606.0,,,log GI50 (M),,UO_0000065,,-4.836
66834,,inactive,10515488,[],CHEMBL1963954,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-78 Central Nervous System cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,53826.98,CHEMBL612543,Homo sapiens,SNB-78,9606.0,,,log GI50 (M),,UO_0000065,,-4.269
66835,,inactive,10531674,[],CHEMBL1963953,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,49431.07,CHEMBL613102,Homo sapiens,786-0,9606.0,,,log GI50 (M),,UO_0000065,,-4.306
66836,,inactive,10585494,[],CHEMBL1963963,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DLD-1 Colon cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,54200.09,CHEMBL614285,Homo sapiens,DLD-1,9606.0,,,log GI50 (M),,UO_0000065,,-4.266
66837,,inactive,10601096,[],CHEMBL1963961,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,13243.42,CHEMBL382,Homo sapiens,CCRF-CEM,9606.0,,,log GI50 (M),,UO_0000065,,-4.878
66838,,inactive,10670627,[],CHEMBL1964004,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,15523.87,CHEMBL614740,Homo sapiens,NCI-H226,9606.0,,,log GI50 (M),,UO_0000065,,-4.809
66839,,inactive,10694745,[],CHEMBL1964006,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,31045.6,CHEMBL384,Homo sapiens,HT-29,9606.0,,,log GI50 (M),,UO_0000065,,-4.508
66840,,inactive,10715081,[],CHEMBL1964007,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,22181.96,CHEMBL614919,Homo sapiens,SK-MEL-28,9606.0,,,log GI50 (M),,UO_0000065,,-4.654
66841,,inactive,10774948,[],CHEMBL1964009,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,68548.82,CHEMBL614886,Homo sapiens,RXF 393,9606.0,,,log GI50 (M),,UO_0000065,,-4.164
66842,,inactive,10812202,[],CHEMBL1964012,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,7464.49,CHEMBL614561,Homo sapiens,COLO 205,9606.0,,,log GI50 (M),,UO_0000065,,-5.127
66843,,inactive,10814672,[],CHEMBL1964015,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12K1 Renal cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,3926.45,CHEMBL1909241,Homo sapiens,SN12K1,9606.0,,,log GI50 (M),,UO_0000065,,-5.406
66844,,inactive,10817281,[],CHEMBL1964014,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-18 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1627440,,7,1,,,GI50,nM,,105925.37,CHEMBL614809,Homo sapiens,HOP-18,9606.0,,,log GI50 (M),,UO_0000065,,-3.975
66845,,,10834498,[],CHEMBL2013296,Binding affinity to calf thymus DNA in presence of citrate-phosphate buffer at pH 7 by spectrophotometry,B,,,BAO_0000192,BAO_0000225,nucleic acid format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2010762,Bioorg Med Chem,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.44,0,http://www.openphacts.org/units/Nanomolar,1631759,=,1,1,=,,Ki,nM,,36400.0,CHEMBL345,,Nucleic Acid,,,,Ki,10'-5/M,UO_0000065,,3.64
66846,,,10834502,[],CHEMBL2013297,Binding affinity to calf thymus DNA in presence of citrate-phosphate buffer at pH 7 by spectrofluorimetry,B,,,BAO_0000192,BAO_0000225,nucleic acid format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2010762,Bioorg Med Chem,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.44,0,http://www.openphacts.org/units/Nanomolar,1631759,=,1,1,=,,Ki,nM,,36400.0,CHEMBL345,,Nucleic Acid,,,,Ki,10'-5/M,UO_0000065,,3.64
66847,,,10834506,[],CHEMBL2013295,Binding affinity to calf thymus DNA assessed as change in melting temperature by thermal denaturation assay,B,,,BAO_0000179,BAO_0000225,nucleic acid format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2010762,Bioorg Med Chem,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#DegreeCelsius,1631759,=,1,1,=,,Delta Tm,degrees C,,9.0,CHEMBL345,,Nucleic Acid,,,,deltaTm,degrees C,UO_0000027,,9.0
66848,,Active,10834510,[],CHEMBL2013298,Binding affinity to calf thymus DNA in citrate-phosphate buffer at pH 7 by circular dichroism spectral analysis,B,,,BAO_0000375,BAO_0000225,nucleic acid format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2010762,Bioorg Med Chem,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1631759,,1,0,,,Activity,,,,CHEMBL345,,Nucleic Acid,,,,Activity,,,,
66849,,,10834512,[],CHEMBL2013299,Binding affinity to calf thymus DNA assessed as fluorescence quenching by fluorescence spectroscopy analysis,B,,,BAO_0000179,BAO_0000225,nucleic acid format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2010762,Bioorg Med Chem,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1631759,=,1,0,=,,KSV,/M,,90.0,CHEMBL345,,Nucleic Acid,,,,KSV,/M,,,90.0
66850,,Active,10834516,[],CHEMBL2013300,Binding affinity to calf thymus DNA in citrate-phosphate buffer at pH 7 assessed as change in viscosity by hydrodynamic method,B,,,BAO_0000375,BAO_0000225,nucleic acid format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2010762,Bioorg Med Chem,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1631759,,1,0,,,Activity,,,,CHEMBL345,,Nucleic Acid,,,,Activity,,,,
66851,,,10834520,[],CHEMBL2013301,Binding affinity to calf thymus DNA in citrate-phosphate buffer at pH 7 by isothermal titration calorimetry,B,,,BAO_0002809,BAO_0000225,nucleic acid format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2010762,Bioorg Med Chem,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1631759,=,1,0,=,,Ka,10'-5/M,,1.28,CHEMBL345,,Nucleic Acid,,,,Ka,10'-5/M,,,1.28
66852,,,10869198,[],CHEMBL2025426,Stabilization of DNA duplex hairpin structure assessed as change in melting temperature at 1 uM by FRET assay,B,,,BAO_0000179,BAO_0000225,nucleic acid format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2021924,Bioorg Med Chem Lett,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#DegreeCelsius,1639566,=,1,1,=,,Delta Tm,degrees C,,0.3,CHEMBL345,,Nucleic Acid,,,,deltaTm,degrees C,UO_0000027,,0.3
66853,,,10869224,[],CHEMBL2025425,Stabilization of human G-quadruplex F21T assessed as change in melting temperature at 1 uM by FRET assay,B,,,BAO_0000179,BAO_0000225,nucleic acid format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2021924,Bioorg Med Chem Lett,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#DegreeCelsius,1639566,=,1,1,=,,Delta Tm,degrees C,,9.7,CHEMBL345,,Nucleic Acid,,,,deltaTm,degrees C,UO_0000027,,9.7
66854,,,10869247,[],CHEMBL2025427,Stabilization of human G-quadruplex F21T assessed as change in melting temperature at 5 uM by FRET assay,B,,,BAO_0000179,BAO_0000225,nucleic acid format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2021924,Bioorg Med Chem Lett,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#DegreeCelsius,1639566,=,1,1,=,,Delta Tm,degrees C,,23.8,CHEMBL345,,Nucleic Acid,,,,deltaTm,degrees C,UO_0000027,,23.8
66855,,Not Active,10869675,[],CHEMBL2026480,Antimycobacterial activity against drug-susceptible Mycobacterium tuberculosis H37Rv measured 24 hrs post dose by microplate alamar blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2021893,Eur J Med Chem,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1639801,,1,0,,,MIC,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,,,,
66856,,inconclusive,11354079,[],CHEMBL2114853,PubChem BioAssay. qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1010458,,7,1,,,Potency,nM,,25118.9,CHEMBL3251,Homo sapiens,Nuclear factor NF-kappa-B p105 subunit,9606.0,,,Potency,uM,UO_0000065,,25.1189
66857,,active,11374557,[],CHEMBL2114850,PubChem BioAssay. Dose-response confirmation of uHTS inhibitor hits of Sentrin-Specific Protease 8 using a kinetic assay with Nedd8 Protein Substrate. (Class of assay: confirmatory) ,F,,,BAO_0000190,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,,IC50,nM,,7660.0,CHEMBL1741207,Homo sapiens,Sentrin-specific protease 8,9606.0,,,IC50,uM,UO_0000065,,7.66
66858,,inconclusive,11375969,[],CHEMBL2114861,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,,Potency,nM,,19952.6,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,19.9526
66859,,active,11425424,[],CHEMBL2114890,PubChem BioAssay. qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1010458,,7,1,,,Potency,nM,,33491.5,CHEMBL1075094,Homo sapiens,Nuclear factor erythroid 2-related factor 2,9606.0,,,Potency,uM,UO_0000065,,33.4915
66860,,inactive,11477931,[],CHEMBL2114743,PubChem BioAssay. HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in primary assay. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1157909,,7,1,,,Potency,nM,,11.2,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606.0,,,Potency,uM,UO_0000065,,0.0112
66861,,inconclusive,11507761,[],CHEMBL2114775,PubChem BioAssay. qHTS Assay for Inhibitors of Hepatitis C Virus (HCV). (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,,Potency,nM,,7079.5,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,7.0795
66862,,inconclusive,11533531,[],CHEMBL2114775,PubChem BioAssay. qHTS Assay for Inhibitors of Hepatitis C Virus (HCV). (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,,Potency,nM,,3162.3,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,3.1623
66863,,active,11655698,[],CHEMBL2114782,PubChem BioAssay. qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1010458,,7,1,,,Potency,nM,,9439.2,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,9.4392
66864,,inconclusive,11779816,[],CHEMBL2114788,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,,Potency,nM,,2818.4,CHEMBL1784,Homo sapiens,Glucagon-like peptide 1 receptor,9606.0,,,Potency,uM,UO_0000065,,2.8184
66865,,inconclusive,11780073,[],CHEMBL2114788,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,,Potency,nM,,2238.7,CHEMBL1784,Homo sapiens,Glucagon-like peptide 1 receptor,9606.0,,,Potency,uM,UO_0000065,,2.2387
66866,,inactive,11933422,[],CHEMBL2114829,PubChem BioAssay. Dose response confirmation of uHTS inhibitor hits of Sentrin-Specific Protease 8 using Nedd8 Protein Substrate. (Class of assay: confirmatory) ,F,,,BAO_0000190,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,,IC50,nM,,100000.0,CHEMBL1741207,Homo sapiens,Sentrin-specific protease 8,9606.0,,,IC50,uM,UO_0000065,,100.0
66867,,inconclusive,11974944,[],CHEMBL2114836,PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,,Potency,nM,,35481.3,CHEMBL2146310,Human immunodeficiency virus 1,Aberrant vpr protein,11676.0,,,Potency,uM,UO_0000065,,35.4813
66868,,inconclusive,11993220,[],CHEMBL2114836,PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,,Potency,nM,,3548.1,CHEMBL2146310,Human immunodeficiency virus 1,Aberrant vpr protein,11676.0,,,Potency,uM,UO_0000065,,3.5481
66869,,active,12015666,[],CHEMBL2114840,PubChem BioAssay. qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1010458,,7,1,,,Potency,nM,,21131.7,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,21.1317
66870,,,12072533,[],CHEMBL2162818,Increase in AMPKalpha phosphorylation in human HepG2 cells at 10 uM after 4 hrs by Western blot analysis relative to untreated control relative to total AMPKalpha level,B,,,BAO_0000179,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2157930,Bioorg Med Chem,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1735379,<=,1,0,<=,,FC,,,3.2,CHEMBL612545,,Unchecked,,,,FC,,,,3.2
66871,,Active,12072539,[],CHEMBL2162817,Increase in total AMPKalpha level in human HepG2 cells at 10 uM after 4 hrs by Western blot analysis relative to untreated control,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2157930,Bioorg Med Chem,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1735379,,1,0,,,Activity,,,,CHEMBL395,Homo sapiens,HepG2,9606.0,,,Activity,,,,
66872,,Active,12072540,[],CHEMBL2162816,Increase in AMPKalpha phosphorylation in human HepG2 cells at 10 uM after 4 hrs by Western blot analysis relative to untreated control,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2157930,Bioorg Med Chem,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1735379,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
66873,,,12072555,[],CHEMBL2162815,Up regulation of LDLR expression in human HepG2 cells at 10 uM after 12 hrs by RT-PCR relative to untreated control,F,,,BAO_0000179,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2157930,Bioorg Med Chem,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1735379,=,1,0,=,,FC,,,2.35,CHEMBL395,Homo sapiens,HepG2,9606.0,,,FC,,,,2.35
66874,,,12096404,[],CHEMBL2166033,Inhibition of amyloid beta (1 to 40) aggregation assessed as induction of disaggregation treated 45 mins after formation of aggregates by thioflavin T fluorescence method,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2163249,Bioorg Med Chem,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1736119,=,1,1,=,,IC50,nM,,105900.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,105.9
66875,,,12096408,[],CHEMBL2166028,Inhibition of HFIP-induced amyloid beta (1 to 40) aggregation after 45 mins by thioflavin T fluorescence method,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2163249,Bioorg Med Chem,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.36,0,http://www.openphacts.org/units/Nanomolar,1736119,=,1,1,=,,IC50,nM,,43840.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,43.84
66876,,,12096416,[],CHEMBL2166022,Inhibition of human AChE by Ellman's method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2163249,Bioorg Med Chem,2012.0,"{'bei': '18.48', 'le': '0.34', 'lle': '3.11', 'sei': '15.23'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,6.21,0,http://www.openphacts.org/units/Nanomolar,1736119,=,1,1,=,,IC50,nM,,610.0,CHEMBL220,Homo sapiens,Acetylcholinesterase,9606.0,,,IC50,uM,UO_0000065,,0.61
66877,,,12096419,[],CHEMBL2166020,Inhibition of electric eel AChE by Ellman's method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2163249,Bioorg Med Chem,2012.0,"{'bei': '16.54', 'le': '0.30', 'lle': '2.46', 'sei': '13.63'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.56,0,http://www.openphacts.org/units/Nanomolar,1736119,=,1,1,=,,IC50,nM,,2740.0,CHEMBL4078,Electrophorus electricus,Acetylcholinesterase,8005.0,,,IC50,uM,UO_0000065,,2.74
66878,,,12096544,[],CHEMBL2166270,Inhibition of electric eel AChE at 2 mg/ml by Ellman's method,B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2163249,Bioorg Med Chem,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1736119,=,1,1,=,,Inhibition,%,,79.03,CHEMBL4078,Electrophorus electricus,Acetylcholinesterase,8005.0,,,INH,%,UO_0000187,,79.03
66879,,,12097039,[],CHEMBL2166271,Inhibition of horse BChE at 2 mg/ml by Ellman's method,B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2163249,Bioorg Med Chem,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1736119,=,1,1,=,,Inhibition,%,,6.87,CHEMBL5763,Equus caballus,Cholinesterase,9796.0,,,INH,%,UO_0000187,,6.87
66880,,,12097444,[],CHEMBL2166032,Inhibition of HFIP-induced amyloid beta (1 to 40) aggregation at 20 uM after 45 mins by thioflavin T fluorescence method,B,,,BAO_0000201,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2163249,Bioorg Med Chem,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1736119,=,1,1,=,,Inhibition,%,,36.0,CHEMBL612545,,Unchecked,,,,INH,%,UO_0000187,,36.0
66881,,Not Determined,12097448,[],CHEMBL2166019,Inhibition of human BChE by Ellman's method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2163249,Bioorg Med Chem,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1736119,,1,0,,,IC50,,,,CHEMBL1914,Homo sapiens,Butyrylcholinesterase,9606.0,,,IC50,,,,
66882,,Not Active,12097462,[],CHEMBL2166018,Inhibition of horse BChE by Ellman's method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2163249,Bioorg Med Chem,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1736119,,1,0,,,IC50,,,,CHEMBL5763,Equus caballus,Cholinesterase,9796.0,,,IC50,,,,
66883,,,12416908,[],CHEMBL3050394,"Antihyperlipidemic activity in high fat-high cholesterol fed New Zealand Oryctolagus cuniculus (rabbit) assessed as total cholesterol level in blood at 15 mg/kg, po for 40 days (Rvb = 8.89 +/- 0.53 mmol/l)",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3046105,Med Chem Res,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1796368,=,1,0,=,,Activity,nmol/L,,7.94,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Activity,nmol/L,,,7.94
66884,,,12416914,[],CHEMBL3050390,"Antihyperlipidemic activity in high fat-high cholesterol fed New Zealand Oryctolagus cuniculus (rabbit) assessed as low-density lipoprotein-cholesterol level in blood at 15 mg/kg, po for 40 days (Rvb = 3.45 +/- 0.56 mmol/l)",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3046105,Med Chem Res,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1796368,=,1,0,=,,Activity,nmol/L,,3.27,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Activity,nmol/L,,,3.27
66885,,,12416927,[],CHEMBL3050392,"Antihyperlipidemic activity in high fat-high cholesterol fed New Zealand Oryctolagus cuniculus (rabbit) assessed as triglyceride level in blood at 15 mg/kg, po for 40 days (Rvb = 2.11 +/- 0.43 mmol/l)",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3046105,Med Chem Res,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1796368,=,1,0,=,,Activity,nmol/L,,2.02,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Activity,nmol/L,,,2.02
66886,,,12416947,[],CHEMBL3050388,"Antihyperlipidemic activity in high fat-high cholesterol fed New Zealand Oryctolagus cuniculus (rabbit) assessed as high-density lipoprotein-cholesterol level in blood at 15 mg/kg, po for 40 days (Rvb = 0.67 +/- 0.22 mmol/l)",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3046105,Med Chem Res,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1796368,=,1,0,=,,Activity,nmol/L,,0.7,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Activity,nmol/L,,,0.7
66887,,,12416952,[],CHEMBL3050395,Toxicity in Mus musculus Kunming (mouse),T,,,BAO_0002117,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3046105,Med Chem Res,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1796368,=,1,1,=,,LD50,mg.kg-1,,763.5,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,LD50,mg kg-1,UO_0000308,,763.5
66888,,Not Determined,12416983,[],CHEMBL3047744,Inhibition of HMGR isolated from Mus musculus (mouse) liver assessed as change in NADPH at 8 umol/l by HPLC analysis,B,,,BAO_0000201,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3046105,Med Chem Res,2012.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1796368,,1,0,,,Inhibition,%,,,CHEMBL2764,Mus musculus,HMG-CoA reductase,10090.0,,,INH,,UO_0000187,,
66889,,,12471990,[],CHEMBL3054823,Cytotoxicity against Mus musculus (mouse) L929 cells assessed as metabolically active cells at 200 ug/ml after 24 hr by MTT assay relative to control,F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3044997,Med Chem Res,2005.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1806567,=,1,0,=,,Activity,%,,23.57,CHEMBL612267,Mus musculus,L929,10090.0,,,Activity,%,UO_0000187,,23.57
66890,,,12471991,[],CHEMBL3054824,Cytotoxicity against Mus musculus (mouse) L929 cells assessed as metabolically active cells at 150 ug/ml after 24 hr by MTT assay relative to control,F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3044997,Med Chem Res,2005.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1806567,=,1,0,=,,Activity,%,,41.77,CHEMBL612267,Mus musculus,L929,10090.0,,,Activity,%,UO_0000187,,41.77
66891,,,12471992,[],CHEMBL3054825,Cytotoxicity against Mus musculus (mouse) L929 cells assessed as metabolically active cells at 100 ug/ml after 24 hr by MTT assay relative to control,F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3044997,Med Chem Res,2005.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1806567,=,1,0,=,,Activity,%,,67.41,CHEMBL612267,Mus musculus,L929,10090.0,,,Activity,%,UO_0000187,,67.41
66892,,,12471993,[],CHEMBL3054826,Cytotoxicity against Mus musculus (mouse) L929 cells assessed as metabolically active cells at 50 ug/ml after 24 hr by MTT assay relative to control,F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3044997,Med Chem Res,2005.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1806567,=,1,0,=,,Activity,%,,106.45,CHEMBL612267,Mus musculus,L929,10090.0,,,Activity,%,UO_0000187,,106.45
66893,,,12499794,[],CHEMBL3052686,Herbicidal activity against Lemna minor (common duckweed) at 1 ppm after 9 days relative to control,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3046565,Biosci Biotechnol Biochem,2000.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1819010,=,1,0,=,,Activity,%,,75.0,CHEMBL613216,Lemna minor,Lemna minor,4472.0,,,Activity,%,UO_0000187,,75.0
66894,,,12499817,[],CHEMBL3052687,Herbicidal activity against Agrostis stolonifera var. palustris at 1 ppm after 9 days relative to control,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3046565,Biosci Biotechnol Biochem,2000.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1819010,=,1,0,=,,Activity,%,,0.0,CHEMBL2366970,Agrostis stolonifera var. palustris,Agrostis stolonifera var. palustris,62759.0,,,Activity,%,UO_0000187,,0.0
66895,,,12499840,[],CHEMBL3052688,Antifungal activity against Ustilago maydis on rice plant at 25 ppm after 24 hr,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3046565,Biosci Biotechnol Biochem,2000.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1819010,=,1,1,=,,Inhibition,%,,0.0,CHEMBL612864,Ustilago maydis,Ustilago maydis,5270.0,,,INH,%,UO_0000187,,0.0
66896,,,12499863,[],CHEMBL3052689,Antifungal activity against Phytophthora infestans on rice plant at 25 ppm after 24 hr,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3046565,Biosci Biotechnol Biochem,2000.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1819010,=,1,1,=,,Inhibition,%,,0.0,CHEMBL613065,Phytophthora infestans,Phytophthora infestans,4787.0,,,INH,%,UO_0000187,,0.0
66897,,,12499886,[],CHEMBL3052691,Antifungal activity against Rhizoctonia solani on rice plant at 25 ppm after 24 hr,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3046565,Biosci Biotechnol Biochem,2000.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1819010,=,1,1,=,,Inhibition,%,,0.0,CHEMBL613272,Rhizoctonia solani,Rhizoctonia solani,456999.0,,,INH,%,UO_0000187,,0.0
66898,,,12499909,[],CHEMBL3052690,Antifungal activity against Magnaporthe oryzae on rice plant at 25 ppm after 24 hr,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3046565,Biosci Biotechnol Biochem,2000.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1819010,=,1,1,=,,Inhibition,%,,0.0,CHEMBL612925,Pyricularia oryzae,Pyricularia oryzae,318829.0,,,INH,%,UO_0000187,,0.0
66899,,,12499932,[],CHEMBL3052692,Antifungal activity against Zymoseptoria tritici on wheat plant at 25 ppm after 24 hr,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3046565,Biosci Biotechnol Biochem,2000.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1819010,=,1,1,=,,Inhibition,%,,90.0,CHEMBL2366940,Zymoseptoria tritici,Zymoseptoria tritici,1047171.0,,,INH,%,UO_0000187,,90.0
66900,,,12499955,[],CHEMBL3052693,Antifungal activity against Phaeosphaeria nodorum on wheat plant at 25 ppm after 24 hr,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3046565,Biosci Biotechnol Biochem,2000.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1819010,=,1,1,=,,Inhibition,%,,0.0,CHEMBL613772,Parastagonospora nodorum,Parastagonospora nodorum,13684.0,,,INH,%,UO_0000187,,0.0
66901,,,12499978,[],CHEMBL3052694,Antifungal activity against Puccinia recondita on wheat plant assessed as disease control at 100 ppm after 24 hr,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3046565,Biosci Biotechnol Biochem,2000.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1819010,=,1,0,=,,Activity,%,,0.0,CHEMBL613776,Puccinia recondita,Puccinia recondita,27348.0,,,Activity,%,UO_0000187,,0.0
66902,,,12502319,[],CHEMBL3052695,Antifungal activity against Phytophthora infestans on potato plant assessed as disease control at 100 ppm after 24 hr,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3046565,Biosci Biotechnol Biochem,2000.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1819010,=,1,0,=,,Activity,%,,0.0,CHEMBL613065,Phytophthora infestans,Phytophthora infestans,4787.0,,,Activity,%,UO_0000187,,0.0
66903,,,12502342,[],CHEMBL3052696,Antifungal activity against Phaeosphaeria nodorum on wheat plant assessed as disease control at 100 ppm after 24 hr,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3046565,Biosci Biotechnol Biochem,2000.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1819010,=,1,0,=,,Activity,%,,0.0,CHEMBL613772,Parastagonospora nodorum,Parastagonospora nodorum,13684.0,,,Activity,%,UO_0000187,,0.0
66904,,,12502365,[],CHEMBL3052697,Antifungal activity against Blumeria graminis f. sp. tritici on wheat plant assessed as disease control at 100 ppm after 24 hr,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3046565,Biosci Biotechnol Biochem,2000.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1819010,=,1,0,=,,Activity,%,,0.0,CHEMBL2367093,Blumeria graminis f. sp. tritici,Blumeria graminis f. sp. tritici,62690.0,,,Activity,%,UO_0000187,,0.0
66905,,,12628161,[],CHEMBL2320381,Induction of apoptosis in human HepG2 cells assessed as late apoptotic cells at 1 uM after 24 hrs using annexin-V/FITC/propidium iodide staining by flow cytometry analysis (Rvb = 3.16%),F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2311303,Bioorg Med Chem Lett,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1843261,=,1,0,=,,Activity,%,,5.51,CHEMBL395,Homo sapiens,HepG2,9606.0,,,Activity,%,UO_0000187,,5.51
66906,,,12628163,[],CHEMBL2320382,Induction of apoptosis in human HepG2 cells assessed as early apoptotic cells at 1 uM after 24 hrs using annexin-V/FITC/propidium iodide staining by flow cytometry analysis (Rvb = 2.05%),F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2311303,Bioorg Med Chem Lett,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1843261,=,1,0,=,,Activity,%,,3.77,CHEMBL395,Homo sapiens,HepG2,9606.0,,,Activity,%,UO_0000187,,3.77
66907,,,12628165,[],CHEMBL2320383,Induction of apoptosis in human HepG2 cells assessed as viable cells at 1 uM after 24 hrs using annexin-V/FITC/propidium iodide staining by flow cytometry analysis (Rvb = 94.29%),F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2311303,Bioorg Med Chem Lett,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1843261,=,1,0,=,,Activity,%,,88.83,CHEMBL395,Homo sapiens,HepG2,9606.0,,,Activity,%,UO_0000187,,88.83
66908,,,12628167,[],CHEMBL2320384,Induction of apoptosis in human HepG2 cells assessed as necrotic cells at 1 uM after 24 hrs using annexin-V/FITC/propidium iodide staining by flow cytometry analysis (Rvb = 0.51%),F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2311303,Bioorg Med Chem Lett,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1843261,=,1,0,=,,Activity,%,,1.88,CHEMBL395,Homo sapiens,HepG2,9606.0,,,Activity,%,UO_0000187,,1.88
66909,,,12628169,[],CHEMBL2320385,Induction of apoptosis in human HepG2 cells assessed as late apoptotic cells at 0.5 uM after 24 hrs using annexin-V/FITC/propidium iodide staining by flow cytometry analysis (Rvb = 3.16%),F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2311303,Bioorg Med Chem Lett,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1843261,=,1,0,=,,Activity,%,,4.49,CHEMBL395,Homo sapiens,HepG2,9606.0,,,Activity,%,UO_0000187,,4.49
66910,,,12628171,[],CHEMBL2320386,Induction of apoptosis in human HepG2 cells assessed as early apoptotic cells at 0.5 uM after 24 hrs using annexin-V/FITC/propidium iodide staining by flow cytometry analysis (Rvb = 2.05%),F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2311303,Bioorg Med Chem Lett,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1843261,=,1,0,=,,Activity,%,,4.39,CHEMBL395,Homo sapiens,HepG2,9606.0,,,Activity,%,UO_0000187,,4.39
66911,,,12628173,[],CHEMBL2320387,Induction of apoptosis in human HepG2 cells assessed as viable cells at 0.5 uM after 24 hrs using annexin-V/FITC/propidium iodide staining by flow cytometry analysis (Rvb = 94.29%),F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2311303,Bioorg Med Chem Lett,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1843261,=,1,0,=,,Activity,%,,89.95,CHEMBL395,Homo sapiens,HepG2,9606.0,,,Activity,%,UO_0000187,,89.95
66912,,,12628175,[],CHEMBL2320388,Induction of apoptosis in human HepG2 cells assessed as necrotic cells at 0.5 uM after 24 hrs using annexin-V/FITC/propidium iodide staining by flow cytometry analysis (Rvb = 0.51%),F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2311303,Bioorg Med Chem Lett,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1843261,=,1,0,=,,Activity,%,,1.17,CHEMBL395,Homo sapiens,HepG2,9606.0,,,Activity,%,UO_0000187,,1.17
66913,,,12628177,[],CHEMBL2320389,Induction of apoptosis in human HepG2 cells assessed as late apoptotic cells at 0.25 uM after 24 hrs using annexin-V/FITC/propidium iodide staining by flow cytometry analysis (Rvb = 3.16%),F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2311303,Bioorg Med Chem Lett,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1843261,=,1,0,=,,Activity,%,,6.4,CHEMBL395,Homo sapiens,HepG2,9606.0,,,Activity,%,UO_0000187,,6.4
66914,,,12628179,[],CHEMBL2317887,Induction of apoptosis in human HepG2 cells assessed as early apoptotic cells at 0.25 uM after 24 hrs using annexin-V/FITC/propidium iodide staining by flow cytometry analysis (Rvb = 2.05%),F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2311303,Bioorg Med Chem Lett,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1843261,=,1,0,=,,Activity,%,,2.99,CHEMBL395,Homo sapiens,HepG2,9606.0,,,Activity,%,UO_0000187,,2.99
66915,,,12628181,[],CHEMBL2317888,Induction of apoptosis in human HepG2 cells assessed as viable cells at 0.25 uM after 24 hrs using annexin-V/FITC/propidium iodide staining by flow cytometry analysis (Rvb = 94.29%),F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2311303,Bioorg Med Chem Lett,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1843261,=,1,0,=,,Activity,%,,89.77,CHEMBL395,Homo sapiens,HepG2,9606.0,,,Activity,%,UO_0000187,,89.77
66916,,,12628183,[],CHEMBL2317889,Induction of apoptosis in human HepG2 cells assessed as necrotic cells at 0.25 uM after 24 hrs using annexin-V/FITC/propidium iodide staining by flow cytometry analysis (Rvb = 0.51%),F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2311303,Bioorg Med Chem Lett,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1843261,=,1,0,=,,Activity,%,,0.84,CHEMBL395,Homo sapiens,HepG2,9606.0,,,Activity,%,UO_0000187,,0.84
66917,,Active,12628184,[],CHEMBL2317890,Induction of apoptosis in human HepG2 cells assessed as morphological changes at 20 uM after 24 hrs using Hoechst 33258 staining by fluorescence microscopic analysis,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2311303,Bioorg Med Chem Lett,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1843261,,1,0,,,Activity,,,,CHEMBL395,Homo sapiens,HepG2,9606.0,,,Activity,,,,
66918,,,12628198,[],CHEMBL2317895,Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2311303,Bioorg Med Chem Lett,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.07,0,http://www.openphacts.org/units/Nanomolar,1843261,=,1,1,=,,IC50,nM,,8450.0,CHEMBL384,Homo sapiens,HT-29,9606.0,,,IC50,uM,UO_0000065,,8.45
66919,,,12628206,[],CHEMBL2317897,Cytotoxicity against human HT-29 cells after 24 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2311303,Bioorg Med Chem Lett,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1843261,>,1,1,>,,IC50,nM,,20000.0,CHEMBL384,Homo sapiens,HT-29,9606.0,,,IC50,uM,UO_0000065,,20.0
66920,,,12628214,[],CHEMBL2317899,Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2311303,Bioorg Med Chem Lett,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.08,0,http://www.openphacts.org/units/Nanomolar,1843261,=,1,1,=,,IC50,nM,,8320.0,CHEMBL395,Homo sapiens,HepG2,9606.0,,,IC50,uM,UO_0000065,,8.32
66921,,,12628222,[],CHEMBL2317898,Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2311303,Bioorg Med Chem Lett,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.95,0,http://www.openphacts.org/units/Nanomolar,1843261,=,1,1,=,,IC50,nM,,11220.0,CHEMBL395,Homo sapiens,HepG2,9606.0,,,IC50,uM,UO_0000065,,11.22
66922,,active,12758730,[],CHEMBL2354221,PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,,Potency,nM,,1299.5,CHEMBL1075138,Homo sapiens,Tyrosyl-DNA phosphodiesterase 1,9606.0,,,Potency,uM,UO_0000065,,1.2995
66923,,inconclusive,12792294,[],CHEMBL2354211,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,,Potency,nM,,4109.5,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,4.1095
66924,,active,12879226,[],CHEMBL2354221,PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1157909,,7,1,,,Potency,nM,,819.9,CHEMBL1075138,Homo sapiens,Tyrosyl-DNA phosphodiesterase 1,9606.0,,,Potency,uM,UO_0000065,,0.8199
66925,,active,12890337,[],CHEMBL2354221,PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1859865,,7,1,,,Potency,nM,,1333.6,CHEMBL1075138,Homo sapiens,Tyrosyl-DNA phosphodiesterase 1,9606.0,,,Potency,uM,UO_0000065,,1.3336
66926,,active,12893324,[],CHEMBL2354221,PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,,Potency,nM,,2310.9,CHEMBL1075138,Homo sapiens,Tyrosyl-DNA phosphodiesterase 1,9606.0,,,Potency,uM,UO_0000065,,2.3109
66927,,active,13019190,[],CHEMBL2354254,PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,,Potency,nM,,1158.2,CHEMBL1075138,Homo sapiens,Tyrosyl-DNA phosphodiesterase 1,9606.0,,,Potency,uM,UO_0000065,,1.1582
66928,,active,13146111,[],CHEMBL2354254,PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1157909,,7,1,,,Potency,nM,,1032.3,CHEMBL1075138,Homo sapiens,Tyrosyl-DNA phosphodiesterase 1,9606.0,,,Potency,uM,UO_0000065,,1.0323
66929,,active,13164350,[],CHEMBL2354254,PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1859865,,7,1,,,Potency,nM,,1496.3,CHEMBL1075138,Homo sapiens,Tyrosyl-DNA phosphodiesterase 1,9606.0,,,Potency,uM,UO_0000065,,1.4963
66930,,active,13169990,[],CHEMBL2354285,PubChem BioAssay. FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000217,biochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.62,0,http://www.openphacts.org/units/Nanomolar,1042837,=,7,1,=,,AC50,nM,,2380.0,CHEMBL2362978,Homo sapiens,DNA repair protein RAD52 homolog,9606.0,,,AC50,uM,UO_0000065,,2.38
66931,,active,13177248,[],CHEMBL2354285,PubChem BioAssay. FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000217,biochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.25,0,http://www.openphacts.org/units/Nanomolar,1264003,=,7,1,=,,AC50,nM,,5690.0,CHEMBL2362978,Homo sapiens,DNA repair protein RAD52 homolog,9606.0,,,AC50,uM,UO_0000065,,5.69
66932,,active,13189524,[],CHEMBL2354254,PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,,Potency,nM,,3662.6,CHEMBL1075138,Homo sapiens,Tyrosyl-DNA phosphodiesterase 1,9606.0,,,Potency,uM,UO_0000065,,3.6626
66933,,inconclusive,13194993,[],CHEMBL2354311,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,,Potency,nM,,2310.9,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606.0,,,Potency,uM,UO_0000065,,2.3109
66934,,,13368837,[],CHEMBL2405158,Antifungal activity against Candida mycoderma after 24 hrs by twofold broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2401717,Bioorg Med Chem,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904718,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612867,Candida,Candida,5475.0,,,MIC,ug ml-1,UO_0000274,,128.0
66935,,,13368861,[],CHEMBL2405160,Antifungal activity against Candida albicans after 24 hrs by twofold broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2401717,Bioorg Med Chem,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904718,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,ug ml-1,UO_0000274,,512.0
66936,,,13368884,[],CHEMBL2405159,Antibacterial activity against Proteus vulgaris after 24 hrs by twofold broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2401717,Bioorg Med Chem,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904718,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,128.0
66937,,,13370086,[],CHEMBL2405161,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by twofold broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2401717,Bioorg Med Chem,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904718,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,256.0
66938,,,13370110,[],CHEMBL2405162,Antibacterial activity against Shigella dysenteriae after 24 hrs by twofold broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2401717,Bioorg Med Chem,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904718,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL612619,Shigella dysenteriae,Shigella dysenteriae,622.0,,,MIC,ug ml-1,UO_0000274,,256.0
66939,,,13370134,[],CHEMBL2405163,Antibacterial activity against Escherichia coli DH52 after 24 hrs by twofold broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2401717,Bioorg Med Chem,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904718,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
66940,,,13370158,[],CHEMBL2405164,Antibacterial activity against Micrococcus luteus ATCC 4698 after 24 hrs by twofold broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2401717,Bioorg Med Chem,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904718,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,512.0
66941,,,13370182,[],CHEMBL2405165,Antibacterial activity against Bacillus subtilis after 24 hrs by twofold broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2401717,Bioorg Med Chem,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904718,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,512.0
66942,,,13370206,[],CHEMBL2405166,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by twofold broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2401717,Bioorg Med Chem,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904718,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,512.0
66943,,,13370230,[],CHEMBL2405167,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 after 24 hrs by twofold broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2401717,Bioorg Med Chem,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904718,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
66944,,,13415823,[],CHEMBL2423042,Inhibition of amyloid beta (1-42) (unknown origin) aggregation at 20 uM after 48 hrs by thioflavin-T based fluorimetric assay relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2417460,Bioorg Med Chem,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1913816,=,1,1,=,,Inhibition,%,,35.5,CHEMBL2487,Homo sapiens,Amyloid-beta A4 protein,9606.0,,,INH,%,UO_0000187,,35.5
66945,,,13415836,[],CHEMBL2423045,Antioxidant activity assessed as ratio of umol of trolox equivalent to umol of compound after 10 mins by oxygen radical absorbance capacity-fluorescein assay,F,,,BAO_0000181,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2417460,Bioorg Med Chem,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1913816,=,1,0,=,,Activity,equiv,,0.4,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,equiv,,,0.4
66946,,,13415857,[],CHEMBL2424418,Selectivity ratio of IC50 for equine serum BChE to IC50 for electric eel AChE,B,,,BAO_0000179,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2417460,Bioorg Med Chem,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1913816,=,1,0,=,,Ratio IC50,,,48.82,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,48.82
66947,,,13415872,[],CHEMBL2424419,Inhibition of equine serum BChE using butylthiocholine chloride as substrate preincubated for 15 mins prior to substrate addition by Ellman's method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2417460,Bioorg Med Chem,2013.0,"{'bei': '14.09', 'le': '0.26', 'lle': '1.64', 'sei': '11.62'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.74,0,http://www.openphacts.org/units/Nanomolar,1913816,=,1,1,=,,IC50,nM,,18210.0,CHEMBL5763,Equus caballus,Cholinesterase,9796.0,,,IC50,uM,UO_0000065,,18.21
66948,,,13415887,[],CHEMBL2424420,Inhibition of electric eel AChE using acetylthiocholine chloride as substrate preincubated for 15 mins prior to substrate addition by Ellman's method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2417460,Bioorg Med Chem,2013.0,"{'bei': '19.11', 'le': '0.35', 'lle': '3.33', 'sei': '15.75'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,6.43,1,http://www.openphacts.org/units/Nanomolar,1913816,=,1,1,=,,IC50,nM,,374.0,CHEMBL4078,Electrophorus electricus,Acetylcholinesterase,8005.0,,,IC50,uM,UO_0000065,,0.374
66949,,,13451228,[],CHEMBL2429123,Antibacterial activity against SCCmec type 3 genotype-positive and methicillin-resistant Staphylococcus aureus clinical isolates after 24 hrs by chequerboard method in presence of levofloxacin,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2424578,Med Chem Res,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1918259,=,1,0,=,,FICI90,,,0.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FICI90,,,,0.75
66950,,,13451229,[],CHEMBL2429124,Antibacterial activity against SCCmec type 3 genotype-positive and methicillin-resistant Staphylococcus aureus clinical isolates after 24 hrs by chequerboard method in presence of cefazolin,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2424578,Med Chem Res,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1918259,=,1,0,=,,FICI90,,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FICI90,,,,2.0
66951,,,13451230,[],CHEMBL2429125,Antibacterial activity against SCCmec type 3 genotype-positive and methicillin-resistant Staphylococcus aureus clinical isolates after 24 hrs by chequerboard method in presence of azithromycin,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2424578,Med Chem Res,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1918259,=,1,0,=,,FICI90,,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FICI90,,,,0.5
66952,,,13451231,[],CHEMBL2429126,Antibacterial activity against SCCmec type 3 genotype-positive and methicillin-resistant Staphylococcus aureus clinical isolates after 24 hrs by chequerboard method in presence of ampicillin,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2424578,Med Chem Res,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1918259,=,1,0,=,,FICI90,,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FICI90,,,,2.0
66953,,,13451232,[],CHEMBL2429123,Antibacterial activity against SCCmec type 3 genotype-positive and methicillin-resistant Staphylococcus aureus clinical isolates after 24 hrs by chequerboard method in presence of levofloxacin,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2424578,Med Chem Res,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1918259,=,1,0,=,,FICI50,,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FICI50,,,,0.5
66954,,,13451233,[],CHEMBL2429124,Antibacterial activity against SCCmec type 3 genotype-positive and methicillin-resistant Staphylococcus aureus clinical isolates after 24 hrs by chequerboard method in presence of cefazolin,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2424578,Med Chem Res,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1918259,=,1,0,=,,FICI50,,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FICI50,,,,2.0
66955,,,13451234,[],CHEMBL2429125,Antibacterial activity against SCCmec type 3 genotype-positive and methicillin-resistant Staphylococcus aureus clinical isolates after 24 hrs by chequerboard method in presence of azithromycin,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2424578,Med Chem Res,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1918259,=,1,0,=,,FICI50,,,0.313,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FICI50,,,,0.313
66956,,,13451235,[],CHEMBL2429126,Antibacterial activity against SCCmec type 3 genotype-positive and methicillin-resistant Staphylococcus aureus clinical isolates after 24 hrs by chequerboard method in presence of ampicillin,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2424578,Med Chem Res,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1918259,=,1,0,=,,FICI50,,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FICI50,,,,2.0
66957,,,13451236,[],CHEMBL2429127,Antibacterial activity against SCCmec type 3 genotype-positive and methicillin-resistant Staphylococcus aureus clinical isolates after 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2424578,Med Chem Res,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1918259,=,1,0,=,,MBC,ug ml-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,64.0
66958,,,13451247,[],CHEMBL2429123,Antibacterial activity against SCCmec type 3 genotype-positive and methicillin-resistant Staphylococcus aureus clinical isolates after 24 hrs by chequerboard method in presence of levofloxacin,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2424578,Med Chem Res,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1918259,=,1,0,=,,FICI,,,0.375,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FICI,,,,0.375
66959,,,13451248,[],CHEMBL2429124,Antibacterial activity against SCCmec type 3 genotype-positive and methicillin-resistant Staphylococcus aureus clinical isolates after 24 hrs by chequerboard method in presence of cefazolin,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2424578,Med Chem Res,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1918259,=,1,0,=,,FICI,,,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FICI,,,,1.5
66960,,,13451249,[],CHEMBL2429125,Antibacterial activity against SCCmec type 3 genotype-positive and methicillin-resistant Staphylococcus aureus clinical isolates after 24 hrs by chequerboard method in presence of azithromycin,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2424578,Med Chem Res,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1918259,=,1,0,=,,FICI,,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FICI,,,,0.25
66961,,,13451250,[],CHEMBL2429126,Antibacterial activity against SCCmec type 3 genotype-positive and methicillin-resistant Staphylococcus aureus clinical isolates after 24 hrs by chequerboard method in presence of ampicillin,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2424578,Med Chem Res,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1918259,=,1,0,=,,FICI,,,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FICI,,,,1.5
66962,,,13451251,[],CHEMBL2429127,Antibacterial activity against SCCmec type 3 genotype-positive and methicillin-resistant Staphylococcus aureus clinical isolates after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2424578,Med Chem Res,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1918259,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
66963,,,13473638,[],CHEMBL2439627,Cytotoxicity against human KB cells after 48 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2434919,Med Chem Res,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.22,0,http://www.openphacts.org/units/Nanomolar,1923295,=,1,1,=,,IC50,nM,,6030.0,CHEMBL398,Homo sapiens,KB,9606.0,,,IC50,uM,UO_0000065,,6.03
66964,,,13473646,[],CHEMBL2439628,Cytotoxicity against human Bel7402 cells after 48 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2434919,Med Chem Res,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.79,0,http://www.openphacts.org/units/Nanomolar,1923295,=,1,1,=,,IC50,nM,,16280.0,CHEMBL614279,Homo sapiens,Bel-7402,9606.0,,,IC50,uM,UO_0000065,,16.28
66965,,,13473654,[],CHEMBL2439629,Cytotoxicity against human BGC823 cells after 48 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2434919,Med Chem Res,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.15,0,http://www.openphacts.org/units/Nanomolar,1923295,=,1,1,=,,IC50,nM,,7040.0,CHEMBL614526,Homo sapiens,BGC-823,9606.0,,,IC50,uM,UO_0000065,,7.04
66966,,,13473662,[],CHEMBL2439630,Cytotoxicity against human HL60 cells after 48 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL2434919,Med Chem Res,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.23,0,http://www.openphacts.org/units/Nanomolar,1923295,=,1,1,=,,IC50,nM,,5830.0,CHEMBL383,Homo sapiens,HL-60,9606.0,,,IC50,uM,UO_0000065,,5.83
66967,,,13799429,[],CHEMBL3039488,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,A,,,BAO_0000201,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3039007,Mol Pharmacol,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1936770,=,1,1,=,,Inhibition,%,,110.43,CHEMBL1697668,Homo sapiens,Solute carrier organic anion transporter family member 1B1,9606.0,,,Inhibition,%,UO_0000187,,110.4336369
66968,,,13801428,[],CHEMBL3039491,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,A,,,BAO_0000201,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3039007,Mol Pharmacol,2013.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,1936770,=,1,1,=,,Inhibition,%,,108.45,CHEMBL1743121,Homo sapiens,Solute carrier organic anion transporter family member 1B3,9606.0,,,Inhibition,%,UO_0000187,,108.4455241
66969,,,13971274,[],CHEMBL3136544,Binding affinity to duplex DNA (unknown origin) assessed as change in melting temperature,B,,,BAO_0000179,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3132805,Medchemcomm,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#DegreeCelsius,1976508,=,1,1,=,,Delta Tm,degrees C,,13.0,CHEMBL612545,,Unchecked,,,,deltaTm,degrees C,UO_0000027,,13.0
66970,,inactive,14113494,[],CHEMBL3215106,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,,Potency,nM,,39810.7,CHEMBL1793,Homo sapiens,Parathyroid hormone receptor,9606.0,,,Potency,uM,UO_0000065,,39.8107
66971,,active,14183964,[],CHEMBL3215169,PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) ,B,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1859865,,7,1,,,Potency,nM,,25118.9,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,25.1189
66972,,active,14184174,[],CHEMBL3215169,PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) ,B,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1157909,,7,1,,,Potency,nM,,11220.2,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,11.2202
66973,,inconclusive,14225411,[],CHEMBL1614166,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,B,,,BAO_0000186,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,,Potency,nM,,7943.3,CHEMBL1293317,Homo sapiens,Muscleblind-like protein 1,9606.0,,,Potency,uM,UO_0000065,,7.9433
66974,,inconclusive,14301765,[],CHEMBL3215270,PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS.   (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,,Potency,nM,,7943.3,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,7.9433
66975,,inconclusive,14302152,[],CHEMBL3215270,PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS.   (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1157909,,7,1,,,Potency,nM,,10000.0,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,10.0
66976,,inconclusive,14309006,[],CHEMBL3215270,PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS.   (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,,Potency,nM,,11220.2,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,11.2202
66977,,inconclusive,14417961,[],CHEMBL3214875,PubChem BioAssay. qHTS Assay for the Inhibitors of FEN1: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,,Potency,nM,,37933.0,CHEMBL5027,Homo sapiens,Flap endonuclease 1,9606.0,,,Potency,uM,UO_0000065,,37.933
66978,,inconclusive,14433807,[],CHEMBL3214913,PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) ,B,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1859865,,7,1,,,Potency,nM,,28183.8,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,28.1838
66979,,active,14437625,[],CHEMBL3214913,PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) ,B,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1157909,,7,1,,,Potency,nM,,10000.0,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,10.0
66980,,inconclusive,14458372,[],CHEMBL3214970,PubChem BioAssay. qHTS Assay for Identifying Gametocytocidal Compounds.   (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1859865,,7,1,,,Potency,nM,,19952.6,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,19.9526
66981,,,14584155,[],CHEMBL3243534,Reversal of high glucose-induced insulin resistance in mouse 3T3L1 cells assessed as relative sensitization rate at 10 umol/ml relative to rosiglitazone,F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3232971,Bioorg Med Chem Lett,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,2081372,=,1,0,=,,Activity,%,,74.23,CHEMBL614510,Mus musculus,3T3-L1,10090.0,,,Activity,%,UO_0000187,,74.23
66982,,,14584156,[],CHEMBL3243535,Reversal of high glucose-induced insulin resistance in mouse 3T3L1 cells assessed as relative sensitization rate at 1 umol/ml relative to rosiglitazone,F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3232971,Bioorg Med Chem Lett,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,2081372,=,1,0,=,,Activity,%,,13.27,CHEMBL614510,Mus musculus,3T3-L1,10090.0,,,Activity,%,UO_0000187,,13.27
66983,,,14584157,[],CHEMBL3243536,Reversal of high glucose-induced insulin resistance in mouse 3T3L1 cells assessed as relative sensitization rate at 0.10 umol/ml relative to rosiglitazone,F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3232971,Bioorg Med Chem Lett,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,2081372,=,1,0,=,,Activity,%,,-2.93,CHEMBL614510,Mus musculus,3T3-L1,10090.0,,,Activity,%,UO_0000187,,-2.93
66984,,,14584158,[],CHEMBL3243537,Increase in glucose transport in rat L6 cells assessed as sensitization rate at 10 umol/ml,F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3232971,Bioorg Med Chem Lett,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,2081372,=,1,0,=,,Activity,%,,43.28,CHEMBL614793,Rattus norvegicus,L6,10116.0,,,Activity,%,UO_0000187,,43.28
66985,,,14584159,[],CHEMBL3243538,Increase in glucose transport in rat L6 cells assessed as sensitization rate at 1 umol/ml,F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3232971,Bioorg Med Chem Lett,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,2081372,=,1,0,=,,Activity,%,,21.3,CHEMBL614793,Rattus norvegicus,L6,10116.0,,,Activity,%,UO_0000187,,21.3
66986,,,14653948,[],CHEMBL3268232,Solubility of the compound in sodium phosphate buffer at pH 8.6 at 25 degC after 1 week by HPLC-ESIMS/MS analysis,P,,,BAO_0002135,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,2100573,=,1,1,=,,Solubility,nM,,9600000.0,CHEMBL2362975,,No relevant target,,,,solubility,mM,UO_0000065,,9.6
66987,,,14653952,[],CHEMBL3268233,Solubility of the compound in sodium phosphate buffer at pH 7 at 25 degC after 1 week by HPLC-ESIMS/MS analysis,P,,,BAO_0002135,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,2100573,=,1,1,=,,Solubility,nM,,9000000.0,CHEMBL2362975,,No relevant target,,,,solubility,mM,UO_0000065,,9.0
66988,,,14653956,[],CHEMBL3268234,Solubility of the compound in sodium phosphate buffer at pH 6 at 25 degC after 1 week by HPLC-ESIMS/MS analysis,P,,,BAO_0002135,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,2100573,=,1,1,=,,Solubility,nM,,7600000.0,CHEMBL2362975,,No relevant target,,,,solubility,mM,UO_0000065,,7.6
66989,,,14653960,[],CHEMBL3268235,Solubility of the compound in sodium phosphate buffer at pH 4.5 at 25 degC after 1 week by HPLC-ESIMS/MS analysis,P,,,BAO_0002135,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,2100573,=,1,1,=,,Solubility,nM,,8200000.0,CHEMBL2362975,,No relevant target,,,,solubility,mM,UO_0000065,,8.2
66990,,,14653964,[],CHEMBL3268236,"1-Octanol-water partition coefficient, log P of the compound at pH 8.6 after 1 week by HPLC-ESIMS/MS analysis",P,,,BAO_0002130,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2100573,=,1,1,=,,LogP,,,-1.2,CHEMBL2362975,,No relevant target,,,,logP,,,,-1.2
66991,,,14653969,[],CHEMBL3268237,"1-Octanol-water partition coefficient, log P of the compound at pH 7 after 1 week by HPLC-ESIMS/MS analysis",P,,,BAO_0002130,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2100573,=,1,1,=,,LogP,,,-1.2,CHEMBL2362975,,No relevant target,,,,logP,,,,-1.2
66992,,,14653974,[],CHEMBL3268238,"1-Octanol-water partition coefficient, log P of the compound at pH 6 after 1 week by HPLC-ESIMS/MS analysis",P,,,BAO_0002130,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2100573,=,1,1,=,,LogP,,,-1.2,CHEMBL2362975,,No relevant target,,,,logP,,,,-1.2
66993,,,14653979,[],CHEMBL3268239,"1-Octanol-water partition coefficient, log P of the compound at pH 4.5 after 1 week by HPLC-ESIMS/MS analysis",P,,,BAO_0002130,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2100573,=,1,1,=,,LogP,,,-1.2,CHEMBL2362975,,No relevant target,,,,logP,,,,-1.2
66994,,,14653984,[],CHEMBL3268240,"1-Octanol-water distribution coefficient, log D of the compound at pH 8.6 after 1 week by HPLC-ESIMS/MS analysis",P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2100573,=,1,1,=,,LogD,,,-1.2,CHEMBL2362975,,No relevant target,,,,logD,,,,-1.2
66995,,,14653989,[],CHEMBL3268241,"1-Octanol-water distribution coefficient, log D of the compound at pH 7 after 1 week by HPLC-ESIMS/MS analysis",P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2100573,=,1,1,=,,LogD,,,-1.2,CHEMBL2362975,,No relevant target,,,,logD,,,,-1.2
66996,,,14653994,[],CHEMBL3268242,"1-Octanol-water distribution coefficient, log D of the compound at pH 6 after 1 week by HPLC-ESIMS/MS analysis",P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2100573,=,1,1,=,,LogD,,,-1.2,CHEMBL2362975,,No relevant target,,,,logD,,,,-1.2
66997,,,14653999,[],CHEMBL3268243,"1-Octanol-water distribution coefficient, log D of the compound at pH 4.5 after 1 week by HPLC-ESIMS/MS analysis",P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2100573,=,1,1,=,,LogD,,,-1.2,CHEMBL2362975,,No relevant target,,,,logD,,,,-1.2
66998,,,14654004,[],CHEMBL3268244,Binding affinity to bovine serum albumin by fluorescence quenching assay,A,,,BAO_0000587,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2100573,=,1,0,=,,Kb,10'3L/mol,,3.37,CHEMBL3728,Bos taurus,Serum albumin,9913.0,,,Kb,10'3L/mol,,,3.37
66999,,,14654009,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '500.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL3268245,"Cmax in human plasma at 500 mg, po by HPLC-ESIMS/MS analysis",A,,,BAO_0002119,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,2100573,=,1,1,=,,Cmax,nM,,0.07,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,Cmax,nM,UO_0000065,,0.07
